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EXECUTIVE SUMMARY  
Project Aims 
This project aimed to understand experiences of stigma and discrimination for people 
experiencing problematic alcohol and other drug (AOD) use in Queensland. Specifically, the 
research examined:  
• Experiences of stigma and discrimination;  
• The potential for legislation to be stigmatising; 
• The settings and sectors in which stigma and discrimination occur;   
• The impacts of stigma and discrimination on health and wellbeing and in particular on 
recovery and the ability to reconnect with the community; and  
• Circumstances where stigma is not experienced, and evidence of what works to address 
stigma and discrimination.   
 
In this report, stigma and discrimination are defined as follows: 
 
Stigma is labelling and stereotyping of difference, at both an individual and structural 
societal level, that leads to status loss (including exclusion, rejection and discrimination). 
 
Discrimination is the lived effects of stigma – the negative material and social outcomes 
that arise from experiences of stigma. 
 
Both stigma and discrimination rely on societal structures and systems that facilitate and 
create the conditions for their operation (for example unequal power is one such 
condition). 
 
In this project we sought to identify effective ways to reduce stigma and discrimination and 
provide recommendations derived from the research findings to support implementation actions 
by the Queensland government.  
 
Methods 
The project consisted of three interrelated components. These were: 
1. Literature review;   
2. Analysis of legislation; and  
3. In-depth qualitative interviews and analytical case studies based on interviews.   
The literature review involved analysing international and Australian research pertaining to: 
definitions of stigma and discrimination; manifestations and experiences of stigma; how stigma is 
experienced by people who use AOD; considerations of stigma and the law; and effective 
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stigma-reducing interventions (drawing on findings from across the AOD, mental health and 
HIV/AIDS fields). 
The analysis of Queensland legislation involved a three-step methodology to capture the full 
range of legislative provisions that deal with AOD in Queensland, establishing the focus of these 
provisions, and then examining the stigmatising and/or discriminatory potential of law. 
Using in-depth qualitative interviews (N = 21) with people experiencing AOD problems in 
Queensland, the third component of the project involved documenting participants’ perceptions 
and experiences of how stigma presents and manifests (including positive experiences where it 
was not experienced) and identifying the settings and sectors where stigma and discrimination 
occurs in participants’ lives (including but not limited to health services, housing, justice, 
education and employment, other social support services and in the broader community). 
Analytical case studies were built using narrative techniques. Interview participants were 
recruited through treatment services and needle and syringe programs across Queensland. 
Results 
Identifying experiences of stigma and discrimination for people with problematic AOD use in Queensland:   
• Experiences of stigma and discrimination were a common occurrence in the everyday 
lives of participants. Every participant could describe, in detail, multiple specific times 
that they had been judged, treated badly, looked down upon or excluded because of 
problematic AOD use;  
• When participants were asked how experiences of stigma and discrimination made them 
feel, they described feelings of degradation, shame and anger; 
• The frequency and commonplace nature of these experiences did not make them any less 
distressing for participants. These experiences had profound effects in participants’ lives. 
These effects were not superficial and cannot be dismissed as insignificant. Experiences 
of exclusion, marginalisation, and discrimination impacted on participants’ access to 
health care (including treatment) and other services, fair treatment in the justice system, 
employment opportunities, and relationships with family, friends and community; 
• Stigma affected drug use. It did not discourage AOD use and was not a motivator for 
getting help. Many participants talked about how stigma and discrimination made them 
feel worthless and hopeless, which in turn triggered them to use alcohol or other drugs 
or give up on seeking change in their lives; 
• Stigma was a barrier to help-seeking, even at times when participants had felt they really 
needed it. Experiences of stigma and discrimination at the moment of help-seeking (for 
example, from health care workers, doctors, psychologists, welfare services, or even 
AOD treatment providers) discouraged participants from seeking help again; 
• Not all problematic AOD use was stigmatised in the same way. Some individuals felt that 
particular groups of people and behaviours were more stigmatised and marginalised than 
others, even amongst those with experience of problematic AOD use. This accords with 
what has been described in the literature as ‘within group’ stigma; 
• Participants could also identify interactions and experiences where stigma had not been 
present. When participants spoke about these positive experiences, they felt understood 
and experienced a different kind of ‘care’. Being seen as a ‘normal’ patient in clinical 
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settings, not as a ‘just a drug user’ or ‘just an alcoholic’ was particularly important. 
Positive experiences in work environments were characterised by employers being 
supportive of participants’ requests to take a leave of absence to seek help, pathways into 
support such as access to confidential counselling through employee assistance 
programs, and a sense that employers had their best interests at heart. 
 
Identifying law that has the potential to be stigmatising: 
• Queensland law was analysed with a view to assessing its stigmatising and/or 
discriminatory potential, which was defined for the purposes of this study as: the 
enabling conditions for the manifestation of stigma and/or discriminatory practices; 
• The stigmatising potential of law is increased wherever the law isolates certain 
individuals, practices, activities and behaviours associated with AOD, enabling key 
stakeholders to exercise power and authority over them (including in ways that are 
potentially arbitrary or insufficiently defined), without sufficient protections for the 
target; 
• A total of 222 provisions in Queensland were identified that were relevant in some way 
to people who experience problematic AOD use. A proportion of provisions in 
Queensland law have the potential to stigmatise and/or discriminate against people 
experiencing problematic AOD use; 
• Relevant provisions appeared across 11 different areas of law, with provisions most often 
being found in the domains of: substantive criminal law, employment law and 
professional regulation, public health, and public order; 
• Only 33% of provisions define the targeted practice, activity or behaviour, with the 
remainder of provisions targeting practices, activities or behaviours that are not defined. 
The lack of definitional precision and clarity is a problem, because it may allow for highly 
subjective and variable assessments to be made; 
• The provisions convey decision-making powers and/or authority to a wide range of 
decision-makers, bodies and authorities. In some instances these decision-makers are 
familiar, highly trained and regulated (e.g. the police) but in others, powers are conferred 
upon private citizens and organisations who may be less familiar, well trained or well 
versed in the exercise of power (e.g. mining operators, employers, sellers of goods); 
• The stigmatising and/or discriminatory potential of law was reduced when targets were 
offered protections in law. While most provisions provide some protections for the 
target, 30.94% do not; 
• The stigmatising and/or discriminatory potential of law might be alleviated or reduced 
where the protections in individual provisions are included and strengthened, or where 
overarching legal protections are provided for people who use AOD (for example a 
Human Rights Charter or anti-discrimination protections).  
 
Identifying settings where stigma occurs: 
• Participants experienced stigma across a range of settings including health care, policing, 
employment, child services, courts, welfare and support services, as well as in 
relationships with family and friends, and in the general community; 
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• These experiences created inequitable barriers in the most fundamental aspects of 
people’s lives including health care, justice, family connection, employment 
opportunities, welfare, housing, and community belonging. Every participant could recall 
such experiences across multiple settings in their own lives, and described these 
experiences as being the norm; 
• Drawing together findings from across the literature review, the analysis of legislation 
and the interviews, stigma and discrimination were found to most commonly and 
pervasively manifest in five specific settings: 1. Health care/public health; 2. Welfare and 
support services, including housing; 3. Police, public order and criminal law; 4. 
Employment; 5. Society at large. 
 
Identifying ‘what works’ from the literature: 
• Stigma-reducing interventions can be universal (addressing an entire population) or can 
be targeted and delivered in particular settings; 
• Stigma-reducing interventions need to be focussed on both the social, political and 
economic causes of stigma, as well as on changing individuals’ discriminatory attitudes 
and behaviours; 
• Approaches must be multifaceted to address the extensive mechanisms which produce 
discriminatory outcomes, but also multilevel to address issues of both individual and 
structural discrimination; 
• Circumscribed interventions that target only one mechanism at a time are unlikely to 
bring about change because they fail to address broader contextual factors; 
• Mass media interventions are ineffective for preventing drug use. Such campaigns aim to 
stigmatise drug use and create fear so as to deter drug use, and lead to further separation 
and stigmatisation of people who use drugs. Extreme and stigmatising depictions in such 
campaigns may prevent people from seeking help; 
• Mass media campaigns aimed at reducing stigma may reduce prejudice, but there is 
insufficient evidence to determine their effects on discrimination; 
• Educational interventions in schools have limited evidence as to their effectiveness; 
• Community-based interventions have been designed to reduce stigma amongst the 
community closest to people affected by stigma and discrimination, for example amongst 
close family members, and aim to increase knowledge, and equalise the relationship 
between people and their families so as to reduce stigma and discrimination. Such 
programs in the HIV field have been shown to reduce experiences of stigma for people 
living with HIV and change the attitudes of people living close to them; 
• Interventions for health professionals and service providers focus on changing the 
attitudes and behaviour of health care workers at an individual level, as well as addressing 
stigma and discrimination in health care settings at both interpersonal and structural 
levels. Changing professional behaviours that may stigmatise people can be accomplished 
by (1) increasing awareness of stigmatising aspects of clinical practice (e.g. being 
conscious of the power of diagnosis and labelling processes, rejecting negative outcome 
beliefs, and enhancing communication with clients), (2) meaningfully involving service 
users and family members, (3) taking on a public advocacy role in challenging stigma (and 
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seeing this as part of the profession), and (4) campaigning at a policy level for adequate 
clinical resources and research in the field. The existing evidence on effectiveness of 
these interventions shows that workplace education without organisational support is 
ineffective; 
• Interventions relating to treatment uptake focus on reshaping clients’ experience of the 
clinic or treatment service environment and holistically addressing health issues (rather 
than just focussing on AOD problems). In the HIV field, these types of interventions 
have been found to effectively reduce the fear and stigma experienced by clients, 
especially the fear of being ‘seen’ at the service, and have been shown to improve 
communication at the service; 
• Interventions relating to internalised stigma seek to decrease the impact of stigma on 
individuals and enable coping by restructuring erroneous beliefs about perceptions of 
enacted stigma and increasing self-esteem. Such interventions have been shown to 
increase perceptions of self-efficacy to cope with stigma, decrease avoidance strategies 
and improve self-esteem and quality of life; 
• Health conditions (such as hepatitis C and HIV/AIDS) come to be inextricably 
associated with (and as such bear the stigma of) illicit drug use. This suggests that 
interventions which seek to reduce the stigma associated with drug use ought to not only 
be directed towards drug and alcohol workers but also other health care providers in 
other fields; 
• Involving people with lived experience of AOD use in policy and practice is an 
important ethical consideration and can help challenge discriminatory or uninformed 
opinions. Consumer participation should be ‘core business’ for treatment services, health 
services, and other welfare and social support services that regularly engage with people 
experiencing problematic AOD use; 
• While much of the intervention literature has focussed on changing the attitudes and 
behaviours of individuals, the literature also shows that in order to bring about meaningful 
change structural factors must also be understood and addressed.  
 
Recommendations for change:   
The research findings led to 34 recommendations. Some of the recommendations focus on 
educating and changing the attitudes of individuals (for example practitioners), some focus on 
reforming legislation, and some focus on structural arrangements (such as organisational 
policies). For success, interventions aimed at ameliorating individuals’ discriminatory attitudes 
and behaviour need to be implemented alongside structural and systemic reforms aimed at 
addressing stigma and discrimination. 
The recommendations for change are as follows: 
Recommendation 01: Implement a Queensland Human Rights Charter 
Recommendation 02: Conduct anti-stigma awareness training across all relevant workforces 
Recommendation 03: Ensure consumer participation in policy and actions designed to reduce 
stigma and discrimination 
Recommendation 04: Increase the access and availability of AOD treatment 
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Recommendation 05: Improve the marketing of AOD treatment  
Recommendation 06: Better support family members of those in AOD treatment, through 
education and information resources 
Recommendation 07: Invest in improvements in the physical facilities within AOD treatment 
services  
Recommendation 08: Employ peer workers/liaison officers in health care settings 
Recommendation 09: Audit complaints mechanisms in health care settings   
Recommendation 10: Conduct consumer rights ‘training’   
Recommendation 11: Develop and disseminate clear clinical advice about pain management in 
people with opioid dependence for emergency departments and primary 
health care settings  
Recommendation 12: Develop and disseminate clear clinical advice about access to medications 
for those with concurrent physical and mental health disorders and AOD 
use 
Recommendation 13: Ensure consumer participation mechanisms are not just part of health care 
service provider’s accreditation, but are implemented 
Recommendation 14: Review reporting and monitoring systems to ensure anti-stigma actions are 
part of organisational Key Performance Indicators 
Recommendation 15: Develop and implement programs aimed at resilience to internalised 
stigma for people experiencing problematic AOD use and AOD 
treatment clients 
Recommendation 16: Consider introducing a supervised injecting facility, denoting that society 
cares, and providing a compassionate and practical health service  
Recommendation 17: Consider reform of the ‘notifiable conditions’ sections of public health law  
Recommendation 18: Amend legislation pertaining to HIV/hepatitis C 
Recommendation 19: Apply the recommendations from health care to welfare and support 
services 
Recommendation 20: Encourage police to be aware of and where possible facilitate access to 
services 
Recommendation 21: Consider a pilot of tracking police encounters 
Recommendation 22: Ensure Memoranda of Understanding are in operation between police and 
health care and harm reduction service providers 
Recommendation 23: Reform areas of criminal law where the definition of the behaviour has the 
potential to be stigmatising or applied in discriminatory ways 
Recommendation 24: Decriminalise the personal use/possession of drugs, removing the stigma 
of a criminal record  
Recommendation 25: Amend laws regarding peer distribution of injecting equipment  
Recommendation 26: Review policies regarding criminal history checks at pre-employment  
Recommendation 27: Encourage uptake of clear employer guidelines regarding AOD use in the 
workplace and how to best respond  
Recommendation 28: Improve access to Employee Assistance Programs 
Recommendation 29: Develop and support pathways into employment for people completing 
AOD treatment  
Recommendation 30: Encourage and support flexible work hours policies  
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Recommendation 31: Exercise extreme caution in mass media campaigns for drug use 
prevention  
Recommendation 32: Explore running a mass media campaign to reduce stigma 
Recommendation 33: Improve Queensland media reporting of AOD issues 
Recommendation 34: Implement guidelines for government department communication about 
AOD issues. 
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1. PROJECT BACKGROUND 
In this report, we present our research findings regarding stigma and discrimination for people 
experiencing alcohol or other drug (AOD) problems, which has a negative impact on the mental 
health and wellbeing of Queenslanders. Specifically the research examined:  
• How stigma and discrimination presents and manifests, including where it is not 
experienced;  
• The settings and sectors in which stigma and discrimination occur including but not 
limited to health services, housing, justice, education and employment, other social 
support services and in the broader community;   
• The impacts of stigma and discrimination on mental health and wellbeing and in 
particular on recovery and the ability to reconnect with the community;   
• The potential for legislation to be stigmatising; and  
• The evidence of what works to address stigma and discrimination.   
1.1 Project Aims 
Our research, and the approach taken (see below), aimed to support implementation actions by 
the Queensland government, and inform the development of a position paper and an action 
plan. The work undertaken aimed to deliver the following outcomes:  
• Identify experiences of stigma and discrimination for people with problematic AOD use in Queensland:  
We interviewed 21 people from across a range of settings to find out about their 
experiences of stigma and discrimination; 
• Identify priority settings: We identified systemic issues in particular settings and sectors 
which contribute to stigma and discrimination;  
• Identify problematic law: We identified key structural elements in Queensland legislation 
that have the potential to negatively impact on people experiencing problematic alcohol 
and other drug use;   
• Identify ‘what works’: Drawing on both the evidence base and the lived experience of 
participants we identified effective approaches to reduce the stigma and discrimination 
experienced by people with problematic alcohol and/or other drug use; and  
• Make recommendations for change:  Based on these data and analysis, we made 
recommendations for change by identifying options for reform and effective actions that 
may be taken to address stigma and discrimination.   
  
9 
 
2. METHODS AND APPROACH TO ANALYSIS  
The project consisted of three interrelated components. These were: 
1. Literature review;   
2. Legislative review; and  
3. Interviews and analytical case studies based on interviews.   
An iterative approach was taken across these three project components. The findings of the 
literature review helped inform the domains of in-depth focus in the legislative review, as well as 
the sampling in the interviews and focus of the analytic case studies. For example, the literature 
review identified drug treatment services as a key site of concern internationally, thus we sought 
to ensure that people with experience of drug treatment were included in our interview sample to 
capture and describe that experience locally. Similarly, where interview participants identified 
housing or family law as key sites of concern in their lives, this finding informed selection of 
domains of in-depth focus in the legislative review. In doing so, we iteratively focussed our 
approach by reference to the evolving findings of each component throughout the research 
process to ensure that domains of most concern were prioritised. We also sought feedback from 
the Queensland Mental Health Commission and Advisory Board throughout this process.   
Here, we outline the methods and approach to analysis used in each of the three components. 
2.1 Literature review 
The literature review involved five parts: 
• Definitions of stigma and discrimination;  
• Manifestations and experiences of stigma;  
• How stigma is experienced by people who use alcohol and other drugs;  
• Considerations of stigma and the law; and 
• Effective stigma-reducing interventions. 
 
The literature review updated and expanded upon a literature review undertaken in 2010 by the 
UK Drug Policy Commission regarding the stigmatisation of people with lived experience of 
problematic drug use (Lloyd, 2010, 2013). For this project, we updated the review to encompass 
research more recently published, expanded the scope to include alcohol (the earlier review 
focussed on illicit drug use), and also sought to capture research which has documented positive 
encounters or settings where stigma is not experienced.  
A key focus was also to identify initiatives, programs or other mechanisms which have been 
developed to address the stigma and discrimination experienced by people with problematic 
AOD use. We focussed here on both what has been shown to work in the AOD field, but also 
examined evidence from the mental health and HIV/AIDS fields, and considered the possible 
generalisability of successful approaches.  
As such, the review encompassed not only literature describing experiences of stigma (and the 
wider social context in which it occurs), but also literature on pragmatic approaches and 
strategies aimed at addressing stigma. 
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Following the methods previously used by Lloyd (2013), we used targeted searches and narrative 
literature review methods. This approach is useful for describing and interpreting the diverse 
range of research and other literature in this domain. We identified relevant papers by searching 
across academic databases, initially using search terms used by Lloyd (2010) including ‘drug’, 
‘substance abuse’, ‘stigma’ and ‘discrimination’, but also building upon these to include ‘alcohol’, 
‘dependence’ and ‘addiction’. Whereas Lloyd only included papers published in peer-reviewed 
journals and book chapters, we also conducted a search of grey literature to examine not only 
academic studies but also government and community programs to fulfil the objectives of both 
parts of the literature review.  
To identify literature relating to effective stigma-reducing interventions, we used search terms 
including ‘anti-stigma intervention’, ‘anti-stigma program’, and search strings such as ‘stigma’ and 
‘change’ or ‘prevent’ or ‘intervention’ or ‘reduction’. Only English language publications were 
included.  
2.2 Legislation review 
Through the legislation review component of the project, we aimed to: 
• Capture the full range of legislative provisions that deal with AOD in Queensland; and 
• Establish how these provisions might be linked to people’s experiences of stigma and/or 
discrimination, through a focus on what we call the ‘stigmatising and/or discriminatory 
potential’ of law.  
 
We met these aims using a three-step approach. 
Step 1: Mapping AOD under Queensland law 
In the first phase, we undertook a mapping exercise, documenting provisions that may influence 
stigma and discrimination experienced by people with a lived experience of problematic AOD 
use. Given the scope of this undertaking and the likelihood that a large number of statutes would 
be identified, we limited our mapping to Queensland law, with a view to confining the scope to 
identifying recommendations.  
We identified all Queensland law statutes and regulations in force (as at 18 July 2016) that would 
likely have an impact on people who use AOD. Searches were conducted using the web-based 
open access AustLII database, using a variety of search terms. The full list of search terms were: 
drug; drugs; alcohol; intoxic*; drunk*; under the influence; blood alcohol concentration; 
BAC; prescribed concentration; permitted concentration; liquor; alcohol limit; tobacco; 
cigarette* 
This search string identified 2582 relevant sections of QLD law. The search results were 
catalogued and screened for relevance. Sections that dealt only with specific, narrow procedural 
elements pertaining to licensees or authorities in regard to AOD (rather than consumers) were 
excluded (e.g. provisions pertaining to the process of applying for a license under the Liquor Act 
1992 were excluded, while provisions pertaining to the powers of licensees to eject consumers 
were not).  
Step 2: Establishing the different areas of law in which AOD is relevant 
The second step of this mapping exercise was to assign a ‘focus area’ to each provision. This was 
an exercise designed to establish which areas of law the provisions fell within (i.e. were they all 
substantive criminal law provisions, or did they fall into other categories, such as health, or 
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employment law)? In undertaking this first level of analysis, we aimed to ascertain just how many 
different areas of law were implicated in the regulation of AOD use, possession, risks, and so on. 
We then sought to undertake a much more detailed analysis of the legislative provisions. For 
this, we adapted a system for coding legislative provisions we had sourced from Corrigan et al. 
(2005) and combined it with another system developed by Quilter et al. (2016a) (see Step 3). 
Step 3: A framework for analysing the relationship between law and stigma 
We adopted aspects of a coding approach developed by Corrigan et al. (2005) (an approach 
which sought to explore the relationship between legislation pertaining to people experiencing 
mental illness and structural stigma or discrimination) and combined them with aspects of a 
methodology designed to map and analyse Australian laws dealing with intoxication (Quilter, et 
al., 2016a; Quilter, McNamara, Seear, & Room, 2016b). Our coding schedule appears at 
Appendix A.  
By adapting elements from Corrigan et al.’s research (2005) and combining it with insights from 
Quilter et al. (2016a, 2016b), the coding schedule sought to establish:  
 
1. What kinds of practices, activities or behaviours were targeted in Queensland law;  
2. Whether and in what ways those targeted practices, activities or behaviours were defined;  
3. Who had the capacity to make determinations or exercise powers pertaining to the 
targeted practices, activities or behaviours;  
4. What the decision-maker or authority identified at step 3 is able to do;  
5. Whether the law offers protections to those individuals whose practices, activities or 
behaviours are the targets of law; and  
6. Whether those laws offer protections to others.  
 
This approach allowed for a rich and thick description of each provision and allowed for an 
analysis, among other things, of whether targeted behaviours are arbitrarily or ill-defined in law, 
whether there are clear requirements for the exercise of power in relation to AOD, and whether 
the law provides (or is intended to provide) protections to the targets of the law.  
(Further detail about the theory and rationale underpinning our development and application of 
this coding schedule is included in the literature review and the legislation review results section 
below.) 
The coding schedule in Appendix A was applied to all provisions we identified. We note that our 
analysis is necessarily limited in at least two ways: 
• It does not include Commonwealth statutes that touch upon AOD use but which might 
be somehow relevant to the lives of people who live in Queensland; and 
• It does not capture more generic legislation that does not deal, specifically, with AOD, 
but which might somehow touch upon or impact people who use AOD in Queensland.  
2.3 Interviews and analytical case studies based on interviews   
Through the interview component of the project, we aimed to: 
 
• Elicit participants’ perceptions and experiences of how stigma presents and manifests 
(including positive experiences where it is not experienced);  
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• Identify the settings and sectors where stigma and discrimination occurs in participants’ 
lives (including but not limited to health services, housing, justice, education and 
employment, other social support services and in the broader community); 
• Understand the impacts of stigma and discrimination (including impacts on mental 
health and wellbeing, and on participants’ ability to seek help).  
 
A semi-structured interview guide was developed (see Appendix B). A narrative approach was 
taken whereby participants were encouraged to tell ‘stories’ (that is, describe specific events or 
encounters, as well as the circumstances of their life’s journey). Qualitative researchers argue that 
“stories are particularly suited as the linguistic form in which human experience as lived can be 
expressed” (Polkinghorne, 1995). A flexible approach to interviewing was also taken, whereby 
probing and follow-up questions were used, as appropriate, to yield rich data and uncover new 
insights (Minichiello, Aroni, & Hays, 2008). The interviewer played an active role in building 
conversation about a particular issue, responsively changing the wording or ordering of 
questions, and allowing for the emergence of individual perspectives (Patton, 1990).  
Interviews were conducted in accordance with national ethical guidelines governing human 
research (National Health and Medical Research Council, 2007). Participants were given a 
Participant Information Statement and Consent form to sign, explaining the study, and were 
offered $40 as reimbursement for their participation. Interviews were on average between 30 
minutes and one hour in length and were all conducted by the same member of the research 
team (KL). Interviews were digitally audio-recorded and then transcribed verbatim by a 
professional transcribing service (Smart Docs). To maintain confidentiality and anonymity, all 
interview data were de-identified prior to analysis. The project was approved by the University of 
New South Wales Human Research Ethics Committee (Approval no. HC16538) and registered 
by Monash University’s Human Research Ethics Committee (Approval no. 1128). 
The foundational principles of thematic qualitative analysis (Braun & Clarke, 2006) were initially 
applied to analyse the interview data. Interview data were read and separately coded by two 
members of the team (KL and KS). Following discussion, interview transcripts were then re-
coded and organised with the aid of NVivo 11 data management software. Both deductive and 
inductive approaches to coding were undertaken. That is, throughout the coding we identified 
key concepts derived from the literature review, as well as allowing other concepts to emerge. As 
the interviews were also used to generate analytic case studies, we also used narrative analysis 
techniques to analyse the data (Polkinghorne, 1995). Narrative accounts were drawn either from 
within the one participant’s experience, or by the research team building illustrative case 
examples by collating similar narratives from across interviews where participants have given 
similar accounts. The aim here was to draw disparate sections of interview data together into a 
coherent whole case study or storied account. This analytic technique is used not to directly 
reproduce observations, but rather provide a dynamic framework in which to connect and bind 
disconnected data segments in a coherent and explanatory way (Polkinghorne, 1995). 
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3. LITERATURE REVIEW 
This review considers and summarises a diverse literature about stigma and discrimination. 
Stigma affects people’s lives in material ways. Stigma is a fundamental social cause of health 
inequalities (Hatzenbuehler, Phelan, & Link, 2013). As Hatzenbuehler et al. (2013, p.5) argue, 
stigma “thwarts, undermines, or exacerbates several processes (i.e. availability of resources, social 
relationships, psychological and behavioural responses, stress) that ultimately lead to adverse 
health outcomes. Each of these stigma-induced processes mediates the relationship between 
stigma and population health outcomes.” Stigma has been shown to worsen stress, reinforce 
differences in socio-economic status, delay or impede help-seeking and lead to premature 
termination of treatment (Hatzenbuehler, et al., 2013; Link & Phelan, 2001; Schulze, 2007). 
Research suggests that greater attention should be paid to stigma as a social determinant of 
population health (Hatzenbuehler, et al., 2013). 
The first section of this review provides the various definitions of stigma and discrimination that 
have appeared in the literature to date, ending with our own working definitions for the purposes 
of this project. 
The second section considers different manifestations and experiences of stigma – felt, enacted, 
and internalised (self) stigma. It is important to understand these different conceptualisations of 
stigma, as each of them provides a different window into experiences of stigma. The third 
section focuses on AOD specifically by reviewing the international literature which describes and 
analyses how stigma is experienced by people who use AOD. The fourth section discusses 
considerations related to stigma and the law.  
The fifth and final section examines the existing literature on how to systematically address the 
issue of stigma through effective interventions. We have spent most of our time focussed on this 
literature because: this literature has not been thoroughly reviewed to date; and the project aims 
concerned generating recommendations for QHMC which need to be informed by the existing 
literature on what works.   
3.1 Definitions: what are stigma and discrimination? 
Stigma is a complex phenomenon (Corrigan & Kleinlein, 2005). ‘Stigma’ has been conceptualised 
in different ways and there is considerable variation in the definitions put forward in the 
literature (Clement, et al., 2013; Link & Phelan, 2001). This variation is partly due to the wide 
range of contexts in which the concept has been explored, and the multidisciplinary nature of 
stigma research which has led to different theoretical frames of reference being applied (Link & 
Phelan, 2001).  
Goffman’s (1963) seminal book Stigma: Notes on the Management of Spoiled Identity has been 
influential for understanding not only the markers of stigma but more importantly the processes 
of stigma; how stigma is produced through social interactions and its structural preconditions. In 
this work, Goffman conceptualised stigma “as an attribute that discredits an individual in the 
eyes of society and results in the person being devalued, discriminated against, and labelled as 
deviant” (Butt, Paterson, & McGuinness, 2008, p.205). 
More recently, Link and Phelan’s (2001) definition has also been taken up widely. In their 
conceptualisation, stigma can be said to exist when several interrelated components converge: 
In the first component, people distinguish and label difference. In the second, dominant 
cultural beliefs link labelled persons to undesirable characteristics – to negative 
stereotypes. In the third, labelled persons are placed in distinct categories so as to 
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accomplish some degree of separation of ‘us’ from ‘them.’ In the fourth, labelled persons 
experience status loss and discrimination that lead to unequal outcomes. Finally, 
stigmatisation is entirely contingent on access to social, economic and political power 
that allows the identification of differentness, the construction of stereotypes, the 
separation of labelled persons into distinct categories, and the full execution of 
disapproval, rejection, exclusion, and discrimination. (Link & Phelan, 2001, p.367) 
It is important to note here that this definition of stigma encompasses more than just labelling, 
stereotyping or assumptions. Stigma also involves status loss ("a downward placement in the 
status hierarchy": Link & Phelan, 2001, p.379) and discrimination means that stigmatised people 
experience a range of negative material and social outcomes which require scrutiny and 
assessment. 
Corrigan and Kleinlein (2005) put forward a model of stigma which distinguishes between 
‘public stigma’ and ‘self-stigma,’ each involving three components: stereotypes, prejudice and 
discrimination. Stereotypes are “knowledge structures” which are learned by members of a given 
social group, which become an “efficient” way of categorising information about social groups 
(Corrigan & Watson, 2007, pp.440-441). Prejudice only occurs when individuals endorse 
negative stereotypes. Prejudice then leads to discrimination; that is, affective responses are 
turned into behaviour (Corrigan & Watson, 2007, p.441). Clement et al. (2013, p.6) propose a 
slightly different formulation of the three components of stigma and suggest that stigma 
comprises “ignorance (lack of knowledge), prejudice (stigmatising attitudes) and discrimination 
(being treated unfairly, a behaviour concept).” 
Corrigan and Kleinlein (2005) argue that individual level analysis of stigma provides only a partial 
picture of the effects of stigma. They identify two levels of stigma in society: “institutional 
policies” and “social structures” (Corrigan & Kleinlein, 2005, p.29). These societal forms of 
stigma differ from stigma at the individual level through “the emergence of social forms and 
structures that restrict the life opportunities of people” (Corrigan & Kleinlein, 2005, p.29). 
Across these various definitions we can draw together some common threads. Stigma is enacted 
at both the individual level, and through institutions and structures. Stigma is more than simply 
stereotyping or over-generalising about a group or characteristic; it also involves the prejudicial 
endorsement of those stereotypes leading to loss of status, discrimination or unfair treatment.  
Unlike stigma (which has been widely theorised), the concept of discrimination is rarely framed 
in relation to any particular theoretical tradition (Parker & Aggleton, 2003). Discrimination is 
often discussed in tandem with stigma, and its meaning taken almost for granted (Parker & 
Aggleton, 2003). In common usage discrimination is often simply equated with being ‘treated 
unfairly,’ however sociological definitions focus more on structural patterns of power, 
dominance, oppression, and social inequality (Scott & Marshall, 2009). In law, discrimination has 
a distinct meaning. Typically, a person has been discriminated against unlawfully where they have 
been treated differently and unfavourably because of some attribute that they possess (e.g. 
because of their race, religious beliefs, or gender). 
In keeping with the focus of the stigma definition chosen above, for the purposes of this project 
we employ a sociological understanding of the term ‘discrimination.’ In doing so, we focus our 
analysis on identifying structural patterns of discrimination and the social conditions which allow 
it, not just ‘unfair treatment’ at the individual or interpersonal level. 
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The definitions employed for this research project are: 
 
Stigma is defined as: “elements of labelling, stereotyping, separation, status loss, and 
discrimination occur together in a power situation that allows them.” (Link & Phelan, 2001, 
p.377). 
 
Put into our own words, stigma is labelling and stereotyping of difference, at both an individual and structural 
societal level, that leads to status loss (including exclusion, rejection and discrimination). 
 
Discrimination relates to: structural patterns of power, dominance, oppression, and social 
inequality. (Scott & Marshall, 2009) 
 
Put into our own words, discrimination is the lived effects of stigma - the negative material and social outcomes that 
arise from experiences of stigma. 
 
Both stigma and discrimination rely on societal structures and systems that facilitate and create the conditions for 
their operation (for example unequal power is one such condition). 
 
3.2 ‘Felt’, ‘enacted’ and ‘internalised’ stigma 
There are a number of different manifestations and types of stigma, described in the literature. 
These include the concepts of ‘felt’ versus ‘enacted’ stigma, along with ‘internalised’ stigma. Each 
of these has the potential to play out differently for people with AOD issues.  
Theorists and researchers have separated the concept of stigma into ‘felt’1 stigma, and ‘enacted’ 
stigma (Brown, Macintyre, & Trujillo, 2003). ‘Felt’ stigma refers to “real or imagined fear of 
societal attitudes and potential discrimination arising from a particular undesirable attribute, 
disease (such as HIV), or association with a particular group or behaviour” (e.g. problematic 
drug use), whereas ‘enacted’ stigma refers to “the real experience of discrimination” (e.g. where 
disclosure leads to the loss of a job or social exclusion) (Brown, et al., 2003, p.50).  
The concept of ‘self-stigma’ or ‘internalised stigma’ has also been described. Research has 
demonstrated the ways in which self-stigma or internalised stigma is conceptually and empirically 
distinct from enacted stigma (Luoma, et al., 2007). Self-stigma refers to “negative thoughts and 
feelings (e.g. shame, negative self-evaluative thoughts, fear) that emerge from identification with 
a stigmatised group” (Luoma, et al., 2007, p.1332) which has been shown to impact negatively on 
behaviour, for example avoiding treatment, lack of employment seeking, and avoiding close 
contact with other people. Internalised stigma shapes an individual’s subjectivity (how they see 
themselves and their place in the world). (We take up the AOD literature on this topic below). 
3.3 Stigma and AOD 
Even in Goffman’s (1963, p.4) early work on stigma, problematic alcohol and other drug use 
(“addiction, alcoholism”) was included in a list of ‘discrediting attributes’ that almost inevitably 
give rise to discrimination. While there is no necessary or inherent reason why drug use should 
give rise to stigma, some aspects of drug use including intoxication, dependence and being 
engaged in treatment attract “near-universal stigma and marginalization” (Room, 2005, p.144). In 
                                                 
1 The concept of ‘felt’ stigma is also sometimes referred to as ‘perceived’ stigma.  
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many ways drug use behaviour becomes conflated with the person. That is, people who use 
drugs become seemingly inseparable from their behaviour and are labelled as “drug users” or 
“addicts” and not, as in other health-related discourse, “a person [who] has cancer, heart disease, 
or the flu” (Link & Phelan, 2001, p.370).  
There are a range of reasons why AOD use is thought to be frequently associated with stigma 
and discrimination, not least because the behaviour is regarded as immoral, illegal, and deviant. 
This leads to tensions in the way that dependence is thought about and described. As Room 
(2005, p.146) notes, drug and alcohol dependence are “on the one hand, from the perspective of 
medical nosology and public health, categories in the international classification of health 
disorders” and on the other hand “thoroughly moralised and derogated categories.” 
There has been a debate in the literature about whether or not stigma might be regarded as a 
public health ‘tool’ and might therefore be ethically acceptable in some situations (Bayer, 2008). 
Some commentators have argued that stigmatisation or de-normalisation of alcohol, tobacco and 
other drugs use might serve a positive public health function, in that such approaches can change 
social norms (the changing social norms around the acceptability of smoking are one example) 
(Bayer, 2008; Bayer & Fairchild, 2015). However, even those who advocate discussion of stigma 
as a public health tool nonetheless recognise that stigma will affect different groups and 
individuals disproportionately, and will marginalise some people (Bayer & Fairchild, 2015). Other 
researchers have strongly opposed the suggestion that stigma is an appropriate public health tool. 
Noting Bayer and Fairchild’s observation that some populations will be disproportionately 
affected and be marginalised, other researchers have pointed to the long term implications of 
stigma for provision of and access to health services, and the ethical tension between seeking to 
empower citizens across health contexts and undermining them (even temporarily) through 
stigma and shame (Williamson, Thom, Stimson, & Uhl, 2015). 
A body of literature has sought to describe how stigma and discrimination is experienced by 
people who use drugs (and particularly people who inject drugs) and how it manifests (e.g. 
AIVL, 2011b; Corrigan, Kuwabara, & O'Shaughnessy, 2009; Lloyd, 2010, 2013; Radcliffe & 
Stevens, 2008; Room, 2005; Simmonds & Coomber, 2009; UKDPC, 2010). Room (2005, p.151) 
suggests that discussion of the experiences and effects of stigma in the alcohol and other drug 
field has actually been quite confined and “have primarily been clinically-orientated 
considerations of the stigma on those treated for alcohol or drug problems, from the 
perspectives of stigma as a barrier to coming to treatment, managing the stigma post- treatment, 
or documenting or decrying public attitudes.”  
The most comprehensive review of this literature internationally was conducted by Lloyd (2010, 
2013) as part of a project for the UK Drug Policy Commission (UKDPC, 2010). Lloyd (2013) 
identified 185 published papers pertaining to the stigmatisation of problematic drug use and 
analysed the literature thematically according to the following nine categories: public attitudes; 
the attitudes of health professionals; the pharmacy as a setting for stigmatization; drug treatment 
services; the particular stigma of methadone; policing and public shame; stigmatising the 
stigmatised; the impact on problematic drug users; and stigma and recovery.  
Here, we summarise Lloyd’s findings and integrate other literature to inform the QMHC project 
more specifically. As Lloyd’s review focussed on illicit drugs and not alcohol, we conducted a 
further literature search to locate papers which discuss the issue of alcohol and stigma 
specifically. We located a further 57 papers using search terms including: alcohol, alcoholism, 
alcohol disorder, alcohol and problem, alcohol dependence, stigma, and discrimination. We also 
updated Lloyd’s earlier review of the drugs literature by searching for articles published from 
2013 onwards.  
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Public attitudes 
Lloyd (2013) described the literature examining general populations surveys which have included 
questions pertaining to public attitudes towards people who use drugs. Surveys undertaken in the 
UK, USA and other countries have shown that the public apportion blame to people who use 
drugs, and hold more stigmatising attitudes towards problematic drug use than to mental health 
(and, correspondingly, were more likely accept discrminatory practices and to oppose policies 
aimed at helping people experiencing problematic AOD use: Barry, McGinty, Pescosolido, & 
Goldman, 2014). Analyses of these general population surveys also demonstrate that public 
attitudes towards problematic drug use are complex and at times contradictory, with people 
being able to simultaneously blame people who use drugs whilst also reporting that they believe 
that people who use drugs come from difficult or disadvantaged backgrounds. Similarly, alcohol-
related stigma is often associated with the belief that individuals are responsible for their own 
behaviour and alcohol use, and therefore do not deserve sympathy (Erofeeva, 2016). In a review 
of population surveys from Europe, North America, New Zealand, Brazil and Ethiopia, 
Schomerus et al. (2011) found that compared with people living with other mental health 
problems, people experiencing problematic alcohol use were highly stigmatised: they were less 
frequently regarded as being mentally ill, were more likely to be held responsible for their own 
condition, more likely to provoke social rejection and negativity, and were at special risk for 
structural discrimination (see also: Schomerus, Holzinger, Matschinger, Lucht, & Angermeyer, 
2010). Van Boekel  et al. (2013) found that underlying negative attitudes about personal 
responsibility for drug and alcohol problems, as well as feelings of anger and fear, explained 
public intentions to impose discriminatory restrictions on people experiencing problematic AOD 
use (including removing children and excluding people from holding public office). It is 
important to note, however, that public attitudes do not necessarily stay constant over time. In 
one study examining  population surveys in Germany, the authors found that while negative 
attitudes towards people with alcohol dependence did not change significantly between 1990 and 
2011, the image of people who had received treatment for alcohol use problems had improved 
over time, indicating an increased acceptability of professional treatment (Schomerus, 
Matschinger, & Angermeyer, 2014; Schomerus, Matschinger, Lucht, & Angermeyer, 2014).  
In addition to analyses of population surveys, other research into public attitudes has also been 
undertaken. In one experimental study, researchers examined implicit and explicit beliefs about 
people who inject drugs. The authors found that participants associated people who injects drugs 
as deserving publishment as opposed to help (Kulesza, et al., 2016). Public attitudes also come 
into play when considering stigma in the workplace. One international mixed methods study 
examining employers’ attitudes in Chicago, Hong Kong and Beijing found that employers’ 
attitudes were more negative when health conditions were seen to be ‘behaviourally driven’ (that 
is, when alcohol and other drug problems were regarded as the result of personal choices and 
behaviour)(Corrigan, Tsang, Shi, Lam, & Larson, 2010). Interestingly, an Italian study found that 
this negative attitude of personal responsibility and blaming individuals for their own alcohol-
related problems remained even when alcohol dependence was described as an illness or a 
disease (Piras, et al., 2016), which suggests that the disease model is not necessarily less 
stigmatising than other constructions of problematic alcohol and other drug use. That said, other 
studies have shown a strong correlation between stigmatisation of alcohol disorders and 
agreement with socio-dynamic explanations of alcohol problems (rather than neurobiological 
explanations) (Heberlein, et al., 2014). 
Police and public shame 
Lloyd (2013) notes the literature which has described experiences of public shame in interactions 
with police. This literature describes adversarial and coercive interactions, with police actions 
often seen to be unjust and punitive by people who use drugs (and especially by those who were 
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in recovery). In a large study examining street-level policing of people experiencing problematic 
drug use, Lister and Wincup (2007) found that interactions with police were often adversarial, 
and people reported often feeling like they were the targets of unwanted police attention (either 
informally or within formal police powers). Participants reported that they felt like police defined 
them in terms of their drug use, which had a demoralising effect. People who were seeking 
treatment often continued to be the subject of police attention, due to their past drug use, which 
was an impediment to recovery and reintegration into society (Lister & Wincup, 2007). This 
body of literature also highlights how particular populations may experience even greater 
discrimination and undue police attention, for example based on race and ethnicity, which 
further compounds drug-related stigma (Khenti, 2014). 
Stigma, drug treatment and help-seeking 
Stigma as a barrier to help-seeking has been widely recognised across different fields (e.g. in 
mental health: Corrigan & Kleinlein, 2005; Schulze, 2007). There is evidence to suggest that this 
is also the case in the alcohol and other drug treatment sector. For example, research shows that 
people experiencing problematic alcohol use are less likely to access and utilise treatment services 
if they perceive higher alcohol-related stigma (Keyes, et al., 2010). For adolescents, alcohol-
related stigma can exacerbate alcohol-related problems and limit access to treatment and social 
supports (Aviram, 2006). Fear of being treated differently, expectations of rejection and self-
stigma have been shown to be associated with delayed treatment seeking as well as lower self-
esteem and greater drug dependence (Cama, Brener, Wilson, & von Hippel, 2016; Luoma, et al., 
2007; Semple, Grant, & Patterson, 2005). Beyond individual factors, varied conditions of social 
and gender inequality, as well as contexts of violence and abuse, have been identified as stigma-
related structural barriers which constitute obstacles to treatment (Mora-Ríos, Ortega-Ortega, & 
Medina-Mora, 2016). Research has shown that people who use drugs will delay seeking treatment 
not only for substance use disorders but also for trauma, infections and other conditions to 
avoid being stigmatised for drug use (Regen, Murphy, & Murphy, 2002). People who use drugs 
reported fears that disclosing their drug use and seeking help would have adverse effects 
including employment problems and legal penalties (for example when in violation of parole 
conditions), and did not trust health services to keep their medical details confidential. Instead, 
people who use drugs turn to informal networks for advice, treatment and referrals so as to seek 
non-judgmental care instead of seeking formal treatment (Regen, et al., 2002).  
Lloyd’s (2013) review highlights the particular stigma associated with drug treatment. The ways 
in which drug treatment services are stigmatised and ‘marked’ as services ‘for junkies’ means that 
would-be help seekers seek to distance themselves from such settings (Radcliffe & Stevens, 
2008) or from assumptions that they were a dependent drug user, an ‘addict’ or had a significant 
drug problem. Lloyd notes that these negative connotations have practical implications, and are a 
barrier to early interventions and treatment seeking. One solution may be increased provision of 
drug treatment through primary care settings to reduce the stigmatising effect of specialist 
treatment settings (Lloyd, 2013). Within the literature examining the stigmatising effects of drug 
treatment and treatment settings, there have been a number of studies documenting the stigma 
associated with methadone (Lloyd, 2013). The shame associated with standing in line at 
methadone clinics and humiliating drug testing (including urine testing) have been described (see 
also Crawford, 2013; Fraser & valentine, 2008). Research shows that people continue to 
experience drug-related stigma from multiple sources after entering methadone maintenance 
treatment and while in recovery, including from family and friends, co-workers and employers, 
health care workers, and government employees (including family services) (Earnshaw, Smith, & 
Copenhaver, 2013). 
Room (2005, p.152) notes the high degree of marginalisation and stigmatisation for people 
engaged in alcohol and other drug treatment, and argues that “improving the social reintegration 
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of such treated populations […] will require a better understanding of how and under what 
conditions the marginalisation and stigmatisation happens.” This is a crucial point: understanding 
and responding to stigma is essential to assisting long term change and recovery for people 
seeking help with alcohol and other drug problems. Indeed, Luoma et al. (2007, p.1342) have 
hypothesised that greater levels of stigma make it “more difficult to succeed in recovery” and 
more likely that individuals will discontinue treatment, which in turn leads to a greater chance of 
relapse and multiple treatment episodes. Stigma impacts on recovery both in terms of 
internalised blame and lack of self-worth, as well as through structural barriers such as 
discrimination by employers (which creates a barrier to returning to working life) (Lloyd, 2013). 
The stigma associated with having experienced problematic alcohol and drug use, even for those 
in long-term recovery, can impact for a lifetime (Lloyd, 2013).  
Stigma and health care settings 
Beyond AOD treatment settings specifically, stigma and discrimination can occur within 
generalist health care settings. Lloyd (2013) examined the literature describing the attitudes of 
health professionals. Lloyd notes that there is a sizable body of research on the stigmatising 
attitudes of health professionals towards people who use drugs, across many different countries. 
Surveys of health professionals have shown the lack of education received by health 
professionals in medical schools about drug and alcohol issues. The belief held by some doctors 
that treating people who inject drugs would be “futile” (Ding, et al., 2005; Lloyd, 2013, p.87) 
meant that a substantial minority of doctors reported that they would prefer not to treat this 
client group. Qualitative research has also shown that nurses’ accounts of caring for a similar 
client group were laden with fear, prejudice and stigma. Lloyd (2013) describes studies 
documenting significant levels of distrust between doctors and patients. Doctors reported being 
concerned about being deceived by opiate dependent patients, while the patients themselves 
were concerned that they would not receive adequate pain relief and appropriate treatment due 
to assumptions about their addiction and ‘drug-seeking.’ Accounts of people who use drugs 
being treated ‘differently’ from other patients in hospital are also given in the literature. Lloyd 
notes that these negative experiences are not universal, and the literature documents both 
positive and negative encounters with health professionals. Positive experiences “tended to be 
where care providers listened and were sympathetic and compassionate” as opposed to situations 
in which clients were told to stop using drugs, had their symptoms dismissed, or were simply 
treated as to blame for their own health conditions (Lloyd, 2013, p.88). Adequate pain relief 
would appear to be a central issue in the literature, however, which often leads to conflict 
between clinical staff and clients with a history of problematic drug use (Lloyd, 2013). Research 
has shown that having been refused medical care or having being verbally abused are factors 
associated with people who inject drugs subsequently avoiding health care services. This 
indicates the need to address broader structures in the health care system to ensure that people 
experiencing problematic AOD use can access care (Heath, et al., 2016). 
In his review, Lloyd (2013) also identified pharmacy settings as a key site of discrimination. 
Negative attitudes by pharmacy staff were reportedly related to concerns about theft and 
shoplifting. Some pharmacists also saw ‘other’ customers as ‘more important’ than customers 
who may be collecting methadone does or injecting equipment, and would sometimes introduce 
systems to ‘separate’ ‘drug using clients’ from other clients by means of separate doors, cubicles 
or allocated spaces within the pharmacy. Lloyd (2013) argues that the stigma experienced in 
pharmacies has a range of practical implications for people who use drugs, including their ability 
to access injecting equipment and methadone maintenance treatment retention.  
Research has shown health care workers’ perceptions of injecting drug use as a ‘controllable’ 
behaviour heavily influences negative attitudes towards health care clients who have a history of 
injecting drug use. Moreover, when health care workers believe than injecting behaviour is within 
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a client’s control or that it is a choice, health care workers are more likely to assume that health 
problems are caused by a person’s injecting drug use status and not any other underlying health 
issue (Brener, Hippel, Kippax, & Preacher, 2010). Where clinicians and health care professionals 
stigmatise clients, access to effective health treatment is limited and the consequences of stigma 
worsen (Varas-Díaz, et al., 2013). 
Co-stigmas 
The stigma associated with drug use also compounds the stigma associated with diseases such as 
hepatitis C (HCV) and HIV/AIDS. Fraser and Seear (2011) argue that HCV is a stigmatised 
condition in part because of its symbolic and literal associations with injecting drug use and 
‘addiction’. Harris (2005) argues that the virtual conflation of injection with infection is an 
important factor in HCV stigmatisation. The connections between HCV, injecting drug use and 
stigma are well documented in the literature (see, for example: Anti-Discrimination Board of 
New South Wales, 2001; Fraser & Treloar, 2006; Harris, 2005; Krug, 1995; Pugh, 2008). Reviews 
of the extant literature on HCV stigmatisation, including stigma associated with treatment 
experiences, point to a range of factors associated with stigma, including individual, structural, 
social and institutional forces (Butt, 2008; Paterson, Backmund, Hirsch, & Yim, 2007; Treloar & 
Rhodes, 2009). It has been suggested that the stigma associated with HIV/AIDS is also “layered 
upon the co-stigmas” (Chan, Stoové, & Reidpath, 2008) associated with injection drug use, 
marginalisation and other “norm-violating behaviour” (Bos, Schaalma, & Pryor, 2008, p.452).  
Since injection drug use is the predominant mode of HCV transmission in western democracies, 
people living with HCV (regardless of how they may have acquired the virus) may experience 
drug-related stigma and become associated with attributes such as criminality, untrustworthiness 
and non-compliance (Butt, et al., 2008). The assumption that people living with HCV not only 
use illicit drugs but also must be ‘irresponsible users’ to have contracted the virus via sharing 
injecting equipment means that people living with HCV often experience discrimination by 
health workers, or withdrawal of care and support (Butt, et al., 2008). In this way, the stigma 
associated with illicit drug use (and injecting practices in particular) has implications for other 
areas of health including blood borne virus prevention and treatment. Similarly, research has 
shown that transgender people who use drugs may experience this kind of layered co-stigma 
when accessing health services and drug treatment (Lyons, et al., 2015). 
Research has shown that stigma can differ by drug type. For example, the stigma associated with 
heroin use is significantly higher than levels of stigma associated with cannabis (Brown, 2015). In 
considering such findings, it is important to note that society’s attitudes towards particular drug 
types are constantly shifting. For example, recent discussion of the legalisation of cannabis or 
increasing rates of opioid overdose can impact the stigma associated with particular drugs 
(Brown, 2015). An Australian study also found that respondents would be more comfortable 
encountering an alcohol dependent person than a heroin dependent person in the workplace or 
at a dinner party (Meurk, Carter, Partridge, Lucke, & Hall, 2014). These differing public attitudes 
towards different drug types was also related to different levels of support for various policy 
interventions including treatment and criminal punishment. For example, the authors found less 
support for coerced treatment for alcohol dependence than for heroin dependence (Meurk, et al., 
2014). The ethnicity and gender of the person who uses drugs may also contribute to the stigma 
associated with particular drugs (Sorsdahl, Stein, & Myers, 2012). What people believe about the 
‘causes’ of conditions such as alcohol dependence, for example, has been shown to be different 
across men and women. In one study, participants were more likely to say that ‘bad character’ 
was a cause of alcohol dependence in women (Lale, Sklar, Wooldridge, & Sarkin, 2014).  
In documenting and describing these various experiences and manifestations of drug-related 
stigma, it is also important to note that within group stigma has also been identified. Research 
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has shown that some groups are seen as ‘worse’ or ‘more problematic’ by others within the drug 
using community (AIVL, 2011b; Lloyd, 2013; Radcliffe & Stevens, 2008; Simmonds & 
Coomber, 2009).  
Stigma has material effects in the daily lives of people who use drugs, and can affect the way an 
individual sees themselves and the world around them, as well as their views of treatment and 
other drug policies (Lancaster, Santana, Madden, & Ritter, 2015). While the stigmatisation and 
alienation of people who use drugs is certainly associated with poorer mental and physical health 
than that in the general population (Ahern, Stuber, & Galea, 2007), the impacts are more far 
reaching than this, with broad implications for citizenship and political subjectivity (Fraser & 
valentine, 2008; Lancaster, Santana, et al., 2015). 
3.4 Considerations of stigma and the law 
Given this project’s focus on identifying key structural elements in Queensland legislation that 
have the potential to negatively impact on people experiencing problematic AOD use, it is 
important to consider the literature relating to stigma and the law. 
Room (2005) argues that AOD stigmatisation and marginalisation stems from three main 
sources. These are: ‘intimate processes of social control and censure among family and friends’, 
as well as ‘decisions by social agents and agencies, which tend to focus attention on the most 
problematic cases and to amplify their marginalization’ and finally, ‘policy decisions at the local 
or national level which result in marginalization’. Room is not alone in drawing attention to the 
role of policy and law in the production of stigma. Law is understood to have an important 
relationship with stigma. According to Nussbaum (2004), for instance, the law can be an 
important ‘bulwark’ that protects people from stigma (e.g. through laws that prohibit 
discrimination against particular individuals, groups, behaviours and attributes). It can also 
produce stigma through processes of labelling and categorisation (e.g. branding certain practices 
as deviant or illegal). In both respects, the law has an important ‘expressive function’ (Sunstein, 
1996) in that it articulates values and norms. In a similar vein, Burris (2006, p.529) suggests that: 
There are three broad areas where law affects the operation of stigma in society. Law can 
be a means of preventing or remedying the enactment of stigma as violence, 
discrimination, or other harm; it can be a medium through which stigma is created, 
enforced, or disrupted; and it can play a role in structuring individual resistance to stigma. 
Burris elaborates on these three categories. In relation to the law’s potential to prevent or protect 
against stigma, he notes that the law can ‘blunt’ stigma’s effects where it deters harmful conduct 
and allows for recompense when damage has been done. In relation to its potential to propagate 
stigma, Burris notes that the law can enforce stigma by, for example, excluding people with HIV 
from being soldiers. In relation to individual resistance, Burris (2006, p.530) argues that we 
should consider: 
How law affects the day-to-day experience of stigma at the individual level, specifically 
whether law affects whether individuals accept or resist a ‘spoiled identity’, and the ways 
they can resist. 
Burris poses a series of questions regarding the law’s structuring capacity regarding individual 
resistance and enacted stigma. He asks (2006, p.531): 
Can law promote resistance by reducing the risks of resistance and by changing self-
conception? Can law facilitate activism by acting against discrimination and providing a 
script to guide social interactions? Can it mobilise collective action? Clearly, resistance to 
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stigma needs to become more prominent in any thinking about how a law can address 
the problem. 
Of course, it is also important to acknowledge that – following Sunstein’s observations on the 
symbolic or expressive function of the law – there are different views on the value, or worth, of 
the law’s capacity to produce stigma. Burris notes that the propagation or enactment of stigma is 
sometimes categorised as either ‘positive’ or ‘negative’. As Room (2005, p.150) has pointed out, 
there are indeed “two literatures on stigma, operating on very different premises”. According to 
the first approach, “stigma is taken for given as a discriminatory social evil” (Room, 2005, p.150). 
This literature emphasises the “negative effects of stigma on the stigmatized person” (Room, 
2005, p.150), and tends to focus on how those effects can be minimised or eradicated. In 
contrast, the second approach often views stigma ‘benignly’; “aligned with this literature, too, are 
public policy initiatives, including those which frequently justify their provisions by the need to 
‘send a message’ about what is and is not considered tolerable behaviour” (Room, 2005, p.150). 
Acknowledging these different approaches Burris (2006, p.530) nevertheless argues that: 
Sensitivity to the way stigma operates, particularly through self-lacerating shame and self-
discrimination, invites reflection on whether it is morally acceptable to use stigma as a 
means of social control, even for public-health purposes. 
Sunstein (1996, p.2025) makes a similar point, arguing that “the expressive function of law makes 
most sense in connection with efforts to change norms and that if legal statements produce bad 
consequences, they should not be enacted even if they seem reasonable or noble”. In this sense, 
Sunstein and Burris share a concern with the potential for law to generate shame, self-
discrimination or adverse consequences, and suggest pause for thought where laws can be 
proven to produce these kinds of effects.  
3.5 Interventions for reducing stigma 
While the experiences and effects of stigma have been extensively documented, there has been 
less focus on how to systematically address these issues through effective interventions (Neema, 
et al., 2012). As part of the UK Drug Policy Commission’s work on stigma (Lloyd, 2010; 
UKDPC, 2010, p.9), they identified five priority actions to reduce stigma towards people who 
use drugs:   
• Improve the knowledge and understanding among the general public about drug 
dependency and recovery to reduce the levels of fear and blame; 
• Ensure training and workforce development across the range of professions who work 
with people with drug problems to improve service responses; 
• Remove the legislative and administrative restrictions which reinforce stigmatisation 
towards people with drug dependency and addictions; 
• Support and promote self-help and mutual aid bodies and the nascent drug-user recovery 
communities as vehicles for reintegration and ‘normalisation’ of recovery; and 
• Engineer new ways to support and promote community participation and increased 
contact with recovering drug users in order to foster more constructive perceptions. 
 
The extent to which these recommendations have a supporting evidence-base was not 
specifically explored in the UKDPC work. 
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In this section we first provide a general overview of stigma-reducing interventions and 
systematic reviews to date, but then move to consider specific interventions: mass media 
interventions; educational and school-based interventions; community-based interventions; 
interventions for health professionals and service providers; interventions relating to treatment 
uptake; interventions relating to internalised stigma; considerations of co-stigma; involving the 
affected community in policy and practice; and, changing cultural constructions. 
 
Anti-stigma interventions can be universal (addressing an entire population) or can be targeted 
and delivered in particular settings (Buechter, Pieper, Ueffing, & Zschorlich, 2013). From the 
health promotion literature we know that interventions are more likely to work if they are based 
in social and psychological theories (Bos, et al., 2008). 
Stigma-reducing interventions should be attendant to the social, political, and economic causes 
of stigma, as well as individual and interaction-level stigmatisation and discrimination (Bos, et al., 
2008). Link and Phelan (2001) argue that given the extensive mechanisms which produce 
discriminatory outcomes, interventions designed to reduce stigma must also be broad ranging. 
Approaches must be multifaceted to address these many mechanisms, but also multilevel to address 
issues of both individual and structural discrimination. More than this, efforts to bring about 
change must “either change the deeply held attitudes and beliefs of powerful groups that lead to 
labelling, stereotyping, setting apart, devaluing, and discriminating, or it must change 
circumstances so as to limit to power of such groups to make their cognitions the dominant 
ones” (Link & Phelan, 2001, p.381). These authors suggest that circumscribed interventions that 
target only one mechanism at a time are unlikely to bring about change because they fail to 
address broader contextual factors. 
To consider what kinds of interventions may be effective for reducing stigma and discrimination 
against people who use drugs, we can consider the evidence from related fields including mental 
health and HIV/AIDS. The alcohol and other drugs field potentially has much to learn from 
evaluation of interventions in these fields. Like the stigma associated with problematic alcohol 
and other drug use, mental health-related stigma and HIV/AIDs-related stigma is widespread 
and has been shown to adversely impact on the lives of people living with these conditions. 
Moreover, the stigma associated with these conditions (like the stigma associated with 
problematic alcohol and other drug use) can impact on help-seeking, and treatment. In the 
mental health field, three general strategies have been identified to reduce stigma and 
discrimination: education, contact and protest (Corrigan, et al., 2001). Education involves 
“overcoming myths” and “replacing them with facts”; contact involves “introducing people with 
mental illnesses to the public or other people who may stigmatise” by sharing experiences in 
person or via media; and protest “aims to challenge inaccurate and negative representations” 
(Buechter, et al., 2013, p.2; see also Corrigan, Morris, Michaels, Rafacz, & Rüsch, 2012; Corrigan 
& Watson, 2007). These strategies have become known as Corrigan’s principles of strategic 
stigma change and have been applied to fields outside of mental health, including HIV-related 
stigma (e.g. Rao, et al., 2012). 
Corrigan et al. (2012) conducted a meta-analysis of strategies designed to change public stigma. 
In this analysis of 72 articles representing 79 independent studies, the authors found that both 
‘education’ and ‘contact’ strategies effectively reduced stigma in both adults and young people. 
However contact was more effective than education for adults, and education was more effective 
than contact among young people. Importantly, they found that face-to-face contact (rather than 
contact mediated through video) had the largest effect. That said, while face-to-face contact had 
better effects, mediated contact was nonetheless effective and has much broader reach and 
greatly increases exposure (Corrigan, et al., 2012). 
24 
 
In the HIV/AIDS field, there have been a variety of strategies employed to address “actionable 
causes of stigma and discrimination” (Wariki, Nomura, Ota, Mori, & Shibuya, 2013) including 
behavioural, educational and social interventions which create awareness of what stigma is, how 
it is produced and its implications. Brown et al. (2003) conducted a review of 22 studies which 
tested the effectiveness of interventions to reduce HIV-related stigma among the general 
population, among health care workers, and within at-risk groups. These studies tested a range of 
interventions including information-based approaches, skills building, counselling approaches, 
and contact with the affected groups (many studies employed multi-intervention approaches 
across these four categories, based on the assumption that no one approach is sufficient). The 
authors found that most of the studies showed that information along with skills building is 
more effective for increasing knowledge and reducing stigmatising attitudes, as compared to 
information alone. Similarly, contact with people living with HIV was found to be a promising 
strategy for reducing stigma, but it is not sufficient without information approaches (Brown, et 
al., 2003). However, the authors concluded that while some interventions work to some extent in 
the short term, the long term impacts of many interventions are still unknown (Brown, et al., 
2003). A more recent systematic review conducted to determine the effectiveness of HIV-related 
stigma-reducing interventions analysed the results of 19 studies (Sengupta, Banks, Jonas, Miles, 
& Smith, 2011). Of these 19 studies, 14 demonstrated statistically-significant effectiveness in 
reducing HIV-related stigma. However, only 2 of these 14 studies met an overall quality rating of 
‘good.’ This highlights the ongoing need for good quality, methodologically rigorous evaluation 
of stigma-reducing interventions.  
In both the HIV/AIDS and mental health fields, intervention designs have mainly been based 
on cognitive-behavioural and social-cognitive models, with a particular focus on education and 
contact strategies (Paterson, et al., 2007). Much of this research assumes that increased 
knowledge will reduce stigma. However, this individualistic focus has been critiqued by 
researchers who argue that more attention should be paid to the interplay of social and structural 
factors (Paterson, et al., 2007; Rhodes, Singer, Bourgois, Friedman, & Strathdee, 2005). It has 
been suggested that continuing to focus on the behaviour and attitudes of individuals “functions 
as a substitute for sustained organisational attention to the stigmatisation that is embedded in 
everyday institutional practices” (Paterson, et al., 2007, p.371). Moreover, the focus of much of 
the research to date has been on how stigma manifests and can be addressed in health care 
settings. Examination of how stigma might be addressed in other institutional settings (for 
example, education and criminal justice) is also required (Paterson, et al., 2007). 
Mindful of this critique and with an awareness of the limitations of the extant literature, in the 
following sections we outline the literature on stigma-reducing interventions from the AOD field 
as well as the HIV and mental health fields.  
Mass media interventions 
Mass media interventions are communications designed to reach large numbers of people via 
print media, radio, cinema, mobile devices and Internet technologies, without being reliant on 
one-to-one personal contact. Government or community groups and other organisations may 
use such interventions. They can vary in their intensity, and may be targeted at a specific time or 
run over a longer period (Clement, et al., 2013). Such mass media or social marketing campaigns 
can potentially influence not only individuals but also communities and policy makers (Clement, 
et al., 2013). It is important to note that our discussion here focuses on mass media campaigns 
designed to reduce stigma and discrimination, and not mass media campaigns aimed at 
preventing drug use per se. A systematic review of the effectiveness of drug prevention mass 
media campaigns (in this review termed ‘anti-illicit drug public service announcements’) by Werb 
et al. (2011) concluded that there was limited evidence to support the use of mass media 
campaigns for illicit drug prevention and that such campaigns were ineffective. A recent study 
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examined what people who had used methamphetamine themselves thought about two well-
known anti-methamphetamine campaigns: Faces of Meth and The Meth Project. Participants said 
they could not relate to the depictions of physical and behavioural change in the campaign, and 
that they had not had a deterrent effect (Marsh, Copes, & Linnemann, 2017). Such campaigns 
aim to stigmatise drug use and create fear so as to deter drug use, and yet they are ineffective and 
lead to further separation and stigmatisation of people who use drugs. Extreme and stigmatising 
depictions in such campaigns may prevent people from seeking help because they do not identify 
with the depictions of “’real’ addicts” (Marsh, et al., 2017, p.60). 
There is a separate body of literature examining the effectiveness of stigma-reducing mass media 
campaigns, however. There has been one comprehensive systematic review of the effectiveness 
of mass media interventions for reducing mental-health related stigma (Clement, et al., 2013). 
This review of 22 randomised controlled trials (RCTs), cluster RCTs and interrupted time series 
studies of mass media interventions examined the findings of these studies in relation to 
discrimination outcomes and prejudice outcomes. The findings of these studies were mixed, and 
the quality of the evidence was low. The authors concluded that mass media interventions “may 
reduce prejudice, but there is insufficient evidence to determine their effects on discrimination” 
(Clement, et al., 2013, p.2). (None of the studies addressed the question of the cost-effectiveness 
of these interventions). The authors suggested that particular kinds of messaging in mass media 
campaigns may be more effective than others. For example ‘first-person narratives’ and social 
inclusion/human rights messages show some promise, however messages depicting acute 
symptoms may increase prejudice and therefore should be avoided.  
Mass media interventions can also have diverse effects. For example, in the HIV field it has been 
found that mass media interventions aimed at reducing HIV-related risk behaviours had the dual 
effect of also reducing stigma by increasing knowledge (Kerr, et al., 2015). This is because 
knowledge is an “antecedent to stigma reduction” (Kerr, et al., 2015, p.154). This same study 
indicated that education programs delivered in the regions where mass media interventions were 
also being broadcast were more effective, suggesting that mass media interventions can augment 
the effectiveness of other educational interventions when delivered concurrently (Kerr, et al., 
2015).  
Another mode of intervention within mass media is through the implementation and monitoring 
of journalistic and broadcast Codes of Practice, ensuring that any clauses relating to 
discrimination within these codes relate to alcohol and drugs (UKDPC, 2010). We could not 
locate any evidence of the impact or effectiveness of these Codes of practice for stigma-
reduction.  
Educational and school-based interventions 
Schachter et al. (2008) conducted a systematic review of the effects of school-based interventions 
on mental health-related stigma. Their analysis of 40 evaluation studies was limited by the overall 
poor quality of the studies and the lack of RCTs which meant that they were unable draw 
conclusions about which interventions were more effective. However, they suggested that 
interventions “should likely involve experiential activities, which in facilitating students’ 
interaction with other human beings, engage students’ feelings and behaviour, not just cognition-
based points of view” and noted that “given how early in life discriminatory viewpoints and 
behaviours can appear, early intervention is a reasonable aim” (Schachter, et al., 2008).  
Focussing on educational interventions aimed at young people, Yamaguchi et al. (2011) analysed 
40 studies involving three types of educational interventions (educational condition, video-based 
contact condition, and contact condition). They found some positive effect on knowledge, 
changes in attitude, and young people’s awareness of mental illness, however the majority of 
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studies did not measure behaviour change. These authors concluded that educational programs 
should have information that can address beliefs about the dangerousness of people with mental 
health problems, and include components which balance information about both psychological 
and biological causes of mental illness. However the long term effects of interventions on 
discriminative behaviour and help-seeking is unknown.  
In another field, there has also been examination of how interventions may reduce ethnic 
prejudice and promote diversity among young people (Keenan, Connolly, & Stevenson, 2016). 
Keenan et al. (2016) describe types of approaches: cognitive development approaches; socio-
emotional development approaches; social-learning approaches; awareness-raising approaches; 
and anti-bias approaches. These different types of approaches emphasise different explanations 
for patterns of stigma and prejudice in young people: internal processes (cognitive); external 
factors through inter-personal interactions (social learning); and locating the acquisition of 
prejudice within broader structural and sociological factors (ecological) (Keenan, et al., 2016).  
One key point, which can be taken from the literature on ethnic prejudice, is that challenging 
existing stereotypes and discriminatory behaviour is only one aspect of reducing stigma. It is also 
important to understand and work to address wider, ingrained institutional processes and 
practices that reinforce inequalities (Keenan, et al., 2016). 
Community-based interventions 
Community-based interventions have been designed to reduce stigma amongst the community 
closest to people affected by stigma and discrimination, for example amongst close family 
members. In the HIV field, one such intervention involved a two-day workshop firstly with 
people living with HIV, followed by a three-day workshop involving both people living with 
HIV and their family members together (Pretorius, Greeff, Freeks, & Kruger, 2016). The aim 
was to increase knowledge, and equalise the relationship between people living with HIV and 
their families so as to reduce stigma and discrimination. This intervention assessed the outcomes 
using qualitative measures, and found that people living with HIV reported feeling accepted and 
respected following the intervention, and family members reported being aware of stigmatising 
behaviour and showed more compassion (Pretorius, et al., 2016). Another similar community-
based stigma-reduction and wellness-enhancement intervention consisted of a two-day workshop 
initially only with people living with HIV, followed by six 3-day workshops involving both 
people living with HIV as well as people living close to them, in the form of small group 
activities and presentations (French, Greeff, Watson, & Doak, 2015). The workshops aimed to 
share information about HIV, balance relationships between people living with HIV and other 
people in their community through contact and interactions, and empower participants to 
become community leaders who challenged HIV-related stigma and implemented programs in 
their communities. Again, this intervention was assessed qualitatively, and the authors found that 
this kind of intervention succeeded in reducing experiences of stigma for people living with HIV 
and changed the attitudes of people living close to them (French, et al., 2015). 
Interventions for health professionals and service providers 
Educational interventions can also be targeted at particular groups or professionals likely to 
come into contact with people who use alcohol or other drugs. Studies have noted that the lack 
of education about alcohol and other drug use in professional education and training courses for 
health care workers is a concern (Harling & Turner, 2012). It has been suggested that deficits in 
knowledge may contribute to stigmatising attitudes and reluctance to engage with people who 
use drugs. However, studies examining the effects of curriculum based interventions with health 
care students find moderate effects. In one study students continued to hold stigmatising 
attitudes towards people with substance use disorders, and also reported that they thought that 
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these attitudes were commonly held by other health care workers and would not influence the 
quality of care they could offer (Crapanzano, Vath, & Fisher, 2014). Thus, it has been found that 
workplace education without organisational support is ineffective for improving the attitudes of 
qualified nurses (Harling & Turner, 2012). Indeed, identifying the structural factors behind 
stigmatisation in health care settings is essential. One study in the AOD field sought to identify 
the structural factors specific to hospitals which contribute to the stigmatisation of people who 
use drugs and are HCV positive (Paterson, Hirsch, & Andres, 2013). Paterson et al. (2013, p.471) 
describe structural stigmatisation as “the structures (e.g. policies, practices, rules, norms) of 
institutions or departments that intentionally restrict the access of care of particular people.” 
Paterson et al. (2013) found that communication structures, departmental and institutional 
structures (including triage systems and lack of privacy in physical spaces within emergency 
departments), as well as external structures in the hospital settings and emergency departments 
studied, contributed to the stigmatisation of people who use drugs. In terms of interventions, 
this research indicates that traditional educational strategies to reduce stigma in health care 
settings are unlikely to be effective when implemented alone, without an awareness of these 
structural issues and attempts to review commonly accepted practices (Paterson, et al., 2013).   
Acceptance and Commitment Training (ACT) and multicultural training have also been trialled 
with alcohol and other drug counsellors (Hayes, et al., 2004). This approach addresses not so 
much a lack of knowledge or contact, but rather more ingrained and culturally conditioned 
biases. Hayes et al. (2004) compared the effectiveness of ACT and multicultural training with a 
biologically-oriented educational program and found that ACT and multicultural training 
changed stigmatising attitudes.  
In the HIV field, it has been noted that the consequences of stigma are more severe when stigma 
emanates from people who are important in the lives of people living with HIV, and particularly 
the health care professionals tasked with their care and treatment (Varas-Díaz, et al., 2013). 
Stigma reduction interventions have been developed and trialled to improve service providers’ 
knowledge about HIV/AIDS and willingness to treat people living with HIV/AIDS. Moving 
beyond passive forms of formal training and didactic formats, small group behavioural 
interventions have also been used which encourage participation, role-plays, group discussion 
and interaction (Wu, et al., 2008). When trialled in health care settings in China, Wu et al. (2008) 
found that participants engaged in this kind of participatory intervention reported stronger 
beliefs in protecting patient confidentiality and right to testing, reduced fear of people living with 
HIV, and better knowledge, as compared to the control group. A similar workshop-style 
intervention (‘the SPACES intervention’) was developed and trialled with medical students in 
Puerto Rico (Varas-Díaz, et al., 2013). This workshop intervention addressed knowledge of HIV 
stigma and its consequences, the role of negative emotions in HIV stigma, and behavioural skills 
for stigma-free interaction with people living with HIV. The results of the randomised controlled 
trial showed significantly lower stigma levels among students at follow-up, and the authors 
suggested that such an intervention should be incorporated into medical schools and training 
policies (Varas-Díaz, et al., 2013). In subsequent research, Varas-Díaz, et al.(2016) demonstrated 
the provision of information alone was insufficient and that the emotional dimension of this 
stigma-reduction intervention was a significant underlying mechanism of change.  
The acceptability and feasibility of introducing a brief stigma-reducing intervention into nursing 
students’ curriculum was trialled at a nursing college in India (Shah, Heylen, Srinivasan, 
Perumpil, & Ekstrand, 2014). This intervention was delivered in two sessions, one targeting 
instrumental stigma by building knowledge and the second targeting symbolic stigma and was 
co-facilitated by a person with lived experience of HIV. Shah et al. (2014) found that participants 
in the intervention group reported an increase in HIV-related knowledge and a reduction in 
misconceptions and stigmatising attitudes towards people living with HIV (however the 
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intervention had a greater effect on nursing students’ willingness to perform low risk activities 
than those involving higher risk of infection, and it is not known what effect such an 
intervention would have over time). Interventions focussing on reducing HIV-related stigma 
amongst health professionals have also been successfully trialled in low-HIV prevalence settings 
(Lohiniva, et al., 2016). 
While many stigma-reducing interventions have focussed on changing the attitudes and 
behaviour of health care workers at an individual level, others have also tried to address stigma 
and discrimination in health care settings at both interpersonal and structural levels (Li, Liang, 
Wu, Lin, & Guan, 2014). One such intervention did so by training respected service providers 
within hospital settings, with the aim that these individuals would then be influential among 
other health care workers. The authors found that this approach was effective, but also identified 
regional differences which means that attention should be paid to variation across sites when 
implementing interventions (Li, et al., 2014). 
In the mental health field, attention has only recently turned to the attitudes of mental health 
professionals because the focus on stigma-reducing interventions has been more firmly focussed 
on changing attitudes of the public. However, mental health professionals can be perpetrators of 
stigma (Schulze, 2007). Schulze (2007) suggests that changing stigmatising professional 
behaviours that may stigmatise people with mental health issues can be accomplished by (1) 
increasing awareness of stigmatising aspects of clinical practice (e.g. being conscious of the 
power of diagnosis and labelling processes, rejecting negative outcome beliefs, and enhancing 
communication with clients), (2) meaningfully involving service users and family members, (3) 
taking on a public advocacy role in challenging stigma (and seeing this as part of the profession), 
(4) campaigning at a policy level for adequate clinical resources and research in the field, and (5) 
synthesising stigma-reducing interventions. 
Given that stigma has been shown to occur widely in medical settings and given that it is a 
barrier to help-seeking and appropriate medical care for people who use drugs, it has been 
suggested that this group’s health needs might be better addressed outside of medical settings. 
Research has shown that people who use drugs seek advice and help through informal and lay 
networks (Regen, et al., 2002). As such, it has been suggested that health workers should 
infiltrate peer networks and provide information and referrals (Regen, et al., 2002). 
We are aware of one program currently running in Queensland which provides training with the 
aim of reducing stigma among health care workers, professionals and students. The ‘Putting 
together the Puzzle’ program was developed by the Australian Injecting and Illicit Drug Users 
League (AIVL) and is delivered in Queensland by QuIHN (Queensland’s peer-based drug user 
organisation). Since 2014, this program has been delivered in a variety of settings including 
Australian Winter School Conference, different pharmacy groups, Probation and Parole, 
Department of Child Safety, as well as youth workers, nurses, GP’s, community workers and 
with staff and volunteers at QuIHN and QuIVAA. An abridged version of the program has also 
been delivered to the Queensland Police Force as part of a more generalist AOD training 
session. There are also plans underway to deliver the training to the Pharmacy Guild and for 
NSP/OST pharmacists and pharmacy staff early next year. This program is designed to be 
delivered by people with lived experience of drug use (see AIVL, 2016). We are not aware of any 
plans to evaluate the effectiveness of the program in Queensland.  
Interventions relating to treatment uptake 
In the HIV field, barriers to HIV testing and HIV treatment have been studied, especially as they 
pertain to stigma. There may be useful lessons for AOD treatment uptake here, especially in 
relation to early intervention and the settings in which treatment takes place. In the HIV field, 
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there have been concerns that HIV-related stigma may be a barrier to testing, despite the 
increasing availability of testing and improvements in technologies (Crawford, et al., 2016). In 
order to remove barriers to HIV testing, pharmacy-based interventions using a comprehensive 
health framework that promoted testing of a range of chronic diseases as well as HIV were 
trialled. The intervention evaluated by Crawford et al. (2016) involved a computer-based video in 
which fictional and real-life HIV and chronic disease advocates were portrayed to (1) normalize 
HIV and HIV testing, (2) increase educational awareness about drug use, (3) destigmatize drug 
use by providing information on how HIV affects the entire community, not just the drug-using 
population, and (4) promote HIV testing and awareness of one’s HIV status as part of general 
health awareness that also encompasses being aware of hypertensive, diabetic, and 
hypercholesterolemic status. Overall, Crawford et al. found that there was an increase in HIV 
testing among participants who viewed the computer-based intervention and were offered HIV 
testing packaged with other health screening tests, as opposed to being offered HIV testing 
alone. The authors suggested that combining testing for HIV with testing for other less 
stigmatised diseases may have normalised testing. For alcohol and other drugs, this suggests that 
interventions which holistically address health issues (rather than just screening for alcohol and 
other drug problems) and the use of a social cognitive model of intervention may be promising 
for reducing stigma.  
Interventions have also been introduced which aim to reshape clients’ experience of the clinic 
environment. While these interventions have been trialled in HIV clinics, such approaches may 
be of relevance to alcohol and other drug services as well given some of the similarities in 
settings and issues to be overcome. For example, Neema et al. (2012) describe sombre and busy 
services, with stressed staff and sometimes long waiting periods which mirrors the experiences 
documented in some Australian alcohol and other drug services as clients queue and wait to be 
seen (e.g. Crawford, 2013; Fraser, 2006). Neema et al. (2012) evaluated a ‘Creativity Initiative’ 
intervention which provided activities in the clinic while clients waited, with the aim of reducing 
the stigma felt by clients. This intervention was found to effectively reduce the fear and stigma 
experienced by clients, especially to fear of being ‘seen’ at the service, and improved 
communication at the service.  
Interventions relating to internalised stigma 
While many stigma-reducing interventions (including those described above) are largely targeted 
at public stigma, or reducing stigma and discrimination perpetrated by specific people such as 
health care workers, there have been fewer interventions developed which are aimed at 
addressing internalised stigma (that is, when individuals take on and endorse public stigma within 
themselves) (Rao, et al., 2012). Interventions which aim to address internalised stigma are 
important as internalised stigma can impact long term by increasing psychological distress and 
hinder help-seeking or medical care (Harper, Lemos, & Hosek, 2014). Moreover, it has been 
suggested that internalised stigma may be a more appropriate target for stigma-related 
intervention because it is associated with measures of functioning and quality of life (Luoma, et 
al., 2007). 
Rao et al. (2012) adapted the HIV Stigma Toolkit (a participatory group format workshop 
program which has primarily used to reduce public stigma) to target internalised stigma for 
African American women living with HIV. Rao et al. (2012) found that the intervention was 
feasible and acceptable to the target group, helped the women to foster social support, and was 
effective for reducing internalised stigma. Another intervention was aimed at decreasing the 
impact of stigma on individuals and enabling coping by restructuring erroneous beliefs about 
perceptions of enacted stigma and increasing self-esteem (Fuster-Ruizdeapodaca, Molero, & 
Ubillos, 2016). The program combined educational information with cognitive-behavioural 
techniques over four 4-hour sessions. The intervention was found to increase perceptions of 
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self-efficacy to cope with stigma, decrease avoidance strategies and improve self-esteem and 
quality of life (Fuster-Ruizdeapodaca, et al., 2016). Harper et al. (2014) evaluated the impact of a 
group-based intervention which was aimed at young people newly diagnosed with HIV, which 
aimed to address personalised stigma, disclosure concerns, negative self-image, and concern with 
public attitudes. This intervention was based on a model developed in the disability field which 
incorporated skills-building activities guided by social cognitive theory. The program was found 
to produce small overall reductions in personalised stigma, disclosure concerns and negative self-
image (however these reductions were not maintained at 3 month follow up for personalised 
stigma or disclosure concerns) (Harper, et al., 2014).  
Considerations of co-stigma 
As noted above, particular health conditions (such as HCV and HIV/AIDS) come to be 
inextricably associated with (and as such bear the stigma of) illicit drug use. This suggests that 
interventions which seek to reduce the stigma associated with drug use ought to not only be 
directed towards drug and alcohol workers but also other health care providers in other fields 
(Chan, et al., 2008). As Chan et al. (2008) argue “since the stigmatisation of [people living with 
HIV/AIDS] can largely be traced back to the stigmatisation of high risk behaviours including 
drug use, it seems logical that reducing the stigma of those behaviours would be crucial to 
lowering the stigma of [people living with HIV/AIDS].” 
While most interventions aimed at reducing stigma have focussed on individual factors which 
contribute to stigma, an increased awareness of intersectionality ("the ways in which social 
identities (e.g. ethnoracial identity, gender, sexuality) converge to produce unique forms of 
marginalisation": Loutfy, et al., 2015, p.2) means that interventions ought to be designed to 
address these intersecting forms of marginalisation and intersectional stigma.  
Involving the affected community in policy and practice 
Another aspect to be considered is how people who use alcohol and other drugs may be 
meaningfully included in policy and practice. In other areas of public health it has been argued 
that including marginalised individuals in the policy-making process is one way of seeking to 
alleviate or minimise stigma and discrimination (Gollust, Apse, Fuller, Miller, & Biesecker, 2005). 
Including the voices of the affected community in decision-making is regarded as an important 
ethical consideration in other policy domains (Childress, et al., 2002). Meaningfully involving the 
community most directly affected by particular policies and practices can help challenge 
discriminatory or uninformed opinions (Childress, et al., 2002; Gollust, et al., 2005; Lancaster, 
Ritter, & Stafford, 2013; Lancaster, Sutherland, & Ritter, 2014). 
The notion of consumer participation at the service level in the Australian drug treatment sector 
has been explored within the Australian drug sector, and barriers to meaningful involvement are 
continually documented (AIVL, 2008, 2011a; Rance & Treloar, 2015; Treloar, Fraser, & 
valentine, 2007; Treloar, Rance, Madden, & Liebelt, 2011). The Treatment Service Users Project 
developed and evaluated practical models for consumer participation in different drug treatment 
contexts (including pharmacotherapy, residential rehabilitation and inpatient detoxification 
settings), and provided education and training to build consumer participation capacity and skills 
(AIVL, 2011a). The final report identified increasing awareness and understanding of consumer 
participation, making consumer participation ‘core business’ for treatment services, developing a 
stronger theoretical basis for consumer participation in drug treatment services, understanding 
power and empowerment in the drug treatment context, and engaging drug user organisations in 
consumer participation, as the key priority areas in all Australian treatment services (AIVL, 
2011a). Analysis of another NSW-based consumer participation project introduced within drug 
treatment services found that both clients and staff described decreases in adversarial 
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relationships through the program. Significantly, service users said that the opportunity to ‘have a 
voice’ and be heard disrupted the routine dehumanisation that consistently characterised their 
usual experience in treatment spaces (Rance & Treloar, 2015). 
Changing cultural constructions 
In the long term, changing cultural constructions of stigmatised groups is essential for reducing 
the political and structural stigmas that have negative health consequences (Clair, Daniel, & 
Lamont, 2016). Stigmatising cultural constructions also serve to legitimate laws and policies 
which exclude and discriminate against particular groups (either intentionally or unintentionally). 
Redefining stigmatised groups can improve beliefs and attitudes, increase positive interactions 
which lead to increases in resources and opportunities, and convey norms which in turn 
structure behaviours (Clair, et al., 2016). While much intervention research has focussed on how 
to reduce stigma at the individual level, developing interventions which reshape cultural 
constructions that manifest in institutions and norms is an important endeavour (Clair, et al., 
2016). For governments, this might include systematically evaluating how policies can be 
changed to produce equivalence and contribute to destigmatisation. Other central institutional 
actors (such as legal experts, social scientists and the media) could also be enjoined to foster 
social conditions which contribute to the making of new cultural constructions of stigmatised 
groups (Clair, et al., 2016). 
Another aspect related to changing cultural constructions is challenging, or reshaping, how the 
problem of alcohol and other drugs is understood within society. Research has examined 
whether portraying stigmatised conditions like alcohol and other drug problems as treatable health 
conditions might improve public attitudes towards people living with these stigmatised 
conditions. One study found that portrayals of untreated and symptomatic conditions increased 
negative public attitudes, whereas portrayals of successfully treated conditions led to less desire 
for social distance, greater belief in the effectiveness of treatment and less willingness to 
discriminate against people living with these conditions, suggesting that this is a promising 
strategy to reduce stigma and discrimination and improve public perceptions (McGinty, 
Goldman, Pescosolido, & Barry, 2015). In recent years, an Australian website ‘Lives of 
Substance’ (http://www.livesofsubstance.org/) has been developed by researchers with the aim 
of informing the public by sharing personal stories of people who consider themselves to be 
alcohol or drug dependent. The aim of this website is to challenge media stereotypes, open up 
public discussion of AOD problems, and counter stigmatising misconceptions. 
The use of person-centred language is another way that communication about drug use can be 
destigmatised. Research shows that language can shape how the public thinks about substance 
use and recovery, and perpetuate stigma (Broyles, et al., 2014). The US Office of National Drug 
Control Policy (2017) under the Obama Administration issued a memorandum to all 
government departments and agencies about changing the use of terminology regarding 
substance use and substance use disorders in all government communication. According to this 
memorandum, all internal and public government communication about drug issues should 
conform with current medical terminology (rather than using terms like ‘drug habit’ or ‘abuse’ 
which research shows negatively shape public perceptions about drug use, and construct the 
person as being to blame for their problems), and similarly, use person-first or person-centred 
language when discussing people experiencing AOD problems (as we have also done throughout 
this report) to respect the dignity and worth of all people, rather than using stigmatising terms 
such as ‘addict’ or ‘alcoholic’ which depersonalise and disgrace individuals (Broyles, et al., 2014; 
Office of National Drug Control Policy, 2017). 
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Conclusion 
While much of the intervention literature has focussed on changing the attitudes and behaviours 
of individuals, the literature also shows that in order to bring about meaningful change structural 
factors must also be understood and addressed (Paterson, et al., 2013). Link and Phelan’s (2001) 
definition of stigma (discussed at the opening of this literature review) is important to keep in 
mind. By bringing together both sociocognitive and structural elements, this framework 
emphasises the need for interventions to incorporate both sociocognitive and structural 
approaches recognising that social, political and economic power inequalities perpetuate stigma 
(Misir, 2015).  
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4. LEGISLATION REVIEW 
There are an extremely broad range of possible laws that may impact on experiences of stigma 
and discrimination. This includes but is not limited to international and interstate legislation 
directly relating to drug laws (such as laws that prohibit the possession of specific substances), 
but also a plethora of other intersecting domains which affect people’s lives including health, 
employment, family law, housing etc. In earlier work we (KS) comprehensively mapped all 
statutes in Australia that incorporate reference to alcohol and other drug (AOD) ‘intoxication’ 
(see: Quilter, McNamara, Seear, & Room, 2016a; Quilter, McNamara, Seear, & Room, 2016b). 
That earlier research identified over 500 provisions across Australia which deal with 
‘intoxication’ either directly or indirectly (Quilter, et al., 2016a). Even this vast body of law only 
relates to ‘intoxication’ and does not capture the many other ways in which AOD use might 
feature in legislation; nor other (perhaps seemingly unrelated) laws that potentially contribute to 
stigma and discrimination for people with AOD dependence or problematic use. Moreover, it is 
not enough to merely identify legislation that pertains to AOD. Legislation needs to be 
operationalised and it is in this process of moving from ‘law on the books’ to the law as interpreted 
and implemented in practice that stigma and discrimination can occur in both anticipated and 
unanticipated ways, impacting either directly or indirectly in people’s lives. Our previous work 
(KS) has demonstrated the way that the minutiae of legal practices, rules and processes, 
definitions and language can enable the production and entrenchment of certain stereotypes 
about people who use drugs, and how these processes may be linked to both stigma and 
discrimination (Seear, 2015).  
The approach we used was designed to capture, first, the full range of provisions that deal with 
AOD in Queensland; and second, to explore how these provisions might be linked to people’s 
experiences of stigma and/or discrimination, through a focus on what we call the ‘stigmatising 
and/or discriminatory potential’ of law. This was established through a three-step methodology 
(see the methods section of this report). 
4.1 Mapping AOD under Queensland law 
In Step 1 of the research (the mapping exercise), we located a total of 222 provisions that we 
determined were in some way relevant to AOD in Queensland. These provisions were then 
sorted into two categories: ‘principal’ provisions (which had substantive content pertaining to 
AOD) and ‘auxiliary’ provisions (linked provisions that contained only procedural content or 
other protections). An example of each appears in Table 1, below. In this instance, as we can see 
section 68 of the Health Ombudsman Act 2013 provides the health ombudsman with the ability to 
make an order prohibiting a practitioner from practising in certain circumstances (an example of 
a ‘principal’ provision). On the other hand, section 69 allows the practitioner to make a 
submission in their defence (an ‘auxiliary’ provision).  
Table 1: Sample of ‘auxiliary’ and ‘principal’ provisions coded under coding schedule in 
Appendix A 
Principal 
provision 
s68 Provides for the health ombudsman to issue an initial 
prohibition order if a practitioner is practising their 
profession unsafely, incompetently or while intoxicated by 
alcohol or drugs 
Auxiliary 
provision 
s69 Provides that a practitioner can make submission in their 
defence as outlined above. 
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4.2 Establishing the different areas of law in which AOD is relevant 
Each provision was assigned a general focus area (in accordance with Step 2, see method 
section), which identified 11 relevant areas of law:  
• Child protection; 
• Civil Liability;  
• Corrections;  
• Criminal Procedure2;  
• Substantive criminal law;  
• Employment law/professional regulation;  
• Public health;  
• Public order;  
• Purchase and sale of goods;  
• Residential tenancy; and 
• Wills and estates. 
 
Table 2 contains an example of a provision for each of these 11 areas of law. 
Table 2: Sample provisions for each area of law  
Area/s of 
law 
Section and 
Law 
Example provision 
Child 
Protection 
Section 95 of 
the Child 
Protection Act 
1999 
(For the purposes of child protection): 
(8) Also, the police commissioner may give the chief executive 
a copy of, or extract from, the police commissioner's records 
in relation to— 
(a) the commission or alleged commission of the following 
offences by the person— 
(i) a personal offence against anyone; 
(ii) an offence against the Drugs Misuse Act 1986 ; 
(iii) an offence against section 162, 164, 166, 167 or 168; or 
(b) an application for a protection order under the Domestic 
and Family Violence Protection Act 2012 in which the person 
is an aggrieved or respondent under that Act. 
Civil liability  Section 41 of 
the Civil 
The protection from personal liability conferred on a 
volunteer by this subdivision in connection with any 
                                                 
2 Criminal procedure relates to the conduct of criminal proceedings in court (e.g. processes relating to 
complaints, summonses, and warrants; evidence, witnesses, remands/adjournments etc.) and is distinguished 
from substantive criminal law.  
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Area/s of 
law 
Section and 
Law 
Example provision 
Liability Act 
2003 
 
community work does not apply if the volunteer— 
(a) was intoxicated when doing the work; and 
(b) failed to exercise due care and skill when doing the work. 
Corrections Section 6 of the 
Corrective 
Services 
Regulation 2006 
Each of the following acts or omissions if committed by a 
prisoner is a breach of discipline— […] wilfully consuming or 
inhaling something likely to induce an intoxicated state, other 
than medication taken as prescribed by a doctor.  
Criminal 
procedure 
Section 423 of 
the  
Police Powers 
And 
Responsibilities 
Act 2000 
 
(1) This section applies if a police officer wants to question or 
to continue to question a relevant person who is apparently 
under the influence of liquor or a drug. 
(2) The police officer must delay the questioning until the 
police officer is reasonably satisfied the influence of the liquor 
or drug no longer affects the person's ability to understand his 
or her rights and to decide whether or not to answer 
questions. 
Substantive 
Criminal law 
Section 9A of 
the Drugs 
Misuse Act 1986 
(1) A person who unlawfully possesses a relevant substance or 
thing commits a crime. 
Maximum penalty—15 years imprisonment. 
(1A) It is a defence to a charge of an offence against 
subsection (1) for a person to prove that the person has a 
reasonable excuse for possessing the relevant substance or 
thing. 
(2) In this section— 
relevant substance or thing means— 
(a) a substance that is, or contains, a controlled substance and 
the gross weight of the relevant substance is of, or exceeds, 
the gross weight specified in the Drugs Misuse Regulation 
1987, schedule 8A in respect of the relevant substance; or 
(b) substances that together are, or contain, a controlled 
substance and the total gross weight of the relevant 
substances is of, or exceeds, the total of the gross weights 
specified in the Drugs Misuse Regulation 1987, schedule 8A in 
respect of the relevant substances; or 
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Area/s of 
law 
Section and 
Law 
Example provision 
(c) a thing specified in the Drugs Misuse Regulation 1987, 
schedule 8B. 
Employment 
law and 
professional 
regulation 
Section 84 of 
the  
Mining and 
Quarrying Safety 
Regulation 2001 
 
(1) A person must not carry out operations at a mine, or enter 
an operating part of a mine, if the person is under the 
influence of alcohol, or is impaired by a drug, to the extent the 
alcohol or drug impairs, or could impair, the person's ability to 
safely carry out the person's duties at the mine. 
(2) A person must not consume alcohol at a mine other than 
in— 
(a) an accommodation facility; or 
(b) a recreation area designated, in writing, by the site senior 
executive for the purpose under a written procedure for 
designating the area. 
Public health Section 70 of 
the Public 
Health Act 
(1) A doctor must, under subsection (2), notify the chief 
executive if an examination of a person by the doctor 
indicates that the person— 
(a) has or had a clinical diagnosis notifiable condition; or 
(b) has or had a provisional diagnosis notifiable condition. 
Maximum penalty—20 penalty units. 
(2) The notice must— 
(a) comply with the requirements prescribed under a 
regulation; and 
(b) be in the approved form. 
(3) Subsection (1) does not apply if the examination was 
carried out in a hospital. 
Public order Section 188 of 
the  
Transport 
Operations 
(Marine Safety) 
Act 1994 
(1) In this section— 
master includes a person authorised by the master.  
(2) A ship’s master may refuse to allow a person to board a 
ship if the master is of the opinion, on reasonable 
grounds, that the person may annoy or injure other 
persons on the ship because of the person’s intoxicated 
condition or disorderly or violent behaviour.  
(3) A ship’s master may refuse to allow a person to board a 
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Area/s of 
law 
Section and 
Law 
Example provision 
 ship for another reasonable reason (including, for 
example, that the ship was full).  
(4) A ship’s master may ask a person to leave the ship at a 
convenient port if the master is of the opinion, on 
reasonable grounds, that the person is likely to annoy or 
injure, or further annoy or injure, persons on the ship 
because of the person’s intoxicated condition or disorderly 
or violent behaviour.  
Purchase of 
sale and 
goods 
Section 156 of 
the Liquor Act 
1992 
(1) A person must not, on premises to which a licence or 
permit relates— 
(a) supply liquor to; or 
(b) permit or allow liquor to be supplied to; or 
(c) allow liquor to be consumed by; 
a person who— 
(d) is a minor; or 
(e) is unduly intoxicated or disorderly. 
 
(2) A person must not, on a street or place adjacent to 
premises to which a licence or permit relates, or in a public 
place supply liquor, or cause or permit liquor to be supplied, 
to a minor. 
 
(3) A person must not send, or cause or permit to be sent, to 
premises to which a licence or permit relates a minor with a 
view to the minor or another person being supplied with 
liquor . 
 
Maximum penalty for subsections (1) to (3)— 
(a) for an offence committed by the licensee or permittee of, 
or an approved manager working at, the premises— 
(i) if the person to whom the offence relates is a minor—250 
penalty units; or 
(ii) if the person to whom the offence relates is unduly 
intoxicated or disorderly—500 penalty units; or 
(b) for an offence committed other than by the licensee or 
permittee of, or an approved manager working at, the 
premises— 
(i) if the person to whom the offence relates is a minor—80 
penalty units; or 
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Area/s of 
law 
Section and 
Law 
Example provision 
(ii) if the person to whom the offence relates is unduly 
intoxicated or disorderly—80 penalty units. 
(4) Subsection (2) does not apply to the supply of liquor to a 
minor in a public place, designated under section 173C, if the 
minor is accompanied by a responsible adult who is 
responsibly supervising the minor. 
Residential 
tenancy 
Section 268 of 
the Residential 
Tenancies and 
Rooming 
Accommodation 
Act 2008 
 
 
 
(1) A provider may make house rules for rental premises 
about any of the following matters— 
(a) using shared facilities; 
(b) parking motor vehicles; 
(c) drinking alcohol or illegally consuming other drugs; 
(d) smoking; 
(e) making noise; 
(f) keeping pets; 
(g) guests; 
(h) another matter prescribed under a regulation. 
(2) A rule made under subsection (1) has effect as a house rule 
for the rental premises only if— 
(a) it is consistent with— 
(i) the prescribed rules; and 
(ii) the provider's obligations and the resident's rights under 
this Act; and 
(b) the rule is made under division 2. 
(3) Subsection (2)(b) does not apply to the making of a rule 
when there are no residents for the rental premises. 
 
(4) A provider must not make a rule about a matter not 
provided for under subsection (1). 
 
Maximum penalty for subsection (4)—20 penalty units. 
Wills and 
Estates 
Section 65 of 
the Public 
Trustee Act 
1978 
(1) Where, upon the application of the public trustee, the 
court is satisfied that a person who is under 18 years—  
(a) by reason of age, disease, illness, or physical or mental 
infirmity or of the person's taking or using in excess alcoholic 
liquors, or any intoxicating, stimulating, narcotic, sedative or 
other drug is, either continuously or intermittently—  
(i) unable, wholly or partially, to manage the person's affairs; 
or  
39 
 
Area/s of 
law 
Section and 
Law 
Example provision 
(ii) subject to, or liable to be subjected to, undue influence in 
respect of the person's estate, or any part thereof, or the 
disposition thereof; or  
(b) is otherwise in a position which in the opinion of the court 
renders it necessary in the interest of that person or of those 
dependent upon the person that the person's property should 
be protected;  
the court may make a protection order appointing the public 
trustee manager to take possession of and to control and 
manage all or such part or parts as the court directs of the 
estate of that person.  
(2) Notice of every application under this section shall be 
served upon the person whose property is sought to be 
protected, unless the court in any special case otherwise 
directs.  
(3) Upon such an application the court may receive in 
evidence a report by the public trustee and may have regard to 
the matters contained therein (including any medical or other 
reports incorporated therein).  
 
We then undertook a basic analysis of the frequency for area of law. Table 3 contains a summary 
of these data. Our analysis suggests that the most common areas of law are: substantive criminal 
law (33.78%), employment law and professional regulation (20.72%) and public health (17.12%).  
Importantly, a number of provisions could have been coded in more than one area of law. A 
number of provisions that were substantive criminal offences (i.e. substantive criminal law) 
pertained to the maintenance of public order. Although public order is the fifth most frequent 
category, when these overlaps are taken into account, it becomes the fourth most frequent 
category, above criminal procedure.  
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Table 3: Analysis of frequency of areas of law 
Area of law Total 
Number of 
provisions 
Total as % 
Child Protection 1 0.45 
Civil liability  6 2.70 
Corrections 2 0.90 
Criminal procedure 22 9.91 
Employment law and professional regulation 46 20.72 
Public health 38 17.12 
Public order 14 6.31 
Purchase of sale and goods 6 2.70 
Residential tenancy 5 2.25 
Substantive criminal law 75 33.78 
Wills and Estates 7 3.15 
NB: total may not add to 100%. 
4.3 Analysing the relationship between law and stigma 
We then undertook a further analysis using the coding schedule we developed (see methods 
section Step 3, and Appendix A), to examine the stigmatising potential of each provision. As noted 
in the methods section earlier, the approach we developed and used here requires some more 
detailed explanation. 
In a paper on mental health law in the United States, Corrigan et al. (2005) sought to explore the 
relationship between legislation pertaining to people experiencing mental illness and structural 
stigma or discrimination. They define structural discrimination as ‘formed by sociopolitical forces 
and represents the policies of private and governmental institutions that restrict the 
opportunities of stigmatized groups’ (Corrigan, et al., 2005, p.557). Their research aimed to 
isolate, in the first instance, all ‘legislative activities’ (a slightly wider category of interest which 
included bills introduced into parliament) related to mental illness in the United States in the year 
2002 (a process similar to our mapping exercise, described above). In the second instance, using 
a comprehensive coding schedule designed to assess the extent to which those legislative 
activities were stigmatising, they analysed and coded all legislative activities. They then drew a set 
of conclusions about the relationship between law and stigma. Their research used a 
combination of methods (collection and analysis of laws and focus group interviews) through 
which they devised an approach in which bills were characterised in one of three ways: 
[…] those that expand or contract liberties (the intent or goal of a bill is to deal with 
procedural or substantive rights of persons with mental illness with respect to refusing 
41 
 
treatment or restrictions on physical liberty), those that expand or contract protections 
against discrimination (the bill deals with protections for people with mental illness in 
terms of housing, employment, or other benefits or services), and those that expand or 
contract privacy (bills that deal with privacy or confidentiality for persons with mental 
illness). (Corrigan, et al., 2005, p.558) 
Importantly, ‘the target of bills related to liberties or discrimination protections was [also] coded 
in terms of whether the bill referred to people with a diagnosis of a mental illness or to people 
who were disabled or incompetent’ (2005: 558). In this study, Corrigan et al. (2005, p.558) note 
that their intention was not to establish what ‘the actual or practical effect of the legislation once 
implemented’ was. Instead, the focus was on the ‘intended effect’ of legislation. We suggest this 
is an important and complementary approach to those of Burris (2006) and Bacchi (2009), in 
that it encourages a focus on the subjects (e.g. ‘the mentally ill’) of legislation, thus revealing, in 
the process, potential assumptions regarding the nature of problems and problem cohorts and 
the ways to solve those problems.  
Corrigan et al. assume that law should offer protections to people who experience mental illness 
wheresoever they are targeted. In the context of laws that target varied aspects of AOD use, this 
might seem controversial. It might be argued, for instance, that it is not the targets of those laws 
who require protection, but the many others who may be impacted by AOD use and AOD-
related harms. How governments approach these issues depends in part on the extent to which 
they subscribe to Burris’ (2006) view, on the merits of stigmatising individuals, activities, 
behaviours and practices through law, and also how governments approach the task of balancing 
these competing considerations. Quite often, in any event, legislative systems provide 
overarching protections for both targeted populations/ individuals and for others. There are 
many ways that laws offer such protections. In both the United States (where Corrigan et al. 
2005 were working) and Australia, there are overarching legislative protections provided to 
individuals in the form of anti-discrimination laws. In a simple sense, anti-discrimination 
legislation is designed to provide a form of ‘check and balance’ against the potential exercise of 
power over individuals on the basis of identified attributes (e.g. sexuality and race). There are 
also two Australian jurisdictions (the Australian Capital Territory and Victoria), in which human 
rights acts have been implemented.3 These acts seek to provide broad, overarching human rights 
protections to individuals in certain circumstances, including, in particular, where so-called 
‘public authorities’ (such as the police) make decisions that impact upon them. In this sense, 
human rights laws are intended to act as a ‘backstop’ – or a check and balance – against 
infringements of certain basic rights and the use of excessive power by public authorities.  
Of course, the provision of legal rights and protections is often a balancing act (between 
different rights or perceived rights, for example). In general terms, and wherever possible, 
however, the potential for law to stigmatise and/or discriminate against people who use AOD 
will be reduced where such law offers protections to those whose practices, activities and 
behaviours are the targets of that law and where there are clear principles and guidelines 
pertaining to the enforcement of those laws.  
We take as valuable Corrigan et al.’s focus on targeted populations and protections. As outlined 
in the methods section earlier, we thus adopted aspects of the Corrigan et al. approach and 
combined them with aspects of a methodology designed to map and analyse Australian laws 
dealing with intoxication (Quilter, et al., 2016a, 2016b). Quilter et al.’s work examined how 
                                                 
3 These are the Human Rights Act 2004 (ACT) and the Charter of Human Rights and Responsibilities Act 2006 
(VIC), respectively. 
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Australian criminal law attached significance to the fact of ‘intoxication’. As we noted earlier, 
their research identified more than 500 provisions across Australia which deal with ‘intoxication’ 
either directly or indirectly (Quilter, et al., 2016a). Although the nature and meaning of 
‘intoxication’ might be thought to be self-evident, (Quilter, et al., 2016a) argued the use and 
significance of ‘intoxication’ in the criminal law changed over time, becoming wider and more 
complex, and extending to a range of different drugs. It was important, in this sense, to consider 
not only how and why the criminal law attached significance to ‘intoxication’, but whether the 
law defined ‘intoxication’, how it defined it, what approaches were used to its definition (i.e. was 
a biological detection test required, or something else?), and what the implications of defining 
and not defining intoxication might be. They found that 41 per cent of provisions examined 
contain no definition or a limited definition of intoxication, that statutory language lacked 
precision and was often inconsistent. They concluded that: 
[…] where criminal punishment or the deployment of coercive state powers is a 
consequence of the label ‘intoxicated’ being applied, it is reasonable to expect that the 
line of demarcation should be drawn with clarity. Indeed, it might be expected that the 
proliferation of statutes that attach significance to intoxication might be associated with a 
trend towards greater specificity as to the meaning of intoxication. To the contrary, our 
analysis shows that: under-definition is widespread; there is considerable variation both 
within jurisdictions and nationally as to how intoxication is defined; and the language 
used to define and describe intoxication is frequently ambiguous, leaving considerable 
scope for subjective assessments to be made by persons in authority. (Quilter, et al., 
2016a). 
Importantly, Quilter, et al., 2016a acknowledged that ambiguity and flexibility might on occasion 
be appropriate (where the appearance of ‘intoxication’ in legislation is designed to protect 
intoxicated persons – as with provisions that prevent police from questioning intoxicated 
persons, for instance). Before such conclusions can be drawn, however, it is important to assess 
what the targeted activity or behaviour is (e.g. intoxication), whether it is defined (and how), and 
the purpose of the provision (e.g. to protect intoxicated persons from the exercise of a coercive 
power). We took the view that this method aligned with and built upon that of Corrigan et al., 
noted earlier, and added it to the methodology we ultimately utilised.  
The coding schedule we developed sought to establish: (1) what kinds of practices, activities or 
behaviours were targeted in Queensland law; (2) whether and in what ways those targeted 
practices, activities or behaviours were defined; (3) who had the capacity to make determinations 
or exercise powers pertaining to the targeted practices, activities or behaviours; (4) what the 
decision-maker or authority identified at step 3 is able to do; (5) whether the law offers 
protections to those individuals whose practices, activities or behaviours are the targets of law; 
and (6) whether those laws offer protections to others. This approach allows for a rich and thick 
description of each provision and allows for an analysis, among other things, of whether targeted 
behaviours are arbitrarily or ill-defined in law, whether there are clear requirements for the 
exercise of power in relation to AOD, and whether the law provides (or is intended to provide) 
protections to the targets of the law. Read together, these results can tell us a great deal about the 
stigmatising and/or discriminatory potential of law, by which we mean: the enabling conditions for the 
manifestation of stigma and/or discriminatory practices. We suggest that the stigmatising 
potential of law is increased wherever the law isolates certain individuals, practices, activities and 
behaviours associated with AOD, enabling key stakeholders to exercise power and authority over 
them (including in ways that are potentially arbitrary or insufficiently defined), without sufficient 
protections for the target. Importantly, even where law has stigmatising potential, it may be that 
that potential can be justified on public policy grounds (e.g. because of significant risk to the 
public).  
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The coding schedule in Appendix A was applied to all provisions we identified. Table 4 contains 
an example of how the coding schedule was applied against a provision from each of the 11 
focus areas detailed in Table 2, above. For ease of reference, we use the same provisions that 
were listed in Table 2. 
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Table 4: Sample provisions coded using coding schedule in Appendix A 
Area of law Section and 
Law 
Summary of the 
provision 
What (or 
who) is the 
target of the 
law? 
Is the target 
defined? 
How is the target 
defined? 
Who is the 
decision-
maker/ 
authority? 
What can the 
decision 
maker or 
authority do? 
Protections 
for target? 
Protections 
for others? 
Child 
Protection  
Section 95 of 
the Child 
Protection Act 
1999 
Allows the police 
commissioner to 
disclose criminal 
history to the chief 
executive of CPS 
for a report or 
recommendation 
made to the 
Children's Court. 
In particular allows 
disclosure for any 
offence made 
under the Drugs 
Misuse Act 1986 
(QLD)  
Parent who has 
a child which 
authorities 
believe is in 
need of 
protection 
Yes, 
somewhat 
Parent is defined in s11 
as encompassing many 
kinds of relationships. 
Section 11 defines "child 
in need of protection" as 
one who (a) has suffered 
significant harm, is 
suffering significant 
harm, or is at 
unacceptable risk of 
suffering significant 
harm; and (b) does not 
have a parent able and 
willing to protect the 
child from the harm.  
Chief 
executive or 
Court 
Decides 
whether it 
require the 
information 
and the 
significance of 
the information 
on any order. 
It is up to the 
discretion of 
the chief 
executive and 
the court as to 
whether the 
information is 
required.  
Designed to 
protect the 
child at risk. 
Civil liability  Section 41 of 
the Civil 
Liability Act 
2003 
 
Provides against 
excluding civil 
liability of an 
intoxicated 
volunteer 
 
An intoxicated 
volunteer 
Yes Dictionary - intoxicated, 
in relation to a person, 
means that the person is 
under the influence of 
alcohol or a drug to the 
extent that the person's 
capacity to exercise 
proper care and skill is 
impaired. 
Judiciary Decides 
whether the 
elements of 
negligence are 
met and the 
quantum of 
damages. 
s41(b) states 
that the mere 
fact that a 
person is 
intoxicated isn't 
enough to 
expose them to 
personal 
liability; they 
need to have 
Protects the 
general 
public from 
intoxicated 
volunteers. 
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Area of law Section and 
Law 
Summary of the 
provision 
What (or 
who) is the 
target of the 
law? 
Is the target 
defined? 
How is the target 
defined? 
Who is the 
decision-
maker/ 
authority? 
What can the 
decision 
maker or 
authority do? 
Protections 
for target? 
Protections 
for others? 
failed to 
exercise due 
care and skill 
when doing the 
work.  
Corrections Section 6 of 
the Corrective 
Services 
Regulation 
2006 
Details what 
constitutes a 
breach of 
discipline under 
the Correction 
Services Act. A list 
of prohibited 
items is listed in 
s20 and includes 
drug, medicine, 
syringe or drug 
taking device.  
 
A prisoner 
who possesses 
or conceals 
anything not 
allowed. The 
wilful 
consuming or 
inhaling some 
likely to cause 
intoxication. 
As well as 
possessing, 
taking, giving 
or 
administering 
medication 
without 
approval.  
 
No N/A Corrections Take 
disciplinary 
action against 
the prisoner / 
separate 
criminal 
offence / 
seizing 
property 
 
Yes.  
Section 113 of 
the Corrective 
Services Act 
2006 allows a 
discretion in 
applying 
discipline 
noting at 
s113(2) that:  
A corrective 
services officer 
need not start 
proceedings 
against a 
prisoner for a 
breach of 
discipline if the 
officer 
considers the 
proceedings 
should not be 
started having 
Protects 
corrections 
from civil 
liability. 
Protects 
fellow 
prisoners 
from 
intoxicated 
fellow 
inmates. 
 
46 
 
Area of law Section and 
Law 
Summary of the 
provision 
What (or 
who) is the 
target of the 
law? 
Is the target 
defined? 
How is the target 
defined? 
Who is the 
decision-
maker/ 
authority? 
What can the 
decision 
maker or 
authority do? 
Protections 
for target? 
Protections 
for others? 
regard to—  
 (a) the trivial 
nature of the 
breach; or (b) 
the 
circumstances 
surrounding 
the commission 
of the breach; 
or  (c) the 
prisoner's 
previous 
conduct.  
Substantive 
Criminal law 
Section 9A of 
the Drugs 
Misuse Act 
1986 
Provides an 
offence for 
possessing relevant 
substances or 
things 
 
A person who 
unlawfully 
possesses a 
relevant 
substance or 
thing  
No, but drug 
quantity 
defined 
s9A(2) relevant substance 
or thing means— (a) a 
substance that is, or 
contains, a controlled 
substance and the gross 
weight of the relevant 
substance is of, or 
exceeds, the gross weight 
specified in the Drugs 
Misuse Regulation 1987, 
schedule 8A in respect of 
the relevant substance; or 
(b) substances that 
together are, or contain, 
a controlled substance 
and the total gross 
Law 
Enforcemen
t / Judiciary 
Offence with 
up to 15 years 
imprisonment 
as penalty. 
Standard 
criminal 
protections 
apply. 
Protect the 
public from 
drug-related 
harm. 
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Area of law Section and 
Law 
Summary of the 
provision 
What (or 
who) is the 
target of the 
law? 
Is the target 
defined? 
How is the target 
defined? 
Who is the 
decision-
maker/ 
authority? 
What can the 
decision 
maker or 
authority do? 
Protections 
for target? 
Protections 
for others? 
weight of the relevant 
substances is of, or 
exceeds, the total of the 
gross weights specified in 
the Drugs Misuse 
Regulation 1987, 
schedule 8A in respect of 
the relevant substances; 
or (c) a thing specified in 
the Drugs Misuse 
Regulation 1987, 
schedule 8B.  
Employment 
law and 
professional 
regulation 
Section 84 of 
the  
Mining and 
Quarrying 
Safety 
Regulation 
2001 
Prohibits 
somebody from 
carrying out 
operations at a 
mine, or enter an 
operating part of a 
mine, if the person 
is under the 
influence of 
alcohol, or is 
impaired by a 
drug, to the extent 
the alcohol or drug 
impairs, or could 
impair, the 
person's ability to 
safely carry out the 
A person who 
is under the 
influence of 
alcohol, or is 
impaired by a 
drug, to the 
extent the 
alcohol or drug 
impairs, or 
could impair, 
the person's 
ability to safely 
carry out the 
person's duties 
at the mine. 
No N/A Mining 
Operators 
Prohibit 
someone from 
working 
Standard 
employment 
protections 
Protect 
workplace 
health and 
safety 
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Area of law Section and 
Law 
Summary of the 
provision 
What (or 
who) is the 
target of the 
law? 
Is the target 
defined? 
How is the target 
defined? 
Who is the 
decision-
maker/ 
authority? 
What can the 
decision 
maker or 
authority do? 
Protections 
for target? 
Protections 
for others? 
person's duties at 
the mine. 
Public health s70 Provides that a 
doctor must notify 
the chief executive 
if after examining 
a person reaches a 
clinical diagnosis 
or a provisional 
diagnosis of a 
notifiable 
condition. 
Penalises non-
compliance. 
A person with 
a notifiable 
condition 
Yes Section 64 notes that a 
notifiable condition is 
one prescribed by 
Schedule 1 of Public 
Health Regulation 2005. 
See 
http://tinyurl.com/jxbp
8y8 
Doctor Requires 
disclosure 
when reaching 
a diagnosis of a 
notifiable 
condition 
Section 77 of 
the Act 
penalises the 
disclosure of 
confidential 
information 
except as 
provided by the 
Act. 
Protect the 
public from 
transmissible 
disease. 
Public order Section 188 of 
the  
Transport 
Operations 
(Marine Safety) 
Act 1994 
 
Provides that a 
ship's master can 
refuse entry of a 
person onto a ship 
or ask someone to 
leave if the person 
may annoy or 
injure other 
persons on the 
ship because of 
the person's 
intoxicated 
condition. 
A person 
entering or on 
a ship in an 
intoxicated 
condition. 
 
No N/A Ship master  Eject or refuse 
entry onto ship 
 
No Protect ship 
passenger 
from alcohol 
related 
disturbance 
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Area of law Section and 
Law 
Summary of the 
provision 
What (or 
who) is the 
target of the 
law? 
Is the target 
defined? 
How is the target 
defined? 
Who is the 
decision-
maker/ 
authority? 
What can the 
decision 
maker or 
authority do? 
Protections 
for target? 
Protections 
for others? 
 
Purchase of 
sale and goods 
Section 156 of 
the Liquor Act 
1992 
Penalises a licensee 
for supply / 
allowing liquor to 
be consumed by 
somebody who is 
unduly intoxicated 
or disorderly. 
 
A person who 
is unduly 
intoxicated or 
disorderly. 
Yes Section 9A defined 
unduly intoxicated if (a) 
the person's speech, 
balance, coordination or 
behaviour is noticeably 
affected; and (b) there 
are reasonable grounds 
for believing the affected 
speech, balance, 
coordination or 
behaviour is the result of 
the consumption of 
liquor, drugs or another 
intoxicating substance.  
Proprietor 
of Licensed 
Premises 
Allows refusal 
of liquor to 
certain people 
No Minimise 
alcohol 
related harm 
and public 
disorder 
Criminal 
procedure 
Section 423 of 
the  
Police Powers 
And 
Responsibilitie
s Act 2000 
 
Provides that the 
police must delay 
questioning of a 
person who is 
apparently under 
the influence of 
liquor or a drug.  
 
A person who 
is apparently 
under the 
influence of 
liquor or a 
drug. 
 
No N/A Police Regulates 
whether police 
can question a 
person 
Protect the 
person under 
the influence 
Protects the 
integrity of 
due process 
Residential 
tenancy 
Section 268 of 
the Residential 
Tenancies and 
Provides for 
providers of 
rooming 
A resident of a 
rooming house 
No N/A Rooming 
House 
Provider 
Breaching of a 
rooming house 
rule will 
Section 272 
allows a 
resident to 
Protects 
fellow 
residents 
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Area of law Section and 
Law 
Summary of the 
provision 
What (or 
who) is the 
target of the 
law? 
Is the target 
defined? 
How is the target 
defined? 
Who is the 
decision-
maker/ 
authority? 
What can the 
decision 
maker or 
authority do? 
Protections 
for target? 
Protections 
for others? 
Rooming 
Accommodatio
n Act 2008 
accommodation to 
make house rules 
on smoking, 
drinking alcohol or 
illegally consuming 
other drugs 
constitute a 
breach of the 
rooming 
accommodatio
n agreement. 
Section 368 
provides that 
notice will be 
given to the 
resident to 
remedy the 
breach, and if 
not remedied 
Section 369 
allows for a 
notice to leave 
to be served. 
object to a 
proposed rule 
change at a 
rooming house 
if 
"unreasonable". 
Section 274 
allows a 
resident to 
challenge an 
existing rule for 
being 
unreasonable 
via an 
application to 
the tribunal. 
from drug 
and alcohol 
related harm. 
Wills and 
Estates 
s65 Provides for a 
court to make a 
protection order 
for a person under 
18 years if they are 
unable to manage 
their affairs or are 
liable to undue 
influence "by 
reason of age, 
disease, illness, or 
physical or mental 
A person 
unable, wholly 
or partially to 
manage their 
affairs or are 
liable to be 
subject to 
undue 
influence due 
to "taking or 
using in excess 
alcoholic 
No N/A Judiciary Can appoint a 
public trustee 
manager to 
take possession 
of and to 
control and 
manage all or 
such part or 
parts as the 
court directs of 
the estate of 
Section 69 
allows for the 
protection 
order to be 
amended or 
varied on 
application of 
the protected 
person or the 
public trustee. 
Appears 
solely 
designed to 
protect the 
incapacitated 
person. 
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Area of law Section and 
Law 
Summary of the 
provision 
What (or 
who) is the 
target of the 
law? 
Is the target 
defined? 
How is the target 
defined? 
Who is the 
decision-
maker/ 
authority? 
What can the 
decision 
maker or 
authority do? 
Protections 
for target? 
Protections 
for others? 
infirmity or of the 
person's taking or 
using in excess 
alcoholic liquors, 
or any 
intoxicating, 
stimulating, 
narcotic, sedative 
or other drug is, 
either continuously 
or intermittently" 
liquors, or any 
intoxicating, 
stimulating, 
narcotic, 
sedative or 
other drug is, 
either 
continuously 
or 
intermittently" 
that person.  
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In the next section we present a summary of the findings across all laws, detailing results from 
our analysis using the coding schedule at Appendix A. We outline who the targets of the laws 
are; whether the targeted practices, activities or behaviours are defined; who is empowered to 
make decisions or exercise powers; what kinds of decisions or powers can be exercised; and what 
kinds of protections are offered.  
Targets of law 
The analysis revealed a wide range of terminology to describe targeted practices, activities and 
behaviours relevant to AOD. These included: 
• Persons who consume alcohol; 
• Persons who possess alcohol; 
• People possessing or consuming alcohol within a residence in a community area; 
• People who are unduly intoxicated or disorderly; 
• Intoxicated volunteers; 
• People who are adversely affected by an intoxicating substance; 
• People who are drug dependent; 
• People who unlawfully produce a relevant substance or thing; 
• Persons who have in their possession anything (not being a hypodermic syringe or needle) 
– for use in connection with the administration, consumption or smoking of a 
dangerous drug; 
• People affected by alcohol or drugs, including prescription medications, in ways that impair 
their capacity to undertake certain activities; 
• People consuming liquor; 
• People who appear to be drunk or adversely affected by a drug; 
• People who are under the influence of alcohol, or impaired by a drug, to the extent the alcohol or 
drug impairs, or could impair their ability to undertake certain activities; 
• People apparently under the influence of liquor or a drug; 
• Persons with a notifiable condition; 
• Persons who are unable to manage their affairs or are liable to be subject to undue 
influence due to taking or using in excess alcoholic liquors, or any intoxicating, stimulating, narcotic, 
sedative or other drug; 
• Persons incompetent due to drunkenness or incapacity; 
• Persons purchasing liquor while in uniform; 
• Persons wishing to purchase drug paraphernalia; 
• Persons smoking; 
• Persons over the prescribed limit of alcohol; 
• Persons who are habitually drunk; 
• Persons who are addicted to deleterious drugs; and 
• Persons who unlawfully traffic in drugs. 
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These findings overlap with findings by Quilter et al. (2016a, 2016b), where legislation that 
attaches significance to the fact of intoxication was found to use a wide array of variable 
language to describe intoxication (as in: intoxicated, unduly intoxicated, apparently intoxicated, 
affected by and under the influence). As the above list reveals, however, Queensland law not 
only targets the use, consumption, possession and trafficking of both AOD and AOD 
‘paraphernalia’, but other activities, including smoking, habitual drunkenness, addiction, 
purchasing AOD (or paraphernalia) and wishing to purchase AOD (or paraphernalia).  
Definitions of the targeted practices, activities and behaviours 
Of the 222 provisions we identified, a proportion was ancillary and thus not coded for 
definitions. Of the remaining 181 coded for definitions, most (67%) had no definition, while 
33% had a definition or partial definition of the targeted practice, activity or behaviour. An 
example of a provision that targets a practice, activity or behaviour that is defined in the 
legislation is section 328A of the Criminal Code 1989. That section provides an offence for 
someone who dangerously operates a vehicle whilst adversely affected by an intoxicating 
substance. In this instance, the targeted behaviour undertaken ‘while adversely affected by an 
intoxicating substance’ is defined in the Act, at section 365C. That section provides that: 
 
In this first example, the targeted practice, behaviour or activity is one that attracts a criminal 
penalty. By way of contrast, another example relates to a practice, activity or behaviour that 
attracts a penalty, but in a way that reduces (mitigates) a person’s culpability and their eventual 
sentence. Section 8 of the Drugs Misuse Act 1986 makes it an offence to unlawfully produce a 
dangerous drug. However, section 8(b) of the Act provides that a person found guilty of that 
offence can be imprisoned for up to 25 years, or – if they are a ‘drug dependent person’ – up to 
20 years. The meaning of ‘drug dependent person’ is defined in section 4 of the Act, as follows: 
(1) A person is taken to be adversely affected by an intoxicating substance if—  
(a) the concentration of alcohol in the person's blood is at least 150mg of alcohol in 
100mL of blood; or  
(b) the concentration of alcohol in the person's breath is at least 0.150g of alcohol in 
210L of breath; or  
(c) any amount of a drug prescribed by regulation is present in the person's saliva; or  
(d) the person fails to provide a specimen as required under the Transport 
Operations (Road Use Management) Act 1995, section 80 as applied under the Police 
Powers and Responsibilities Act 2000, chapter 18A. 
drug dependent person means a person— 
 
(a) who, as a result of repeated administration to the person of dangerous drugs— 
 
(i) demonstrates impaired control; or 
(ii) exhibits drug-seeking behaviour that suggests impaired control; 
 
over the person’s continued use of dangerous drugs; and 
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In this example, we note two things of interest. First, each example adopts a different approach 
to defining the targeted practice, activity or behaviour (in the first example the definition uses a 
form of biological detection, whereas the second uses observation of behaviours in accordance with 
established criteria, see Quilter et al. 2016a).  
An example of a provision that targets a practice, activity or behaviour that is not defined in the 
legislation is section 173B of the Liquor Act 1992. That section provides that: 
(1) A person must not consume liquor in— 
(a) a public place that is— 
(i) a road; or 
(ii) land owned by, or under the control of, a local government (other than a 
regional park (general) under the Nature Conservation Act 1992); or 
(iii) relevant land prescribed under a regulation; or 
(b) a doorway, entrance or vestibule that gives access to premises from a public place 
mentioned in paragraph (a). 
Maximum penalty—1 penalty unit. 
 
In this example, the meaning of ‘consuming liquor’ in a public place is not defined. In some 
instances where targeted practices, activities or behaviours are not defined in law (as with 
offences relating to possession or consumption) this may be because there is case law 
establishing the parameters of, for instance, possession, or because the meaning of each element 
of the offence appears to be identifiable as a matter of ‘common sense’. In other cases, however, 
the undefined targeted practice, activity or behaviour may be significantly less precise, or require 
an evaluation as to the degree or extent to which a person’s behaviour can be said to fit the 
requirements of the Act.  
So, for example, section 18(3) of the Major Events Act 2014 provides that: 
 
A person who appears to be drunk or adversely affected by a drug must not enter a major 
event area.  
 
Maximum penalty—20 penalty units. 
 
In this example, the targeted behaviour (the appearance of being drunk or adversely affected by a 
drug) is not defined. The addition of two qualifying factors – appearing to be drunk, adversely 
affected – necessitates the need for a judgment call to be made by the relevant decision-maker or 
authority tasked with determining whether a person has fallen foul of the law.  
(b) who, when the administration to the person of dangerous drugs ceases, suffers or is 
likely to suffer mental or physical distress or disorder. 
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Who makes decisions and what kinds of decisions can be made?  
Our analysis suggests that a wide range of decision-makers, authorities and bodies can make 
decisions or exercise powers in relation to targeted practices, activities and behaviours, and that 
the kinds of decisions that can be made are extraordinarily broad. Relevant decision-makers or 
authorities include: 
• Law enforcement officials; 
• Judiciary; 
• Corrections staff; 
• Education providers; 
• Certain regulatory boards (e.g. Veterinary Surgeons Board);  
• Staff from the Department of Health; 
• Health practitioners; 
• The Health Ombudsman; 
• Proprietors of licensed premises; 
• Venue operators; 
• Mining operators; 
• Employers; 
• Sellers of goods; 
• Second-hand brokers; 
• Rail safety officers; 
• Environmental health officers; 
• Licensees; and 
• Firing range operators. 
 
As this list reveals, a wide range of figures are implicated in decision-making processes that might 
affect the lives of people who use, consume, possess (etc.) AOD. The range of decisions that 
might be made is also broad. These include: 
• The ability to impose a condition on a person’s bail; 
• The ability to mitigate (reduce) an offender’s sentence; 
• The ability to determine whether a person is criminally responsible; 
• The ability to refuse access to certain medications; 
• The ability to refuse access to medical treatments; 
• The ability to prevent a person from engaging in certain forms of employment; 
• The ability to limit where and how liquor is consumed; 
• The power to stop and search people; 
• The power to prevent someone from working; 
• The power to seize liquor; 
• The power to search someone without a warrant; 
• The power to search a vehicle without a warrant; 
• The power to use drug detection dogs on people; 
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• The power to give a move-on direction; 
• The power to question (or not) a person; 
• The power to detain a person; 
• The power to take control of someone’s affairs or someone’s estate; 
• The power to take disciplinary action; 
• The power to issue a penalty in the form of a fine; 
• The power to limit access to certain goods (e.g. weapons); 
• The power to prevent entry to or access of certain spaces. 
 
As this list reveals, powers are not just confined to those we might consider to be more obvious 
or highly visible, such as the power to arrest and jail offenders or ‘move on powers’. As we shall 
explain in the next section, these decisions sometimes confer rights and protections, and 
sometimes inhibit rights.  
What kinds of protections are offered?  
As Corrigan et al. (2005) note, one way of establishing whether legislation is stigmatising and/or 
discriminatory (or, as we prefer, whether it has stigmatising or discriminatory potential), is to examine 
whether it affords protections to targeted individuals, practices, activities and behaviours. There 
are a range of ways in which laws may offer protections to targeted individuals, including via the 
use of review and appeal mechanisms. Where we speak about protections in this report, we mean 
(following Corrigan et al. 2005) specific initiatives or measures designed to prevent stigma or 
discrimination. Although most provisions (69.06%) offer protections of some kind to the target, 
a large proportion (30.94%) offer no protection to the target. Although there may be sound 
public policy grounds for this, provisions that offer no protection to target groups have a greater 
potential to be stigmatising and/or discriminatory.  
It is also important to acknowledge that laws may not always offer protections to the targets of 
those laws, and that they may instead offer or seek to offer protections to others. Examples of 
the latter are laws that seek to protect public spaces and public amenity, to minimise the risks 
that might be associated with AOD consumption (including, for example, risks to oneself, to 
fellow workers, to children, users of public transport and to members of the public more 
broadly). As we noted earlier, protections for others might be deemed necessary and appropriate 
where the targeted activity or behaviour is of a kind that might pose a risk to the community or 
public safety. The question in part is how competing rights might be balanced in ways that 
minimise the potential for stigma or discrimination.  
In some instances, laws might confer rights on targeted populations (and thus extend protections 
to targeted practices, activities or behaviours), while other laws may inhibit the rights of 
individuals who are targeted, while conferring rights and protections to others. An example of a 
provision that confers rights and protections can be found in section 423 of the Police Powers and 
Responsibilities Act 2000. That provision provides that the police must delay questioning of a 
person who is apparently under the influence of liquor or a drug. Here, at least one purpose of 
the legislation is to protect a person who is under the influence of AOD from speaking to police 
and potentially incriminating themselves. Importantly, this law simultaneously affords 
protections to others by protecting the integrity of the criminal justice system, ensuring due 
process and preventing miscarriages of justice. An example of a provision that confers rights and 
protections to others while inhibiting or reducing the rights or the targeted populations is section 
34 of the Aboriginal and Torres Strait Islander Communities (Justice, Land and Other Matters) Act 1984. 
That provision makes it an offence to possess or consume alcohol in a designated ‘dry place’. 
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This provision appears to be designed to provide protection to the wider community, by 
minimising the potential for alcohol-related harms, by impeding the right of community 
members to possess or consume alcohol.  
Summary 
In this section, we summarised findings from the legislative component of the study. We located 
a total of 222 provisions in Queensland that were relevant in some way to people who 
experience problematic AOD use. We analysed all 222 provisions with a view to assessing their 
stigmatising and/or discriminatory potential, which we defined for the purposes of this study as: 
the enabling conditions for the manifestation of stigma and/or discriminatory practices. We 
suggested that the stigmatising potential of law is increased wherever the law isolates certain 
individuals, practices, activities and behaviours associated with AOD, enabling key stakeholders 
to exercise power and authority over them (including in ways that are potentially arbitrary or 
insufficiently defined), without sufficient protections for the target. It is important to note that 
the stigmatising and/or discriminatory potential of each individual provision can only be 
established through a comprehensive/holistic reading of that provision using the 
aforementioned coding schedule. After undertaking such an analysis, we conclude that a 
proportion of provisions in Queensland law have the potential to stigmatise and/or discriminate 
against people experiencing problematic AOD use. Our analysis revealed that: relevant 
provisions appeared across 11 different areas of law, with provisions most often being found in 
the domains of: substantive criminal law, employment law and professional regulation, public 
health and public order. We also found that Queensland law targets a very wide range of 
practices, activities and behaviours, and uses a wide array of terms to describe the practices, 
activities and behaviours that are targeted. Only 33% of provisions define the targeted practice, 
activity or behaviour, with the remainder of provisions targeting practices, activities or 
behaviours that are not defined. The lack of definitional precision and clarity is a problem, 
because it may allow for highly subjective and variable assessments to be made. In other words, 
problems such as disproportionate, arbitrary or discriminatory policing may stem from 
insufficiently precise legislation, and these problems might be able to be alleviated or minimised 
through specific reforms that more precisely define targeted practices, activities and behaviours. 
We also found that the provisions convey decision-making powers and/or authority to a wide 
range of decision-makers, bodies and authorities. In some instances these decision-makers are 
familiar, highly trained and regulated (e.g. the police) but in others, powers are conferred upon 
private citizens and organisations who may be less familiar, well trained or well versed in the 
exercise of power (e.g. mining operators, employers, sellers of goods). We noted that the 
stigmatising and/or discriminatory potential of law was reduced when targets were offered 
protections in law. While most provisions provide some protections for the target, 30.94% do 
not. The stigmatising and/or discriminatory potential of law might be alleviated or reduced 
where the protections in individual provisions are included and strengthened, or where the 
strengthening of overarching legal protections for people who use AOD is embedded in other 
laws (e.g. anti-discrimination protections).  
 
  
58 
 
5. INTERVIEWS AND ANALYTICAL CASE STUDIES BASED ON INTERVIEWS 
In total, 21 interviews were conducted at three sites in Queensland during September and 
October 2016. Interviews were conducted at a residential rehabilitation treatment service located 
in outer Brisbane (n=6), a residential rehabilitation treatment service located in northern regional 
Queensland (n=9), and a needle and syringe program and primary care clinic in inner city 
Brisbane (n=6).4 
Fifteen men and six women were interviewed across the three sites. Participants were aged 
between 25 and 59 years (with a mean age of 38 years across the sample).  
For the majority of participants, poly-drug use was common. Most participants reported having 
used alcohol, cannabis and methamphetamine, and five participants had also used heroin at some 
point in their lives. Three participants also mentioned non-medical use of pharmaceutical drugs 
including dexamphetamine, benzodiazepines and oxycodone, and two reported morphine use. 
Two participants primarily used alcohol. Fourteen participants had injected drugs in their 
lifetime.  
The majority of participants had engaged with multiple drug and alcohol treatment services, at 
various times, including residential rehabilitation services, detoxification services, AA and NA, 
workplace employee assistance programs, counselling, psychologists, psychiatrists, opioid 
treatment programs (including methadone and suboxone), as well as seeking help through 
general practice and primary care.  
Many participants had been employed in industries including hospitality, hairdressing, finance, 
fishing and trawling, building and construction, nursing, truck driving, and public service. None 
of the participants were working fulltime at the time of interview due to engagement in a 
residential treatment program, homelessness, issues related to their drug use, health or criminal 
history (some participants were planning to return to work after treatment, and had jobs held for 
them). Eleven participants said that they had children (at the time of interview, the majority of 
these participants did not have their children in their care).  
Six participants said they were originally from Brisbane, and seven participants were originally 
from regional Queensland (including Mackay, Townsville and Charters Towers). Seven 
participants were born interstate (NSW, Victoria and Western Australia) and one participant was 
born overseas. All participants had been living in Queensland for a significant period prior to the 
time of interview. While we did not specifically ask about Aboriginal and Torres Strait Islander 
status, two participants identified as Aboriginal when introducing themselves to the interviewer.  
Analysis of the interviews is presented in two sections. In this first section, we present a thematic 
analysis exploring experiences across the interview sample as a whole. In the second section, we 
build a series of illustrative analytic case examples.  
                                                 
4 The names of these services have been anonymised to protect the confidentiality and anonymity of the 
interview participants. We are grateful to QNADA for facilitating collaboration with the participating interview 
sites, and we thank the services for their assistance. 
59 
 
5.1 Experiences and effects of stigma  
Experiences of stigma and discrimination were ubiquitous as participants told their stories. Every 
participant said that they had been stigmatised, judged, treated differently or discriminated 
against because of their alcohol or other drug use at multiple times in their lives, and could 
describe specific instances when this had occurred.  
Participants experienced stigma across a range of settings including health care, policing, 
employment, child services, courts, welfare services, as well as in relationships with family and 
friends, and in the general community. Experiences ranged from social isolation and family 
exclusion, to verbal abuse, denigration and being called names, to looks of disgust, violence and 
being spat on in the street, as well as denial of service or dismissive or abusive treatment from 
professionals in positions of care, power or responsibility. These experiences created inequitable 
barriers in the most fundamental aspects of people’s lives including health care, justice, family 
connection, employment opportunities, welfare, housing, and community belonging. Every 
participant could account for such experiences across multiple settings in their own lives, and 
described these experiences as being the norm.  
First, we describe participants’ experiences in broad terms, including participants’ own 
descriptions of the impact of stigma in their lives. We then turn to examine participants’ 
descriptions of how stigma and discrimination manifests in particular settings and sectors, and 
contrast these experiences with (comparatively rare) positive examples of instances where 
participants had not felt judged in these settings.  
Stereotypes and assumptions 
Participants described the ways in which they were labelled, stereotyped and had assumptions 
made about them because of their problematic AOD use:  
“Society has painted a certain picture that they see us to be. Unfortunately, it’s not a nice 
picture. […] They assume that we’re all low lives, dole bludgers, pretty much want 
everything given to us on a silver plate. We don’t want to work for it, we’d rather sit at 
home and do drugs than actually work and make a living. That’s not the case. Yes, there 
are a small group of people out there that do fit that lifestyle, but there’s a large portion 
of us that don’t do it for that particular reason. […] A lot of people in here, including 
myself, we’re very switched on. We’ve done apprenticeships, we’ve got certificates and 
degrees and all that sort of stuff. It’s just that we’ve been stuck at a certain point in our 
life that we’ve got nothing to look forward to. But we’re not all street bums, and that’s 
how I think we’re looked at. But it’s hard. Society has just blanketed a certain picture and 
everyone just goes with it, because they don’t know any different.” (Interview 6, Female 
32 years) 
The pervasiveness of this stereotypical “picture” of people with a lived experience of 
problematic AOD use meant that participants were treated differently in many aspects of their 
lives. Such assumptions and stereotypes led to status loss, discrimination and unfair treatment: 
“I’ve been treated differently now because I’m using drugs.”  (Interview 17, Female 42 
years) 
These experiences of stigma and discrimination had profound effects on participants’ self-
esteem, alcohol and other drug use, and produced barriers to seeking help, as detailed below.  
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Subjectivity, self-esteem and self-worth 
When participants were asked how experiences of stigma and discrimination made them feel, 
they described feelings of degradation, shame and anger: 
“It made me feel like a piece of s**t, really. It made me feel like I was nothing better than 
the thing on the bottom of your shoe.” (Interview 6, Female 32 years) 
“It doesn't do anything for my self-esteem or my confidence, that's for sure, and it gets 
me really angry.” (Interview 10, Male 38 years) 
Such experiences had adverse impacts on individuals’ feelings of self-worth, mental health and 
sense of connection to community: 
“Puts you into a spiral, I suppose - it affects your mental health, your self-esteem and 
your self-worth, who you are as a person. If you’re not - if you’re being stigmatised as 
that and - you know, one thing that people in the world strive for is connection, and if 
no one wants to connect with you then you have nothing, and you’re just going to a 
mental health spiral of darkness in the end. It leads down the roads to suicide and self-
harm and things like that. I mean, we put ourselves there but that’s where that stigma 
takes you, because no one wants to be around you so you’re only with you and yourself 
and your mind.” (Interview 3, Male 30 years) 
Repeated experiences of stigma and discrimination shaped how participants saw themselves and 
their place in the world. Where certain stereotypical “junkie” attributes were assumed or 
expected, some participants talked about how they would end up performing that role out of 
sheer frustration: 
“Yeah, it’s got a way of bringing out the worst in you.  And the more you get pushed in 
the corner, the more you hate, because you’re not fitting in, these people are doing this to 
you, so you’re, in a roundabout way, giving them the ammunition that they need.” 
(Interview 13, Male 38 years) 
“Having that put on you by people that don’t even know you, don’t know your story, if 
they don’t know you from a bar of soap, they only know you through someone else, for 
them to judge you and class you as something that is worthless, it’s hard to deal with. 
That just spins you into a further addiction because you’re like, people already think less 
of me. I’m not a Class A citizen. I might as well just be a junkie. So it is hard.” (Interview 
6, female 32 years)  
“By the end of it, I suppose you’re worse because you get that idea of, I don’t give a f**k 
what you think. It’s - I’m like, you want to portray me as a junkie? I’ll show you what a 
junkie acts like. That’s the way my mind - yeah. Not - just bung it on, I suppose, you 
know what I mean? Play up like a junkie.”(Interview 1, Male 32 years) 
As we discussed in the literature review, theorists have also described the notion of ‘self-stigma’ 
or ‘internalised stigma’. In these interviews, it was evident that participants had internalised the 
shame associated with the “picture” of problematic AOD use presented by society. Given the 
frequent experiences of stigma and discrimination in their lives, some participants found it 
difficult to believe in their own worth or hold onto an identity outside of this stigmatised image: 
“When you’ve heard it for long enough, after a while people who treat you differently 
and say this, that and the other, you start to almost feel like that. You start to think 
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whether or not what they’re saying is true. Sometimes I’ve second guessed myself.” 
(Interview 19, Male 47 years) 
“You feel a little bit of shame and guilt because of where - you know that you made your 
own bed. You feel a little bit untrustworthy, you feel dirty and you feel like you have to 
climb up a mountain to say, ‘Hey, I'm actually a decent person when I'm straight’.” 
(Interview 4, Male 27 years) 
Effects on drug use 
Stigma did not provide a discouragement to problematic AOD use and was not a motivator for 
getting help. Many participants talked about how stigma and discrimination made them feel 
worthless and hopeless, which in turn triggered them to use alcohol or other drugs or give up on 
seeking change in their lives: 
“Being told that you’re worthless, you’re good for nothing, you’re a low life, you’ll never 
accomplish anything, makes you feel if I’m not good enough, why should I even bother? 
So for me personally, it made me want to go harder in my addiction, because I was 
always - I was already classified as nothing, a no-hoper, so why should I even bother 
trying?” (Interview 6, Female 32 years) 
“Yeah it’s like that’s why you take drugs is to forget that s**t.” (Interview 11, Male 44 
years) 
“Quite often it triggers me to just give up and go back to using drugs.” (Interview 7, 
Male 51 years) 
Stigma as a barrier to help-seeking 
As such, experiences of stigma and discrimination created barriers to seeking help or getting 
treatment, even at times when participants had felt they really needed it. Experiences of stigma 
and discrimination at the moment of help-seeking (for example, from health care workers, 
doctors, psychologists, welfare services, or even AOD treatment providers) discouraged 
participants from seeking help again or finding other pathways into treatment: 
“There’s no good feeling from it, so as an addict, you take the bad from every - you take 
the worst from anything. F**k it, I’ll just go and use. They don’t help me, no one wants 
to help me. You’d think a doctor would if anyone’s going to. And you go and use.” 
(Interview 1, Male 32 years) 
“The judgment does come in, when you really need that help. So you get knocked back a 
few times, and that’s what makes you go back out using. Well, that’s for me anyway. It 
makes me want to go back out and use and go to the black market to buy it. So it’s a lot 
harder in so many ways.” (Interview 15, Female 27 years)  
Within group stigma 
While experiences of stigma and discrimination were ubiquitous across the sample, participants 
also noted that different stigma attached to different kinds of drug use. Not all problematic 
AOD use was stigmatised in the same way. Some individuals felt that particular groups of people 
and behaviours were more stigmatised and marginalised than others, even amongst those with 
experience of problematic AOD use. This accords with what has been described as ‘within 
group’ stigma (as we noted earlier in the literature review). As one participant said: 
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“The heroin addicts all look down on the speed addicts, and the speed addicts look down 
on the alcoholics and all three all look down on the petrol sniffers. There's always going 
to be judgement, even within the drug world.” (Interview 8, Male 45 years) 
Given the heightened public attention given to methamphetamine in recent years, participants 
felt that methamphetamine use carried a particular stigma, over and above the stigma associated 
with other kinds of drug use. Whereas some participants could be quite open about their 
cannabis use for example, they described hiding their methamphetamine use and being pushed 
away by family and friends due to the stigma associated with this particular drug: 
“When I say treated differently, it’s almost like - with the ice, it was - ice was more of a 
hidden addiction. It’s not something you run around and tell everyone that you’re doing, 
whereas dope’s quite a social and a commonly used drug, I find in Australia. You have a 
few cones or you have a joint. You find that there’s a few people around that - yeah, I’ll 
have a puff on that. It’s like the next day, no one talks about it. It’s a common thing.” 
(Interview 3, Male 30 years) 
“My brothers they didn’t talk to me. They pushed me away actually in the ice usage. Not 
because of the pot. Like they were cool for it because they both smoke it.” (Interview 5, 
Female 31 years) 
Many participants also described the particular shame and judgement associated with injecting 
drug use. The stigma of injecting was compounded by the co-stigma associated with blood borne 
viruses such as hepatitis C and HIV: 
“‘You're a filthy disease-spreading’ - I feel that's come into play a lot, there's an 
undercurrent of almost, ‘Ice smoking is fine, but let's hotshot the IV users, because 
they're the real maggots who spread disease and cause all the trouble’.” (Interview 8, 
Male 45 years) 
5.2 Settings 
As participants talked about their experiences of stigma and discrimination, they were 
encouraged to give accounts of specific times when stigma had occurred in particular settings. 
Participants were also asked to describe times when they had not felt stigmatised in particular 
settings, and talk about what had been different in those instances. In this next section of the 
thematic analysis, we present participants’ accounts and experiences in each of these settings:  
• Family/social;  
• Health care;  
• Employment; 
• Police/public order;  
• Child services/Legal issues/Courts;  
• Other services; 
• Society at large. 
Family/social  
Participants described the ways in which family, friends and others in their social worlds had 
distanced themselves because of the participant’s problematic AOD use. Participants felt that the 
stigma associated with problematic AOD use led to separation and status loss. Many participants 
had suffered social exclusion, or had been treated as though they were an embarrassment to their 
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family and friends. This manifested in multiple ways, often by being excluded from important 
social gatherings (such as birthday celebrations or weddings): 
“I would not get invited to certain things because they didn’t want their children or their 
friends to be around me. Even though I wasn’t using at that point, I was still classed as a 
junkie and they still saw me to me that dirty person. If I did go to an event, there would 
always be talking or whispering behind your back, or pinpointing, and you could feel it, 
and you heard it. It made me feel like a piece of s**t, really.” (Interview 6, Female 32 
years) 
“Birthdays, gatherings, weddings, dinners and not - no invites being handed out, because 
you’re an embarrassment. That’s what it comes down to.” (Interview 3, Male 30 years) 
The stigma and discrimination associated with problematic AOD use led to many participants 
being estranged from their families, friends and communities:  
“Not very long ago my sister and my brother stopped talking to me because they found 
out that I used to inject.  Well, they asked me about it because someone else told them 
and so I was honest with them and I told them and they just stopped talking to me, so 
they judged me pretty harshly on that.” (Interview 18, Male 25 years) 
Underlying these experiences of social exclusion, were stereotypical assumptions about drug use 
and the people who use them. Endorsement of the stereotypical ‘junkie’ image pervaded many 
interactions, leading to separation and isolation. Participants spoke about how friends and family 
members assumed that they were untrustworthy, violent, and erratic because they had a history 
of drug use, and would distance themselves often without discussion: 
“With one of my best mates, and he still doesn’t talk to me now. Same thing. He has two 
kids. One’s the same age as my daughter and because he knew what I was doing, using 
ice and that, he still hasn’t talked to me since February this year. If that’s not a little bit of 
- he doesn’t know anything about drugs so he would’ve just researched and seen what’s 
on TV, and gone, ‘He’s like that? He’s not coming near my family.’ I’ve tried to reach out 
just recently and I still haven’t - I haven’t heard anything back.” (Interview 3, Male 30 
years) 
“They look at me as I’m a junkie and I can’t control or budget money, like they wanted 
to give me vouchers for my birthday instead of like I used to always get money to buy 
something.  And I said, ‘Look mum, like I’m a big boy, I can control what I spend my 
money on’ and like even my kid’s presents, she puts her money into a bank account now 
because my ex said one time when we were on the phone that I was spending all the 
money. My kids always got their birthday money and their present, like it’s there. Like I 
can be a piece of s**t sometimes but I’ve never lowered myself that bad.” (Interview 11, 
Male 44 years) 
“I’m more judged than anything. People are more worried about stuff being laying 
around because they think it’s going to be stolen […] So that makes it a lot harder to 
build a friendship or have a friendship while you’re on drugs.” (Interview 15, Female 27 
years) 
Many participants talked about a lack of understanding about problematic AOD use, which 
meant that negative stereotypes dominated interactions with family and friends and led to social 
exclusion: 
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“instead of trying to understand why, they just put me in one big - you know, put me in 
that category and like don’t want to know you sort of thing. Yeah. Same with my brother. 
We don’t talk because of it. No one ever asked me, ‘Why are you doing it?’ They were 
just like, ‘Oh, you’re nothing but scum.’ Put you in that one category.” (Interview 16, 
Female 38 years) 
Few participants could describe positive situations where they had not felt stigmatised or 
discriminated against by family or friends. Of those who did have positive experiences, two 
factors were important: (1) understanding; and (2) inclusion: 
“Mum’s particularly good. She’s known about my problems for years and she still stands 
by me, you know. […] She used to do a bit of counselling so she understands, which is 
good, and, you know, I rarely see that really.” (Interview 18, Male 25 years) 
“They’ve tried to understand. They’ve tried to understand what was going on through 
their daughter’s mind, but at least they tried.” (Interview 16, Female 38 years) 
“My immediate family don’t judge me; my Mum and my Dad. So they’re really good, 
they’re really supportive.  
Interviewer: What’s different about that support? 
Well, it’s unconditional for starters. What’s different is that it makes you feel included.” 
(Interview 19, Male 47 years) 
Health care  
Participants described experiences of stigma and discrimination in a range of health care settings 
including hospitals, GPs, psychologists, pharmacies, and dentists. Across the interviews, most 
participants could describe stigmatising experiences in these settings.  
Of the many accounts, the most distressing instances were those when stigma and discrimination 
produced barriers to participants accessing appropriate treatment for health conditions. Many 
participants spoke about such experiences, especially in relation to hospital and emergency 
department settings: 
“One time I went into hospital for something. One of the doctors said, ‘She’s a bloody 
drug user. No use keeping her in hospital for the night. May as well just treat her and let 
her go, because she won’t stay in hospital.’ I said, ‘What?! Sorry?!’ I said, ‘I love hospital, 
I’ll stay in here for the night if you want me to.’ But saying that about me? I felt a little bit 
down.” (Interview 9, Female 46 years) 
Due to these kinds of experiences, some participants even reported using self-harm as a strategy 
to ensure they would be looked at and taken seriously when seeking medical attention in 
emergency departments: 
“If I really need to get help, I will honestly do some real damage to actually get looked 
at.” (Interview 14, Male 35 years) 
For people experiencing homelessness, there were particular challenges. The co-stigmas of 
problematic AOD use and homelessness produced multiple barriers to accessing medical care: 
“Well, if an ambulance comes and picks me up after I feel like I’m having a heart attack, 
because I’ve got a swag, I’m homeless, and I be honest, I tell them that I drink a lot, and 
I just had two cans of bourbon, so it’s not withdrawal. And the first thing ambulance 
driver did was tell the doctors it’s just alcohol withdrawal and I got told to leave. I had a 
temperature of 41.9 and they said there was nothing wrong with me. Now, there is 
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something wrong with you when you’ve got a temperature that high. Because I’m 
homeless and alcoholic, ‘No thank you. We don’t need you. We don’t need to help you’.” 
(Interview 7, Male 51 years) 
“When it comes to a homeless person they just write them off as you’re either on drugs 
or you’re trying to get out of sleeping outside as well, because they’re trying to get out of 
sleeping outside, but if they’ve got a problem, they’ve got a problem. Like last time I 
went to hospital, they were about to let me go and then they found out that I had a 
broken ankle and I had cellulitis on one of my legs and septicaemia on my arm and all 
the rest of it. No one really walked me out because they thought I was faking my limp 
and all the rest of it.” (Interview 14, Male 35 years) 
One particular source of stigma and discrimination was the assumption that participants were 
merely ‘drug seeking’ when they were seeking treatment for medical conditions: 
“They just assumed that I was there for something, a big hit of bloody morphine or a big 
hit of Fentanyl or something” (Interview 12, Male 59 years) 
“Look, I've always thought every time I go to a doctor, because it's on my record of 
being a drug user - like I go to a hospital and I've got a toothache, right? I go there and 
I'm like, I really need some painkillers. And I'm sure when they put in my name, it comes 
up colourful and says red flag, don’t give him anything. So then I don’t get anything for 
my pain that I'm having. So there has been times like that, where it's just like wow, 
because of the past, it alters where I'm at, you know what I mean?” (Interview 4, Male 27 
years) 
“There's been a couple of situations where I've been at the hospital because I've been 
really sick with a bad migraine, and what-not, and because it's on my file that I used to 
use, they won't treat me up there, they just put me down that I’m an ice junkie, you 
know, and I don't even use the stuff.” (Interview 10, Male 38 years) 
Such discriminatory treatment was not only a barrier to seeking diagnosis or appropriate pain 
management, but also in relation to psychiatric conditions. Even where participants had been 
assessed and diagnosed, continuity of treatment was often difficult when faced with new doctors 
or health workers: 
“My shrink took off, he went to Tasmania and didn’t tell any of his patients, took all their 
files, everything.  And with dexamphetamines you can’t really stop taking them, you’ve 
got to keep taking them.  And the only way to get them is through a psychiatrist.  So I’ve 
gone down to [a mental health service]  and told them my situation and basically the 
security guard there has thought I’m a f***ing junkie, ‘Oh you just want to get on to med 
– on dexamphetamines’ and I’m like, ‘Mate, I’m f***ing on them, I need to be on them, 
I’ve been told not to stop them because it can really f***ing affect me and you’re putting 
me on a f***ing junkie you piece of s**t, come out here, I’ll f***ing show you what 
junkies are all about c**t.’  And anyway eventually I did get some help.  But why did I 
have to be treated like that and why did I have to react like that for me to get help?  Like 
I just wanted to know how I could get my medication.” (Interview 11, Male 44 years) 
These assumptions about drug-seeking behaviour also created barriers when participants had 
sought help with AOD problems and mental health. The assumption that as a ‘drug user’ all that 
they were interested in was a prescription often meant that other pathways and treatment 
options were not offered by health workers, at times when participants were seeking advice: 
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“I’m not here to get a prescription, I’m actually here to get some help or some 
counselling or some ideas on how the f**k can I get off this merry-go-round?” 
(Interview 11, Male 44 years) 
While it might be assumed that doctors (particularly GPs) might be a first point of contact for 
many people needing help or advice about their problematic AOD use, the stigma associated 
with problematic AOD use meant that many participants said they had been reluctant to talk 
about alcohol and other drug issues with doctors. Participants were fearful of enacted stigma, 
were worried about disclosure and confidentiality (especially with local services or family 
doctors), and anticipated a lack of understanding: 
“I went to my family - my always family doctor, from - which was a hard thing to do, 
because I didn’t want to tell anyone I was an addict. 
Interviewer: Why didn’t you want to tell him that? 
Just - it was still a hard thing. Mum’s house had been raided and stuff before. She had - 
she knew, but your parents don’t want to ‘know’. She knew I was an addict, but she 
didn’t - they don’t want to think you’re still using, you know what I mean? They just - 
yeah. So I didn’t want to tell the family doctor, and I know he wouldn’t have told her 
directly but it still would’ve - yeah.” (Interview 1, Male 32 years) 
“It’s just like that with the doctors. Because they’ve never been a drug user or anything of 
the sort to know what you go through, they have no reason to sit there and judge you for 
the person you are or what life you’ve been through, what steps you’ve taken to try and 
help yourself. You’re doing the right thing coming to a doctor, and then that happens, 
well, it doesn’t make you want to go to the doctor and seek help, or go seek help 
anywhere because you think you’re going to get judged everywhere else because of that 
one thing. So it makes it a lot harder.” (Interview 15, Female 27 years) 
“It was difficult going - because the local doctor looks at you like, “Well, just get off it.” 
They don’t understand. Well, from my experience, they don’t understand that it is a 
disease. They just think, just stop using it. Well, it’s not that easy.” (Interview 1, Male 32 
years) 
Many participants also described times they had been discriminated against in pharmacy settings. 
These experiences often occurred when participants were taking care of their health by accessing 
methadone treatment or buying sterile injecting equipment to help prevent blood borne virus 
transmission. Such purchases in these settings were not looked upon positively, but rather 
‘marked’ them as people who used drugs and therefore not worthy of the same service as other 
customers: 
“The pharmacy assistants you could tell just thought of us as second class because, you 
know, you can just tell by people’s body language and the way they served us and just 
spoke to us and stuff. They weren’t willing, there was just like that sense of disgust, you 
know what I mean. You know when you can just tell, because people, they snatch things 
from you and they - it’s hard to explain, like body language, you know, and they’d sort of 
talk in a different tone of voice. They weren’t in any hurry to serve you when you were 
clearly the next one in line, they’d call other people, stuff like that. […] it was like we 
were second class, just because we were on that [methadone] program, you could just tell 
that they knew, you know, they thought of us as junkies. Well that’s how I felt anyway.” 
(Interview 19, Male 47 years)  
67 
 
“I remember there was a guy behind me in line at the counter and I said, ‘Can I get a 1ml 
sharps kit, please?’ And they’re there on standby. When I said that, I noticed the man 
behind me kind of stood away a bit.” (Interview 17, Female 42 years) 
Some participants spoke positively about times when they had not felt stigmatised or 
discriminated against in health care settings. While the negative experiences certainly outweighed 
the positive experiences, some could describe occasional instances where they had received good 
care and had not felt judged. When participants spoke about these positive experiences in health 
care settings, they spoke of a sense of understanding and the provision of a different kind of 
‘care.’ For people who so often experience marginalisation and exclusion, having health workers 
who understood their problems and engaged with them in a different way was important: 
“They’re more sympathetic, more understanding.  They know people have problems, and 
what-not.”(Interview 10, Male 38 years) 
“She actually listened to what I had to say, she had positive things to say.  Made me feel 
good about myself and said, ‘Look, like you’re just dealing with it the only way you know 
how, don't, stop kicking yourself’.” (Interview 11, Male 44 years) 
“He was giving me a kick in the arse without putting me down.” (Interview 11, Male 44 
years) 
“She actually cared and she looked into alternative things like relaxation and even reiki, 
and just not that she did it, but she gave me the option, the opportunity to look into that 
sort of stuff.  And she researched stuff for me whereas I was too lazy to do it and made 
an effort, you know what I mean?  Like went past what she was supposed to do.” 
(Interview 11, Male 44 years) 
“They were beautiful; both of them were beautiful, they had my best intentions at heart.  
[…] They didn’t see what the society saw, they had understanding, they could see me for 
me.” (Interview 13, Male 38 years) 
Being seen as a ‘normal’ patient in clinical settings, not as a ‘just a drug user’ or ‘just an alcoholic’ 
was particularly important. This sense of being seen as an individual often manifested in very 
simple, yet effective and powerful ways, through conversational style and listening:  
“They just want to talk to you like a normal person.” (Interview 14, Male 35 years) 
“It was a nurse or a mental health worker in the detox, and he was going out of his way 
just to help me.  Like he'd take me down to the little reading corner, the reading nook 
and we’d talk” (Interview 5, Female 31 years) 
“He actually sits there and has a conversation and doesn’t judge you, has a yarn and, you 
know, asks how your days going and how can he help you. He’s like, you know, there’s 
other alternatives and this and that, this might work better. He just supports more in a 
way than tells you what you should and what you shouldn’t. And that’s what I think you 
need more when you’re in a drug problem. You need that support behind you and it’s 
hard to find because you’re so judged by a lot of people, that they don’t have no time for 
you because they see you as somebody else and rarely the person you are inside.” 
(Interview 15, Female 27 years) 
“It’s the little ways about how you speak to someone or what you say. And I would have 
gone into a rehab a long time ago if I was asked to, not told to.” (Interview 7, Male 51 
years) 
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“His demeanour, his attitude, I think.  He asks questions, he just doesn’t wait for you to 
talk, he asks questions, how we are, how we’re going, how this is going, what’s going on 
in your life, that sort of thing.  He’s a sympathetic ear.  He’ll listen to you.  Everything, 
everything about him is different.” (Interview 12, Male 59 years)  
Employment 
Most of the participants had worked throughout their lives, and were qualified and experienced 
in a range of different employment sectors including hospitality, hairdressing, finance, fishing 
and trawling, building and construction, nursing, truck driving, and public service. In some 
industries, alcohol and other drug use was common and acceptable (and sometimes even seen to 
be ‘part of the job’ when participants were required to work long hours or do extra shifts, or take 
part in work lunches): 
“I’ve been in the trucking industry where sometimes you need to use drugs just to get 
through the day, like we were doing 24 hour days at some stages and it’s just ridiculous.  
And people don't care about you, they just want the job done.  When my truck broke 
down I sat on the side of the road for eight hours until another truck come along, I had 
to load that and then go and do all the drops anyway.  And that ended up being like a 22 
hour day.  Which is against the law for one and two, they didn’t care about my safety or 
anyone else’s safety, they just wanted the job done.” (Interview 11, Male 44 years) 
“They used to take me to lunch, the bosses. 
Interviewer: They used to take you to lunch? 
Yeah, big Chinese banquet and a Crown lager. And then about seven Crown lagers and a 
meal later I’m back at my desk curled up sleeping. I get woken up and told to drive 
across Canberra, but because it’s a red Z plate, I couldn’t be done for drink driving. And 
it was just expected of you.” (Interview 7, Male 51 years) 
“Hospitality in pubs. So for my industry, it was always common. Management used and 
stuff. I’ve been in that - did that for about ten years. It was almost like if you did it, you 
were part of the crew, because that was a common thing working in that industry, is 
drugs. Even ice too. See, I wasn’t - because I’ve always done that industry, it wasn’t like I 
was pushed away because of it.” (Interview 3, Male 30 years) 
“[It is] kind of known for hairdressers to be involved with the drug scene.” (Interview 6, 
Female 32 years) 
Stigma and discrimination manifested in different ways in participants’ work lives. For some 
participants, AOD-related stigma was a barrier to employment. In particular, stigma made it 
difficult for some participants to return to work after they had been in treatment. Sometimes this 
resulted in participants being held back from promotion, or being forced to take lower pay rates 
because their alcohol and other drug use history had become ‘known’ in their industry (this was 
particularly problematic for people living in smaller towns or regional centres, where job markets 
were tighter). While participants said they had come to expect stigma and discrimination in many 
areas of their lives, the ways in which it stymied their careers or prevented them from getting 
work was particularly distressing: 
“You get stigma in society, you know what I mean, he’s a f***ing nutter or he’s a junky 
f***ing nutter, but they’re just the haters.  It’s when it affects your career, that’s the 
problem, you know what I mean?” (Interview 13, Male 38 years) 
The intersection of past drug use with criminal histories was a particularly difficult barrier to 
overcome for some participants: 
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“It’s stopped me from getting jobs, certain jobs in the past -  
Interviewer: Tell me a bit about that? 
Actually, not just my drug use, but my criminal history. They both go hand in hand 
because I wouldn’t have had one without the other. I wouldn’t have a criminal history if 
it wasn’t for drugs, so I just use those terms interchangeably. But yeah, I’ve applied for 
jobs and I’ve been knocked back because of security purposes. I’ve applied for a job and 
gone through all of the other steps, you know, and then at the last hurdle when they’ve 
done a security check, I’ve been found not suitable.” (Interview 19, Male 47 years) 
When participants were repeatedly discriminated against by employers or unable to find work, 
this had profound effects. Where AOD-related stigma produced barriers to employment, 
participants felt discouraged from making change in their lives and felt worthless: 
“I didn’t feel worthy. I didn’t feel as worthy because three people knocked me back 
because I had a criminal history. I almost thought - well, I did think, I should just chuck 
this in and just go back to - because I’d battled for a few years to get my clean time up to 
get into a routine of not being an addict and trying to work and stuff like that. So I’d put 
in the hard yards, only just to be kicked in the teeth three times. And then I sort of 
thought, well, stuff it. I’ll just go back to stealing and robbing places. Because you start to 
think is it all worth it, you know. And when people treat you like this, it’s not, or if 
employers treat you like this, what’s the point. What am I doing all this for anyway when 
it doesn’t make any difference? It’s not making any difference - people are still 
marginalising me at work.” (Interview 19, Male 47 years) 
A few participants spoke about positive experiences in the workplace, where they felt they had 
been supported. These experiences and work environments were characterised by employers 
being supportive of participants’ requests to take a leave of absence to seek help, pathways into 
support such as access to confidential counselling through employee assistance programs, and a 
sense that employers had their best interests at heart. Support, understanding and flexibility from 
employers while participants were engaged in treatment were particularly important, and helped 
to validate the choice to be in treatment: 
“When I was on the methadone program - it was out there at this one place I worked, 
because I used to have to go and pick up my methadone after work had started. And I 
used to get support from them. They used to ask me about my story and how I came to 
be the way I was and stuff like that. They were all supportive, and if they could do 
anything for me, you know, they’d ask me, ‘If we can help you in any way, let us know’.” 
(Interview 19, Male 47 years) 
Police/Public order 
Contact with police was one setting in which many participants said they had experienced stigma 
and discrimination (and in some cases, even violence and degradation). Many participants felt 
they experienced stigma and discrimination by being ‘targeted’ as people who were known to 
have a history of problematic alcohol and other drug use. Being the constant subject of police 
attention was particularly difficult for people experiencing homelessness, as they did not have a 
private space to go to. Being ‘known’ to police due to past alcohol and other drug use history 
often resulted in being singled-out, regularly searched and questioned in the street: 
“The police are always, they’re just public enemy number one. They’ll just harass you for 
any reason at all, like they’ll just, they want to pat you down and strip you off. If you’ve 
got anything like of a criminal record or anything to do with a criminal record and say 
you had a drug conviction for a possession of a joint 20 years ago, they’ll still want to pat 
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you down, they’ll still want to do something, see what you, who you know, and they’ll 
want to look at your phone and they’ll want to say, ‘Who’s this?’ and, ‘Who’s that?’  Yeah 
that’s discrimination I suppose.”  (Interview 12, Male 59 years) 
Once ‘known to police’, participants felt they were targeted even when they were not using or 
when they were engaged in treatment. Such experiences were constant reminders to participants 
that shedding the stigmatised drug-using identity was incredibly difficult: 
“I have had organisations like Queensland Police, even though they know that I've been 
rehabilitated, that I'm trying to change my life, they're still down on me like I'm a piece of 
scum.  […] Well, I got spoken to a few months ago, and I hadn't had any drugs in my 
system, but they just spoke down to me just like I was scum, even when I'm trying to 
make an effort.” (Interview 10, Male 38 years) 
There were very few positive examples of non-discriminatory interactions with police across all 
of the participants’ accounts. Only a few participants could describe a time they had not felt 
stigmatised in an interaction with police, and these all occurred after participants had engaged in 
treatment: 
“We were in rehab in a car, but we got pulled over. And the police officer was like, 
‘How's your night been? Have you had anything to drink?’ We're like, ‘No, we're 
recovering addicts.’ And they still went about their business and did the breathalyser, 
which is protocol. And it all came up fine. But his reaction to us was completely 
different. […] Previously in the past when I've been pulled up for drink driving, whether 
I'm high or coming down, either way, I was an addict, my reaction has been short and a 
little bit dismissive, with their reaction being very to the T, to the line, showing no 
respect back. But in this case, we were open about the fact that we were recovering 
addicts and it was like the response was good. He was smiling, saying ‘That's really 
awesome, you guys are doing really well, good on you.’ (Interview 4, Male 27 years) 
When asked how this positive interaction with police made him feel, the participant said: 
“Just encourages you to keep doing what you're doing. Encourages and reaffirms to you 
that you are the person who you were in the beginning. Reaffirms to you that you aren't 
your choices and you aren't your behaviours, that you are who you are. You have worth.” 
(Interview 4, Male 27 years) 
Child services/Legal issues/Courts  
A number of participants in the sample had been involved in various legal processes, not 
necessarily related to alcohol or other drug offences. Sometimes these legal processes had been 
related to family court business and child custody battles, and in other cases participants had 
been involved in various criminal proceedings (ranging from small fines and charges of drinking 
in public, to driving under the influence and domestic violence). Participants said that previous 
history of drug use would come up in court proceedings, even long after participants had 
accessed treatment. In these settings, particular use of language devalued and discredited those 
individuals. Rather than being seen as a person who had successfully made change in their lives, 
recovery was sometimes referred to as an ‘inactive period,’ reinscribing the ‘junkie’ identity: 
“I’ve shown 18 months of clean drug-testing and all the rest of it, but because I’ve had 
previous history on police records, and mental health records, it was all brought up that 
I’d suffered from induced psychosis and all the rest of it, it was basically dismissed as 
yeah, you’re just having an inactive period.  
Interviewer: Okay, so that was the terminology they used?  
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Yeah, it’s kind of all you’re being told is that you’re still a junkie, you’re just inactive.” 
(Interview 14, Male 35 years) 
These stereotypes meant that participants felt like they were often treated as a ‘lost cause’ during 
legal proceedings, given the assumptions being made about their likelihood of recidivism: 
“‘A lost cause,’ you know, ‘He's just going to reoffend anyway. He'll either end up in jail 
or dead like most junkies do.’  Or alcoholics.” (Interview 8, Male 45 years) 
Several participants with children did not currently have their children in their care at the time of 
interview. These participants had engaged with a variety of legal processes around child services 
and access. Participants spoke about how stigma and discrimination were often present in these 
settings and interactions: 
“Like every time, we’d be there for an hour and then your kids are ripped apart from you 
again. So that’s more f***ing trauma you’ve got to go through on a weekly basis and your 
kids are asking you, ‘Why can’t I come home with you?’ Oh because I smoke f***ing 
dope.  That’s the only thing they had on me. And then they wanted me to do urines in 
front of women to prove that I smoke f***ing dope when I told them straight out and 
then they say, ‘Oh amphetamines are coming up,’ I said, ‘Look I’m f***ing prescribed 
this s**t, it’s got my name on it.  It comes from a psychiatrist who’s diagnosed me with 
an illness for me to take this medication.’  And then they want to do separate tests, I said, 
‘Well you go for it.’  I said, ‘But that's going to cost you thousands of dollars extra just to 
find out that he’s actually on medication.’ Because I did stop using drugs when I was 
around my kids, except dope, I refused to, I’ve smoked the s**t for 20 years, it doesn’t 
stop me from being a good dad. You know what I mean?  Like it never stopped me from 
functioning and I went to work, I’ve done everything on the s**t.” (Interview 11, Male 
44 years) 
Given that evidence of any kind of drug use often triggered processes with child services, 
participants who had children were reluctant to disclose their need for help. Seeking support at 
difficult times created major barriers to having access to their children, even after successfully 
seeking treatment. One participant recounted a time when he had been struggling with 
problematic drug use, so he had sought support from services to help him take care of his 
children. By admitting that he needed help and support, he had thought that he was doing the 
right thing. However, this past admission had become an ongoing issue which constantly placed 
him at a disadvantage in current proceedings. He felt that his admission that he needed support 
was now being held as a ‘blanket’ charge against him; a comprehensive and unmitigated 
indication that he could never be a responsible parent, even though he had successfully sought 
treatment and was now in a position to take care of his family: 
“I’d put my hand up and said, ‘Hey, I've got a drug problem, that I can't look after - keep 
up myself, let alone look after my children.’ Since that, for the last six years, now it's a 
nightmare because I've admitted that I have a problem. 
Interviewer: Can you tell me more about that? 
[…] They use that as a blanket […] as in ‘Oh he openly admits he has a drug problem, 
they can't go there.’ It just automatically put me 10 steps backwards when I was trying to 
go and do the right thing.” (Interview 4, Male 27 years) 
A few participants spoke positively about times they had felt supported and not discriminated 
against during legal processes. These experiences were the exception not the norm, and were 
characterised by lawyers providing assistance when it was needed, and recognition of an 
individual’s circumstances: 
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“It was very good, it was very good, yeah. Like I have been seeking assistance to reduce 
my drinking and I have been doing it myself, so I explained that, I’m actually getting 
better, and this was just a mistake, I had just woke up and forgot where I was. To me it’s 
my lounge room, not the street. So I only got an $80.00 fine. Even the prosecutor sort of 
helped me through it. […] Yeah, it was strange but they don’t usually try to help you.” 
(Interview 7, Male 51 years) 
Other services  
In addition to health care, police and courts, many participants also had contact with a range of 
other welfare services such as charities and NGOs, housing services and Centrelink.  While these 
services have a mission to provide support to marginalised and low-income members of the 
community, and would often have contact with people who had experienced problems with 
alcohol and other drugs, these settings were often equally discriminatory and judgemental 
environments. Participants spoke of the way alcohol and other drug use was looked down upon 
and how they were made to feel like they were not worthy of the same kind of help or assistance 
as might be offered to others. Again, this judgement was often borne from stereotypical 
assumptions about problematic AOD use: 
“The Salvation Army and some of the places you get food vouchers from.[…] Well you 
start to tell them about your bills and things like that and you can see in their face that 
they’re like you’re full of f***ing s**t you junkie dog f***ing piece of s**t. Like you can 
just see. I’ve been around a lot of people and I’ve read body language and you can tell 
when someone just despises you or doesn’t even want to give you eye contact. You know 
what I mean? Like you’re not worthy.” (Interview 11, Male 44 years) 
“In homeless shelters a lot, straight off the bat they just assume, well, especially when 
you talk to the HOT team, the homeless outreach team, and then they find out that 
you’ve also been on drugs and all the rest of it, they just assume that you’re a piece of 
s**t and you’re going to knock everything off, and so you get put in dodgier places. Like 
I’ve had a room in a place where there was just broken crack pipes on the ground, 
needles lying around, and I’m a relatively clean junkie when I’m using. Not being able to 
access a lot of homeless places, it sounds bad, but just because of the assumptions and all 
the rest of it, I just used to sleep under a bridge.” (Interview 14, Male 35 years) 
Society at large  
Stigma and discrimination impacted on participants in different ways, as they went about their 
daily lives. Outside of the particular institutions and settings described above, participants’ 
experiences of stigma were perhaps less concretely attached to particular people, circumstances 
and interactions, but nonetheless permeated their lives with real effects.  
Many participants spoke of the ways in which they felt that media portrayals, and in particular 
government-funded advertising campaigns, shaped society’s perception of problematic AOD 
use, and contributed to stigmatising stereotypes. Participants felt that such campaigns and 
portrayals were not reflective of their own experiences. The ice campaigns especially were seen 
to be stigmatising and produce harm in terms of how people who use drugs were seen by 
society: 
“When you see the ads of some guy on meth in a hospital, smashing up stuff and 
punching - I don’t think it’s a good thing. No, people just go, ‘Oh, rehabs going to be full 
of those people.’ When I took it, I just went out dancing and played ping pong all night. 
[…] I had a great time. I know it sounds - I shouldn’t say that. No, no, but I didn’t do 
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anything absolutely crazy. […] So, when you put ads out there saying that we’re horrible 
people, yeah it’s weird.” (Interview 2, Male 38 years) 
“If you look in the papers and social media, and you relate those sort of drugs, they’ve 
already created this image of a person that uses that; that you’ve never seen before in 
your life, you have no idea what they’re like. You hear the word and they’re using this 
drug, you’ve already got an image of what they’re going to look like. A skeleton, frail. 
That’s what I mean.” (Interview 3, Male 30 years) 
One participant spoke about the imbalance in these media portrayals and how he thought that 
different kinds of media portrayals (for example, positive stories of change) could potentially 
reduce stigma and discrimination and increase understanding in the community: 
“I think that with the way that, say, things are portrayed on TV, that’s putting a stigma 
on behaviours, but also what about the reverse side of it; the outcomes for those that 
have succeeded and changed their life. It’s all about the negatives and this is what ice 
users do, this is what heroin - but we don’t get to see any of the other opposite end of 
the scale; of people that are suffering and copping stigma from their friends and family 
and that. There’s nothing out there that shows hey, this guy was in addiction for ten years 
and look at him now, look what he has. He’s got everything, family back. He’s got a job, 
a car. So it’s good to - for stigma, it puts a big downer on things, but we need something 
more about both ends, not always the negative.” (Interview 3, Male 30 years) 
The most common issue participants identified when speaking about experiences of stigma and 
discrimination in the community at large was the pervasive impact of the stereotyped ‘junkie’ 
image: 
“Say if I come to grab needles, or something, and I'm walking down the street, people 
just automatically judge. Like, too bad if I was getting them for medical reason, like if I'm 
diabetic or something. People just assume that you're coming out of there that you're 
automatically a junkie.” (Interview 10, Male 38 years) 
“They automatically stereotype you because they’re unaware of what addiction is. They’re 
very stereotypical to - you know, you’re an addict, you’re a junkie. They pin it to people 
that live on the street or that - it’s like, we’re not all like that. We’re not all - we don’t all 
fit into that one category. There’s such a wide range of people, even in here [in rehab]. 
Everyone’s story’s different.” (Interview 6, Female 32 years) 
“They thought we're disease-spreading junkies.”  (Interview 8, Male 45 years) 
For some participants, experiences of stigma and discrimination in public (in the street) was 
exacerbated by gentrification of inner city suburbs and the tensions this had created alongside 
issues of homelessness and access to existing services which had historically been set up in these 
locations: 
“I'm experiencing a lot more outwardly, sort of - my eyes caught a father carrying a 
daughter down the street and they were both just, like, staring at me, and it's happened to 
me numerous times.  And I try to be thinking, "I hope that man gets better" in their 
heads, but my head will go, "We've got to get rid of that filthy junkie out of our 
suburbs."  It's the gentrification of Bowen Hills.”  (Interview 8, Male 45 years) 
Experiences of stigma and discrimination in public places ranged from ‘looks’ to physical 
violence: 
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“I’ve been spat on in the street. Sitting down and sitting on a swag, nothing to do so I’m 
sitting opposite a pub where there’s a band playing. And I was sitting down, I’m just 
smoking a few cigarettes, sneaky little bit of pot, and listening to the music, I like my live 
music. And I’m just sitting there minding my own business and then people have spat on 
me because I’m homeless.” (Interview 7, Male 51 years) 
“Outside the train station, a lot of drug users, they all stand around The Valley train 
station. I think a lot of people knows that. A lot of the drug users stand around and they 
sort of look - give us dirty looks, because they know we’re on drugs.” (Interview 9, 
Female 46 years) 
For some participants, these experiences of public judgement and exclusion were a part of 
everyday life. Often this was based on how participants looked: 
“Oh day-to-day like just meeting people, they judge you on the way you look or the way 
you talk and won't have nothing to do with you.” (Interview 11, Male 44 years) 
As a result, participants would engage in strategies to avoid being identified as a person with a 
drug use history: 
“Yeah, I’ve got a scar on my arm from it. If you don’t hide it, I’ve got concealer down in 
my room, if I don’t hide it when I go out, it’s a big problem.  
Interviewer: So you put concealer on your track marks? 
Yep. It sounds silly, but it’s the only way you can hide it. People see it and sort of go 
[makes disgusted sound].” (Interview 14, Male 35 years) 
Summary 
Experiences of stigma and discrimination were a common occurrence in the everyday lives of 
participants. Every participant could describe, in detail, multiple specific times that they had been 
judged, treated badly, looked down upon or excluded because of their experience of problematic 
AOD use. The frequency and commonplace nature of these experiences did not make them any 
less distressing for participants. As can be seen from the interview data above (and as will be 
explored in the case examples below) these experiences had profound effects in participants’ 
lives. These effects were not superficial and cannot be dismissed as insignificant. Constant 
experiences of exclusion, marginalisation, and discrimination impacted on participants’ access to 
health care (including treatment) and other services, fair treatment in the justice system, 
employment opportunities, and impeded connection to family, friends and community. 
Importantly, these experiences shaped participants’ sense of self-worth, and how they saw their 
place in the world.  
However, participants could also identify interactions and experiences which were different to 
their usual experiences of stigma and discrimination; where stigma had not been present. We 
suggest that there is much to learn from these descriptions: what does a non-stigmatising 
encounter look like? And how can we foster conditions so as to ameliorate the stigma 
experienced in so many different settings? In the following section, we draw on the interview 
data and examine particular case examples so as to consider these questions, before moving to 
discuss recommendations arising from the project as a whole.   
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5.3 Analytic case examples 
Case example – Accessing medical care 
Belinda is in her late fifties and lives in Brisbane, having grown up in regional Queensland. 
Belinda’s life-long partner died recently, and she’s now living alone. When Belinda was younger 
she used to have a drink after work and use cannabis, but not to any great excess. She still enjoys 
a few drinks when she’s watching TV sometimes. Belinda has also injected heroin throughout 
her life, and has been on the opioid substitution treatment program on and off. Belinda 
contracted hepatitis C when she was very young. She says this is because the pharmacists in her 
home town refused to sell sterile injecting equipment. At the moment, Belinda is in treatment 
and is prescribed Suboxone by a psychiatrist. Belinda has a great relationship with her 
psychiatrist who is “a lovely, caring individual.” Belinda feels that he “honestly cares” and she’s 
“never struck that in a doctor” before now. 
A few weeks ago, Belinda was woken up at 10:30pm by a pain in her hip. She paced around the 
house for 2 hours, trying to relieve the pain with hot and cold packs. At almost 1am, Belinda 
became concerned that there might some something seriously wrong, so she decided to go to 
hospital. Assuming that she might need to be admitted, Belinda packed an overnight bag, 
including a photo of her partner. Belinda lives not far from the hospital, so decided to walk 
there. Belinda arrived at the emergency department and described her symptoms to the nurse at 
the front desk (by now she felt like someone was stabbing her in the hip with a hot iron, and was 
also numb in places). The nurse began the usual intake procedure, and asked if Belinda was on 
any medication. Belinda said she was on Nurolax, Spiriva and Symbicort, and then told the nurse 
that she was also on 14 mls of Suboxone. At this point, the nurse stopped, looked at Belinda, 
changed her tone and said “Oh, you’re on Suboxone are you?  Well you’re a bit clammy.” 
Belinda had just walked some distance from her home with a big jacket and a hat on. Belinda 
was passed over to another nurse, and again described her symptoms: “I’ve got this pain in here, 
it’s burning me, it’s hurting me and I don't know what’s going on.” The second nurse asked her 
if she was on any medication. Again, Belinda was given a “real hangdog look” when she 
mentioned Suboxone. The nurse said “Oh, you’re on that are you?  Okay, all right then, say no 
more” and alluded to pain relief, assuming that Belinda was just drug seeking and wanted 
opioids. Belinda had her week’s supply of Suboxone with her in a locked box, packed along with 
her clothes and partner’s photo in her overnight bag. She wasn’t seeking pain relief or drugs; she 
wanted to see a doctor to find out what was wrong with her. Feeling judged, Belinda said “Don’t 
worry, I’ll be fine” and turned and walked out of the emergency department. Belinda walked 
away, in pain, feeling angry and wondering what it would take to see a doctor and get treated like 
a ‘normal’ patient. “Just that one look” was enough for Belinda to walk away because she could 
see that it was a waste of time, and that she wasn’t going to be taken seriously.  
Belinda was still in severe pain the next morning, and arrived at her local primary care clinic at 
opening time. Belinda had been to the clinic before, and knew many of the staff. After talking to 
the nurse at the clinic, she was able to see her GP straight away, who diagnosed her with 
shingles. Belinda’s GP wrote her a prescription. Before she left, Belinda asked her GP whether 
this new shingles medication was compatible with Suboxone. It was a conversation she didn’t 
want to have with her local pharmacist, even though she knew the pharmacist would ask her if 
she was on other medication when dispensing this prescription. Given the looks she gets when 
she tells people that she’s on Suboxone, Belinda often avoids telling pharmacists that she’s on 
Suboxone. She’s sick of the stigma and the judgment.  
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Points arising: 
• Stigmatising experiences are a barrier to people who use drugs accessing appropriate care 
not only for their drug use but for all medical conditions; 
• In particular, assumptions about ‘drug seeking’ behaviour form a significant barrier to 
health care for this stigmatised population. How can structures in medical environments 
make sure that doctors are protecting against drug seeking behaviour whilst also ensuring 
that people are getting the care/treatment/pain management they need?; 
• Whether or not a patient is known to staff, or a regular client of a service should not 
determine the quality of care received. All patients should be able to access non-
stigmatising and non-discriminatory health care at all services; 
• Discriminatory attitudes are borne from not only the stigma associated with drug use per 
se, but also medications and conditions associated with drug use e.g. 
methadone/buprenorphine, hepatitis C, HIV etc. In trying to find ways to ameliorate 
drug-related stigma, we must also be aware of the impact of these layered co-stigmas;  
• Experiences of stigma can make people reluctant to see doctors, or indeed be honest 
with medical professionals/pharmacists. Obfuscation and avoidance are used by people 
experiencing problematic alcohol and other drug use as strategies to avoid being 
stigmatised and judged, but these protective strategies could lead to harm (e.g. if a client 
does not disclose that she is taking Suboxone to a pharmacist, it is possible that other 
medications may not being compatible or she may not receive the appropriate dosing 
advice); 
• Care and empathy and being listened to are important (and often rare experiences for 
people with experience of problematic AOD use); 
• For many people with experience of problematic AOD use, experiences of stigma and 
discrimination build up over a lifetime. The stigmatising “hound dog look” or 
discriminatory treatment experienced in one setting is unlikely to be a standalone 
experience. For changes to have an impact, they need to be implemented across systems, 
not only at the individual level.    
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Case example – Fear of blood borne viruses 
Paul was diagnosed with hepatitis C in the 1990s. Soon after being diagnosed he went to the 
Dental Hospital for a routine dental appointment. Paul flagged his diagnosis with the staff at the 
hospital, so that they knew.  
After some time waiting, Paul was taken through to the surgery area. All the objects and 
furniture in the surgery area had been crudely and hastily wrapped in glad-wrap, and the dental 
nurses were all wearing “blood spatter space suits.”  
Paul went ahead with the dental procedure but made a complaint afterwards. He called the 
dentist aside to have a conversation about the glad-wrap and how he had been treated by the 
dental staff. The dentist cut him down straight away and rudely said “We’re protecting 
ourselves.” Paul felt like he was being told to “Cop it sweet, mate” and “Stop being so sensitive.”  
Paul felt like he was the contagion; that he was the one contaminated and that they were very 
reluctantly treating him. While Paul’s experience at the dentist was over twenty years ago, he 
thinks that attitudes towards people who inject drugs haven’t changed in the community. He 
thinks that people who inject drugs are thought of as “the real maggots who spread disease and 
cause all the trouble” and a “scourge to be eradicated.” 
Points arising: 
• Educating health professionals about blood borne virus prevention and precaution is 
important to avoid extreme behaviour where people are made to feel like they are a 
‘contagion’. Blood borne virus prevention procedures should apply to every patient, and 
should never been applied in a stigmatising or discriminatory way. Such procedures 
should follow best practice, not be driven by fear; 
• There need to be clear and accessible information about the avenues for people to make 
complaints and be taken seriously. Such complaints mechanisms should take into 
account people’s experiences of stigma (and often internalised stigma). Peer liaison 
officers in health care settings may assist individuals to navigate such systems; 
• People should not be made to feel like second-rate patients being reluctantly treated. 
Everyone deserves quality health care; 
• There is a consensus building that the criminal law is not the most appropriate avenue 
for dealing with issues around blood borne virus transmission, and that alternatives to 
prosecution such as public health management are preferable. We note that in other 
jurisdictions this area of law is being reformed (NSW). How Queensland might reform 
these laws is worthy of consideration, given their stigmatising effects.  
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Case example – Employment dismissal without warning or support 
Steve grew up in Brisbane and is now in his thirties. He was a good student at school and his 
first job was in his parents’ small business. Steve’s not really sure why he started taking drugs, but 
he started smoking cannabis when he was a teenager and found that dealing a bit made him very 
popular at school. He was engaged to a “beautiful” woman when he was 22 years old, and 
stopped selling cannabis when that relationship broke up. It was around this time that he started 
using speed. It was easy to do; Steve’s best friend dealt speed and had the “ultimate life” partying 
every night.  
Steve was trying to “get clean” but was still using a bit. He was working in property management 
cleaning properties, and looking after gardens. While the other guys he worked with would 
knock off at 3pm or so, Steve would just keep working. He wanted the money and because he 
was still using, he was highly productive. He’d often offer to stay back and take extra jobs. 
Steve’s supervisor loved his work ethic and that Steve was prepared to work 15 or 16 hour days. 
Steve would sometimes ask his supervisor whether he could get some of his pay in advance, 
rather than waiting for pay day. This made Steve’s supervisor a bit suspicious and he pulled Steve 
aside one day to ask if he was ok. Steve told him he was alright, and sensing there was some kind 
of an issue, asked straight out if there’d been any complaints about his work. Steve’s supervisor 
said “No, no, you do great work” but then said “I’m going to have to let you go, mate.” Steve 
asked why, and his supervisor was a bit cagey. Without being direct he said: “I can’t have what 
you promote around my business.” Steve was a bit confused and offended by this because he 
was a hard worker, there hadn’t been any complaints, and he worked longer hours than anyone. 
Steve asked “What is it that I promote?” and was just told “You know what I’m talking about, 
mate. We can’t have this around.” 
Steve was taken aback by this. He had been using, but he’d never used around his work 
colleagues. As far as he knew, no one knew he was using drugs. The only issue was that Steve 
had asked for his pay in advance a few times, often only a few days after he’d been paid. A few 
weeks earlier he’d tried to explain his requests for advance pay by pretending that he had a 
gambling problem. At that stage his supervisor had been very understanding and asked if he 
needed help with his gambling. When it was about gambling, his supervisor was asking if there 
was anything they could do at work to help Steve out. But now, the tone was very different. 
Steve was pretty sure that his supervisor had worked it out, and that the gambling excuse was no 
longer convincing. Once Steve’s supervisor worked out that Steve’s money problems were drug 
related, there was no offer of help. He was fired from his job, without any discussion. It was 
“See you later. We can’t have your type here.” 
Steve just walked away. Losing this job was hard because Steve had been trying to reduce his 
drug use and had been working to avoid dealing drugs. Losing the job at this time just made his 
situation worse.  
Points arising: 
• The stigma of problematic AOD use means it sometimes cannot be talked about openly. 
Employers should be provided with training and resources to have conversations with 
employees. The workplace should be an avenue for support and help; 
• Where AOD problems are affecting an employee’s work and issues have arisen, 
employers should be equipped to help provide employees with pathways into help and 
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support. There should be mechanisms for returning to work, or adjusting work hours to 
accommodate the employee’s needs; 
• Assumptions that alcohol and other drug use is always associated with poorer 
performance at work is not always the case (we found many examples across the 
interviews where drug use was compatible in the workplace due to workplace culture, or 
just the need to stay awake for long periods). Such case examples challenge assumptions 
that people experiencing problematic AOD use are unemployed ‘junkies’. People 
experiencing problematic AOD use could be in any workplace and need access to 
support; 
• It is important to note that many workplaces are not large organisations with access to 
employee assistance programs and enterprise agreements which allow for periods of 
leave etc. Many people work as casuals, or as contractors or in small businesses. These 
workplaces need government initiatives to ensure that staff members have equal access 
to support and help. Equally, employers need access to information and education to 
support their staff and contractors.  
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Case example – Supportive employers 
Debbie moved to Queensland a few years ago. She has a son, and a young grandson. Debbie is 
currently seeking help for her methamphetamine use and has committed to a three-month 
residential rehab program. Debbie knew it was time to get some help when she nearly lost her 
job this year. 
Debbie works as a carer in nursing home. Debbie was beginning to have trouble turning up for 
work, and had been giving her supervisor excuse after excuse. After a while, Debbie told her 
supervisor that she was struggling with depression and she referred Debbie to a psychologist 
through the workplace employee assistance program. Debbie found it easier to tell her 
supervisor that she was struggling with depression than mention drug use. She was worried 
about what the response would be if she mentioned drugs, and didn’t want to lose her job. 
Debbie had already experienced judgement from her family about her drug use, and felt as 
though she was an embarrassment to them. Debbie didn’t have a good experience with the 
psychologist she was referred to through the employee assistance program, and didn’t feel 
comfortable with her. Debbie felt like the psychologist didn’t really care because Debbie wasn’t 
paying for the session, and she felt judged and shamed when she mentioned her drug use 
problems.  
Things did not improve and a month later matters came to a head at work. Debbie had a 
meeting with her supervisor but took a support person into the meeting with her. The support 
person was a really good friend at work. Debbie had been honest with this friend recently about 
her drug problems. Before the meeting, Debbie’s friend had researched drug treatment and had 
looked into rehab service options. When the meeting began, Debbie could sense that her 
supervisor was building up to saying “We’re going to have to let you go.” At that point, Debbie 
was honest and said “Look, I’ve got an addiction.” Her supervisor asked her “What kind?” and 
Debbie talked about her methamphetamine use. Debbie’s supervisor “was really good about.” 
When Debbie felt like she didn’t know what to say her support person was there to jump in and 
say that she’d done some research, and looked into treatment options. 
Within 24 hours, Debbie’s supervisor at the nursing home had organised an interview for her at 
a local rehab service. Debbie knows that sometimes people wait for ages to get into treatment, 
but thinks that her supervisor must have made special arrangements or done some work behind 
the scenes to make sure she got help straight away. Debbie was in the rehab program within 4 
days.  
Debbie’s workplace has given her extended leave and is holding her job for her for as long as she 
needs. Knowing that her job is being held for her gives Debbie an incentive “keep going.” 
Debbie has a few people from work saying hi and sending her supportive messages via 
Facebook. 
Had she known that this would be her workplace’s response, Debbie thinks she would have 
talked about her drug problems a month earlier, when she’d talked to her supervisor about her 
depression.  
Points arising: 
• Debbie’s story is a good news example, and there is much to learn from these processes 
for other workplaces. From this case example, we can see the ways in which workplaces 
can provide pathways for employees to seek treatment and help as part of workplace 
policies and procedures; 
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• The stigma of drug use is greater than the stigma associated with mental health problems. 
As such, seeking help with mental health can be a doorway into confidentially accessing 
help for drug problems, and may be easier to talk about with employers. Emphasising 
that support services provided through the workplace are confidential may increase 
employees’ willingness to access them. Employee Assistance Programs should be 
equipped to manage both mental health and AOD issues; 
• Employees should be told that help is available so they seek help early. If policies and 
procedures are made clear to all employees then individuals may be less worried about 
what the response might be, knowing that systems of support are in place. Friends and 
colleagues can also play a supporting role, if they too are aware of what support 
structures are in place. Policies should be transparent and employees should be aware 
that pathways are available should they need help (in ways that won’t jeopardise their 
employment); 
• Quick and easy access to treatment is important, so that people can get help when and 
where they need it; 
• There is a need to review Queensland protocols for AOD in the workplace to ensure 
that the competing policy priorities of workplace safety, employee privacy and also 
avenues for help and treatment (not mere dismissal) are balanced effectively.  
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Case example – Centrelink and social services 
Joel is 44 years old. Joel moved to Queensland in the late 1990s when his ex-partner decided to 
move north with their daughter. Joel has two other children with his current partner, but the 
relationship has been a bit of a rollercoaster. Joel feels like he struggles to fit into the “normal 
world” and was diagnosed with adult ADHD when he was in his thirties. Joel uses cannabis 
regularly and methamphetamine occasionally. Joel will use for a few days and then go for weeks 
at a time without using, and feels that he has control over his use. Lately, Joel has had some good 
support from a GP who made him feel that he wasn’t a hopeless case, and took the time to 
listen. It is rare for Joel to feel like someone is willing to help him.  
Joel was very close to his grandfather who had brought him up for nine years when his Dad 
wasn’t around. Joel’s grandfather was dying, so Joel went to Centrelink to make an application to 
access a bereavement payment so he could travel to see him before he died. Joel’s application 
was refused on the basis that his grandfather wasn’t his immediate family. Joel was very 
distressed and felt like Centrelink wasn’t taking his application seriously even though he was 
providing proof of his grandfather’s illness. While the application was being discussed, the 
worker at Centrelink said “Where do you spend your money? You’re putting it up your arm.” 
Joel was already feeling very low and upset, knowing that his grandfather was so ill. He was 
angered by the worker’s insinuation that he wanted the money for drugs and refused to leave the 
Centrelink office. Eventually they let Joel use the phone to call his grandfather at the hospital. 
They only spoke for a few minutes. That was the last time Joel got to speak to his grandfather, 
who died soon after.  
Joel never made a formal complaint about the worker’s comments. He was too distressed. He 
never went back to that particular Centrelink office, though.  
Joel is angry about how he is treated at services that are meant to be providing support for 
people who need it: “They’re supposed to be helping poor people that are in those circumstances. 
You know what I mean?” 
Points arising: 
• Stigma manifests in a range of settings, including welfare and support services. Anyone 
who works in a service capacity with people who may be experiencing problematic AOD 
use should be educated about non-stigmatising practices. Comments like “you’re putting 
it up your arm” are completely unacceptable for any service provider, in any setting; 
• Often people experiencing problematic AOD use will not make formal complaints, 
precisely because they feel judged and shamed. There need to be clear and accessible 
information about the avenues for people to make complaints and be taken seriously. 
Peer liaison officers may be helpful to provide assistance in welfare services;  
• It is important to recognise that not everyone’s drug use is ‘out of control.’ There is 
research in the AOD literature demonstrating controlled drug use. Even where people 
understand their drug use to be out of control or problematic in their lives, stigmatising 
and discriminatory behaviour (of the kind experienced in Joel’s case) is never justified; 
• Feeling listened to and supported is the exception not the norm for many people who 
use drugs.   
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Case example – Being heard  
Paul is 45 years old. He was born in Brisbane but spent 5 years living in Melbourne in the late 
1990s. Paul has been in and out of rehab a few times, and has a history of methamphetamine and 
heroin use. Paul has experienced homelessness at a few points in his life and constantly feels like 
housing services are dragging their feet.  
While Paul was in rehab, the new Housing Minister came to visit the service. He gave a 
presentation and mentioned a new approach to housing policy, which planned to combine 
private and public housing options. Given Paul’s experiences of homelessness, drug dependence 
and seeking help with housing, he spoke up and shared what he thought about this proposal. 
Paul spoke to him “straight up” about what he thought was the failure of a similar scheme in 
Brisbane, which had become “centres for drug addiction, drug addicts and criminality.” Paul 
really enjoyed being able to share his thoughts and speak authoritatively on a topic he cared 
about, to a person in a position to make decisions and implement change. 
After the presentation, Paul sat down and spoke to the Minister more over lunch. The Housing 
Minister was “really cool” and Paul felt like he was “non-judgmental” and wasn’t treating him 
“like an addict.” Paul respected that the Housing Minister had to “stick to the party line” and 
thought that some of his arguments were “fair enough”. He was genuine. 
Paul is concerned about how the gentrification of inner city suburbs of Brisbane impacts on 
people like him.  
Points arising: 
• People who use drugs should have their voices heard in policy discussions about issues 
that directly affect their lives; 
• Being heard can reduce experiences of stigma. Research in the public health domain 
about consumer participation in health policy and practice has demonstrated that 
participation can be destigmatising; 
• It is important to recognise that people who use alcohol and other drugs have knowledge 
to share; 
• Urban development and gentrification is an issue for accessing services which have 
historically been in these areas and has a day to day impact in people’s lives. Services 
should be included in planning processes and partnerships developed to ensure that 
people accessing services are not increasingly marginalised; 
• AOD-related stigma is not isolated in one particular setting. Stigma manifests in multiple 
ways in people’s lives. Consideration must be given to the intersection of stigma across 
health, housing, social services, policing etc.  
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Case example – Police attention 
Steve went fishing every night for a while. It was something he could do which meant he wasn’t 
at home bothering his parents or annoying anyone. He found it also calmed him down when he 
felt paranoid. Often he’d go fishing by himself, sometimes with a friend. He would never drive 
under the influence if he’d taken any drugs (Steve used cannabis and methamphetamine) and he 
would usually ride his pushbike or walk to a local fishing spot. 
Steve has never been charged with any drug offences but felt like he was becoming a ‘police 
target’ at that time. For a while, the Police were pulling Steve up every single night and would 
search him. The Police would constantly stop him to ask what he was up to. Steve never had 
drugs on him and he never used drugs in public (it wasn’t his thing to do that). Steve felt he was 
being targeted because he “looked like a junkie.” 
Constantly being pulled up and searched made Steve feel like a fugitive. Every night for six 
months he’d have to talk to the Police, sometimes for up to an hour. He was never charged with 
anything. But more than this, he was never offered any help. Things were hard for Steve, and he 
was using fishing to get away from the feelings of paranoia he’d often experience. Night after 
night the Police officers would establish that Steve didn’t have any drugs on him, and he wasn’t 
doing anything wrong. Steve thought that instead of repeatedly strip searching him on the side of 
the road at night, if they were concerned about him or his behaviour, perhaps they could have 
offered some other help or advice. Steve felt degraded by these experiences. 
Points arising: 
• Police are often the ‘front line’ workers in the community who come into contact with 
people experiencing problematic AOD use, but their role as ‘law enforcers’ is sometimes 
problematic if people are subject to constant police attention; 
• For some people experiencing problematic AOD use, this level of police attention can 
become a form of harassment (this is especially problematic if people are experiencing 
psychological distress). It is important that clear and accessible systems be put in place to 
help people make complaints when this occurs, without retribution. Peer liaison officers 
may assist here, given that individuals may feel reluctant to make complaints; 
• In any police encounter, individuals should be treated with dignity and not be made to 
feel degraded by police questioning;  
• Consideration should be given to whether police might be an avenue for offers of help 
rather than just punitive actions, especially for people ‘known’ to police. How could such 
pathways we built into police protocols and operating procedures? Within particular local 
communities are there untapped opportunities for partnerships between police and other 
services better equipped to assist? This could take the form of a Memorandum of 
Agreement, for example. Police should be provided with resources to make referrals and 
direct people to appropriate services.  
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Case example – Homelessness and public order 
Gary doesn’t like to admit that he’s over the age of 50. Gary has been a binge drinker since he 
was a teenager but has only recently become alcohol dependent. Living on the streets for the last 
three years and a battle through the family courts became the triggers for Gary’s alcohol 
problems. Drinking numbs the anger. But he’s been doing well lately and has reduced his 
drinking substantially and he’s not drinking at all two days a week.  
 
Since Gary has been homeless, it has been too easy to drink because he doesn’t have anything 
else to do. He tells people that ‘he’s in the park because he’s drinking and he’s drinking because 
he’s in the park.’ He feels that every time anyone sees the swag they decide that he’s not worth 
helping; that there’s no use in helping a ‘homeless alcoholic.’ Gary says his biggest problem is 
getting help. 
The Police regularly harass Gary about his drinking. On the weekends, Gary will often find 
somewhere to sit outside a pub or a music venue, and will listen to the music and watch the 
world go by. He says, “It’s like my television.” If the Police saw him, they’d check if he had a 
bottle on him. Because they knew Gary had been caught for drinking in public before, and they 
saw him regularly in parks and public spaces, they’d look for a bottle and tip it out or slash the 
cask.  
 
One time, Gary had just woken up. Gary had a bottle tucked in behind his swag while he slept. 
There was a Police officer sitting across the road, watching and waiting for Gary to take a swig 
after he woke up. Gary was charged with drinking in public. He admits he was doing the wrong 
thing, and knows it’s against the law to drink in public. But when you’re homeless, as he says, 
“Hey, I’m drinking in my lounge room. But that doesn’t mean a thing to them.” 
 
The court date coincided with Gary’s birthday that year. Gary represented himself in court and 
explained to the Magistrate that he’d been reducing his alcohol use and had been getting better, 
and this incident had been a mistake. He thought of the park as his lounge room, not the street. 
The Prosecutor helped him through the legal process too, offering to guide him through and get 
it over and done with so he didn’t have to come back. Even though she was helpful, Gary 
assumes she was thinking that he wanted it over with just so that he could “piss off and get 
drunk.” On this occasion, Gary got an $80 fine. He felt like it was all very petty.  
 
Points arising: 
• As noted earlier, police are often the ‘front line’ workers in the community who come 
into contact with people experiencing problematic AOD use; 
• Increased police attention is a particularly significant issue for people experiencing 
homelessness, as they do not have access to private spaces and are often in the eye of the 
public and the police; 
• Homelessness is another issue where police (as ‘front line workers’) could be a vehicle 
for offers of help rather than just enforcement actions, especially in cases where 
individuals are ‘known’ to police; 
• It is important to consider how people experiencing problematic AOD use, or other 
vulnerable people, might be better supported in legal processes and court environments. 
Peer liaison officers in courts could be appointed to work with this population, to ease 
the process and reduce stigma and discrimination in legal settings.  
  
86 
 
6. RECOMMENDATIONS 
We have developed these recommendations from a synthesis across the three primary data 
sources: the literature review, the legislation review and the participant interviews. Given the 
extensive mechanisms which produce discriminatory outcomes, approaches put in place to 
reduce stigma must also be broad ranging (Link & Phelan, 2001). In making these 
recommendations, we are mindful that approaches must be multifaceted to address these many 
mechanisms, but also multilevel to address issues of both individual and structural discrimination. 
Circumscribed interventions that target only one mechanism at a time are unlikely to bring about 
change because they fail to address broader contextual factors (Link & Phelan, 2001).  
There are 34 recommendations in total, as listed in the below table.  
Table 5: List of all Recommendations 
Overarching recommendations: 
Recommendation 01: Implement a Queensland Human Rights Charter 
Recommendation 02: Conduct anti-stigma awareness training across all relevant workforces 
Recommendation 03: Ensure consumer participation in policy and actions designed to reduce 
stigma and discrimination 
Recommendation 04: Increase the access and availability of AOD treatment 
Recommendation 05: Improve the marketing of AOD treatment 
Recommendation 06: Better support family members of those in AOD treatment, through 
education and information resources 
Recommendation 07: Invest in improvements in the physical facilities within AOD treatment 
services  
Recommendation 08: Employ peer workers/liaison officers in health care settings 
Recommendation 09: Audit complaints mechanisms in health care settings   
Recommendation 10: Conduct consumer rights ‘training’   
Recommendation 11: Develop and disseminate clear clinical advice about pain management in 
people with opioid dependence for emergency departments and primary 
health care settings  
Recommendation 12: Develop and disseminate clear clinical advice about access to medications 
for those with concurrent physical and mental health disorders and AOD 
use 
Recommendation 13: Ensure consumer participation mechanisms are not just part of health care 
service provider’s accreditation, but are implemented 
Recommendation 14: Review reporting and monitoring systems to ensure anti-stigma actions are 
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part of organisational Key Performance Indicators 
Recommendation 15: Develop and implement programs aimed at resilience to internalised 
stigma for people experiencing problematic AOD use and AOD treatment 
clients 
Recommendation 16: Consider introducing a supervised injecting facility  
Recommendation 17: Consider reform of the ‘notifiable conditions’ sections of public health law 
Recommendation 18: Amend legislation pertaining to HIV/hepatitis C 
Recommendation 19: Apply the recommendations from health care to welfare and support 
services 
Recommendation 20: Encourage police to be aware of and where possible facilitate access to 
services 
Recommendation 21: Consider a pilot of tracking police encounters 
Recommendation 22: Ensure Memoranda of Understanding are in operation between police and 
health care and harm reduction service providers 
Recommendation 23: Reform areas of criminal law where the definition of the behaviour has the 
potential to be stigmatising or applied in discriminatory ways 
Recommendation 24: Decriminalise the personal use/possession of drugs  
Recommendation 25: Amend laws regarding peer distribution of injecting equipment  
Recommendation 26: Review policies regarding criminal history checks at pre-employment  
Recommendation 27: Encourage uptake of clear employer guidelines regarding AOD use in the 
workplace and how to best respond  
Recommendation 28: Improve access to Employee Assistance Programs 
Recommendation 29: Develop and support pathways into employment for people completing 
AOD treatment  
Recommendation 30: Encourage and support flexible work hours policies  
Recommendation 31: Exercise extreme caution in mass media campaigns for drug use 
prevention  
Recommendation 32: Explore running a mass media campaign to reduce stigma 
Recommendation 33: Improve Queensland media reporting of AOD issues 
Recommendation 34: Implement guidelines for government department communication about 
AOD issues 
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Recommendations are discussed in sub-groups pertaining to the five settings where stigma and 
discrimination were found to most commonly and pervasively occur: 
1. Health care/public health 
2. Welfare and support services, including housing 
3. Police, public order and criminal law 
4. Employment 
5. Society at large 
There are three overarching recommendations, which apply across all of the above. We discuss 
these three overarching recommendations first, before addressing each of the five settings.  
6.1 Overarching recommendations 
Recommendation 1: Implement a Queensland Human Rights Charter 
Throughout the data collection for this project, we were made aware of and identified the 
importance of human rights, and in particular the rights of people who are stigmatised and 
marginalised. A Human Rights Charter would provide protection for all members of Queensland 
society, not only people with experience of problematic AOD use. As noted in the literature 
review, in order to bring about meaningful change, it is essential to address structural factors 
(and not only individual attitudinal and behavioural factors). A Human Rights Charter is one 
mechanism through which widespread structural stigma and discrimination can be alleviated. A 
Human Rights Charter would seek to provide broad, overarching human rights protections to 
individuals in certain circumstances, including, in particular, where ‘public authorities’ make 
decisions that impact upon them. In this sense, human rights laws are intended to act as a 
‘backstop’ – or a check and balance – against infringements of certain basic rights and the use of 
excessive power by public authorities.  
Two jurisdictions in Australia (Australian Capital Territory and Victoria) have human rights 
charters. The relevant Acts are the Human Rights Act 2004 (ACT) and the Charter of Human Rights 
and Responsibilities Act 2006 (Vic). In a recent statutory review of the Victorian Charter, Michael 
Brett Young noted that “The Charter is designed to improve the lives of individuals and the life 
of the community as a whole. It performs an integral role in our democratic society by protecting 
fundamental rights and freedoms” (Brett Young, 2015, p.iii). In imposing obligations on public 
authorities to consider human rights in the carrying out of their statutory duties, human rights 
charters can help to foster and encourage a culture of human rights and respect, particularly for 
marginalised populations. In both Victoria and the ACT, human rights charters have been used 
to successfully challenge and/or prompt revisions to discriminatory health care practices and 
policies and to disrupt entrenched perspectives on particular cohorts (for examples, see Brett 
Young, 2015). In Victoria, for instance, the Charter has been utilised to prompt changes to 
hospital policies and processes to better accommodate the needs of patients from Muslim, 
Jewish and Aboriginal backgrounds who require same-gender medical care for religious or 
cultural reasons. In practical terms, this might mean that a pregnant Jewish woman will now have 
access to a female obstetrician for maternity care if that is her preference and the hospital can 
accommodate it. Were human rights legislation to be introduced in Queensland, we think it 
highly likely that similar systemic and culture change could be effected.  
We understand that discussions regarding a Human Rights Charter have been underway in 
Queensland for some time and that a Legal Affairs and Community Safety Committee Inquiry in 
2016 was unable to agree on whether a Charter was necessary and appropriate (Queensland 
Parliament, 2016). The Queensland Mental Health Commission (2016) expressed support for a 
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Charter based in part on its potential to provide much-needed support to people who experience 
AOD problems. Calls for a Human Rights Charter in Queensland are ongoing, and include a 
campaign which is generating public support (http://www.humanrights4qld.com.au/). The 
findings of our report provide further evidence of the likely benefit of the introduction of a 
Human Rights Charter in Queensland, should parliament revisit the issue in future.  
Recommendation 2: Conduct anti-stigma awareness training across all relevant workforces 
Within Recommendation 2 we specifically recommend the following: 
• Evaluate the ‘Putting the puzzle together’ program; 
• Subject to evaluation findings, provide resources to roll out the ‘Putting the puzzle 
together’ program across services in Queensland and develop different modalities of 
delivery; 
• Develop and evaluate a similar program focussed on alcohol; 
• Identify opportunities to provide awareness training, beginning with a needs assessment 
within the priority targets of health practitioners (as well as the Health Ombudsman’s 
office and Department of Health employees), law enforcement officials (including police 
and Corrections employees), and employers.  
The lived experience of the participants as reported in the interviews has shown the impact that 
health care providers, police and welfare staff attitudes (both positive and negative) can have on 
how they feel about themselves, and access to and provision of services. Awareness training 
broadly refers to behavioural, educational and social intervention programs that address 
actionable causes of stigma, by creating an awareness of what stigma is, how it is produced and 
its implications. We note the findings of the literature review, that information-based approaches 
along with skills building is more effective for increasing knowledge and reducing stigmatising 
attitudes, compared to simply providing information alone (Brown, et al., 2003). The literature 
review identified a number of successful awareness programs from the AOD, HIV and mental 
health fields, particularly education and awareness programs aimed at health care workers and 
other professionals (e.g. Brown, et al., 2003; Hayes, et al., 2004; Li, et al., 2014; Lohiniva, et al., 
2016; Sengupta, et al., 2011; Shah, et al., 2014; Varas-Díaz, et al., 2013; Varas-Díaz, et al., 2016; 
Wu, et al., 2008). 
We note that QuIHN (Queensland’s peer-based drug user organisation) is already equipped to 
deliver an awareness program which has been developed by the Australian Injecting & Illicit 
Drug Users League (AIVL). It is called the ‘Putting together the Puzzle’ program. As noted in 
the literature review, QuIHN has adapted this national program to be suitable for delivery across 
a variety of settings in Queensland. This program focuses on reducing stigma and discrimination 
experienced by people who inject drugs, people on opioid pharmacotherapies and people 
affected by HCV and other BBVs. Delivered over five sessions, the objectives of the workshop-
based program are to: develop deeper understandings and awareness on how stigma and 
discrimination occurs; develop a comprehensive understanding of the impact of stigma and 
discrimination; develop a comprehensive working knowledge of strategies and initiatives to 
prevent and challenge stigma and discrimination directed at people who inject drugs from an 
individual, organisational and community perspective; and help participants to identify at least 
one personal or individual strategy to reduce barriers to access and services that they can 
implement within their personal and/or professional lives. A particular strength of this 
QuIHN/AIVL program is that it has been developed by people with lived experience of drug 
use, and is delivered by people with lived experience of drug use. The engagement of people with 
lived experience in the development, planning and delivery of awareness training is essential. 
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Since 2014, the ‘Putting together the Puzzle’ program has been delivered in a variety of settings 
in Queensland including the Australian Winter School Conference, different pharmacy groups, 
Probation and Parole, Department of Child Safety, as well as youth workers, nurses, GPs, 
community workers and with staff and volunteers at QuIHN and QuIVAA. An abridged version 
of the program has also been delivered to the Queensland Police Force as part of a more 
generalist AOD training session. There are also plans underway to deliver the training to the 
Pharmacy Guild and for NSP/OST pharmacists and pharmacy staff. This program is designed to 
be delivered by people with lived experience of drug use (see AIVL, 2016). To our knowledge, 
QuIHN has not received dedicated funding to ensure the ongoing delivery of this program, nor 
expand its remit. This is currently an untapped resource which could be rolled out across 
Queensland. In the first instance, an evaluation of the QuIHN program would provide the 
necessary evidence-base to either adjust or expand their program to these other target groups, 
and tailor it to a variety of settings, professional groups and workforces in Queensland. 
Expansion and tailoring to cover alcohol is also required. 
As identified in the legislation review, there are many decision makers and professionals beyond 
health, welfare and police who exercise power and discretion in relation to people experiencing 
problematic AOD use. These are listed on page 63, and repeated here: 
• Law enforcement officials; 
• Judiciary; 
• Corrections staff; 
• Education providers; 
• Certain regulatory boards (e.g. Veterinary Surgeons Board);  
• Staff from the Department of Health; 
• Health practitioners; 
• The Health Ombudsman; 
• Proprietors of licensed premises; 
• Venue operators; 
• Mining operators; 
• Employers; 
• Sellers of goods; 
• Second-hand brokers; 
• Rail safety officers; 
• Environmental health officers; 
• Licensees; and 
• Firing range operators. 
 
Awareness training for these workforces is also required. Given the evidence provided in 
participants’ interview accounts, we suggest that health practitioners (as well as the Health 
Ombudsman’s office and Department of Health employees), law enforcement officials 
(including police and Corrections employees), and employers should be priority targets within 
this list. As noted in the literature review, stigma-reducing programs tend only to be effective 
when based on context-specific needs assessment and collaborative planning (Bos, et al., 2008). 
We suggest that needs assessment and collaborative planning be undertaken as a priority in the 
settings identified as of primary concern.  
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We recognise that a face-to-face multi-session training program may not be feasible in all 
workplaces and with all workforces. While QuIHN’s ‘Putting together the Puzzle’ program is 
currently designed to be delivered in a particular way, there may well be scope to adapt this 
program to be delivered through different modalities (e.g. face-to-face programs of various 
duration, online, self-completion etc). Where different modalities are developed, we again 
emphasise that the engagement of people with lived experience of problematic AOD use in the 
development, planning and delivery of awareness training is nonetheless essential for a variety of 
reasons. One obvious example is the choice of language and imagery used in such programs; the 
involvement of people with lived experience can help ensure that language and representations 
of alcohol or drug use are non-stigmatising.  
There are a number of ways in which the uptake of awareness training might be enhanced across 
a variety of workplaces and industries. AOD awareness training might be incentivised for 
example through the award of continuing professional development points for various 
professions including health care, psychology and law, where such professional accreditation 
systems are already in place. It would also be possible to use regulation to enhance uptake by 
making AOD awareness training a requirement of accreditation for particular organisations or 
services, or when in receipt of Queensland government funding.  
As noted in the literature review, individual attitudinal awareness is not enough on its own, and 
should be regarded as just one aspect of a multifaceted and multilevel approach. It is essential to 
consider how sustained change in practices might be introduced.   
Recommendation 3: Ensure consumer participation in policy and actions designed to reduce stigma and 
discrimination 
As noted in the literature review, including marginalised individuals in policy processes 
(consumer participation) is one way of reducing stigma and discrimination, and an important 
ethical consideration. Consumer participation may be understood broadly along a scale ranging 
from information, to consultation, partnership, delegation and control (Duckett & Willcox, 
2011).  
Consumer participation should be implemented and integrated at all levels: planning, design, 
delivery, monitoring and evaluation. Consumer participation should be resourced and 
implemented across all areas of health care, welfare and housing, and whenever AOD-specific 
resources are being developed to ensure that such resources are not stigmatising and 
discriminatory. This is an especially important consideration in designing and implementing 
strategies aimed at preventing stigma and discrimination, and should be resourced accordingly. 
6.2 Health care/public health 
Recommendation 4:  Increase the access and availability of AOD treatment 
AOD treatment reduces stigma through a number of mechanisms. Provision of treatment shows 
care and concern for the welfare and wellbeing of people who experience problematic AOD use, 
and treats with respect and dignity the problem of AOD use. It emphasises that problematic 
AOD use is a health and social issue, to be addressed as such. Of course, treatment provision 
also has many other substantial benefits simply in terms of recovery. AOD treatment has been 
shown to reduce consumption of alcohol and other drugs, improve health status, reduce criminal 
behaviour, improve psychological wellbeing, and improve participation in community (Ritter, et 
al., 2014).  
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Increasing the availability of AOD treatment was seen by interview participants are an essential 
part of reducing stigma. When explicitly asked what they would like to see changed to reduce 
stigma, many participants said that they would like to see more treatment available and more 
avenues for seeking help. As one participant said: 
“More rehabs, so there’s not big waiting lists so guys aren’t waiting for a month. I mean, 
they could be dead in a month, more rehabs.” (Interview 13, Male 38 years) 
The increase in availability of AOD treatment in Queensland should also consider the settings of 
treatment. As noted in the literature review, increased provision of treatment through primary 
care settings may help reduce stigma and increase access (Lloyd, 2013), provided that 
practitioners have received awareness training (see Recommendation 2). 
Recommendation 5:  Improve the marketing of AOD treatment 
Improving AOD treatment marketing reduces stigma associated with treatment seeking, and 
increases the uptake of AOD treatment. Marketing materials (whether generated by the 
Queensland government or by NGO treatment services) should redress stigma by normalising 
AOD treatment, providing accurate information about access paths and outcomes (and self-
evidently not use images or language that may increase stigma). The involvement of consumer 
and family representatives in the development of such materials is essential. 
AOD treatment marketing and information materials have dual audiences: (1) people 
experiencing problematic AOD use who may wish to access treatment; and (2) concerned family 
and friends who may need information and support. Carefully designing AOD treatment 
marketing to reduce stigma associated with AOD and treatment itself will also help to inform the 
community, increase awareness among family members and friends, and ultimately enhance 
social reintegration and connection. As many participants noted in the interviews, isolation and 
family rejection even when seeking treatment was a great concern, largely due to lack of 
information and awareness. 
Recommendation 6: Better support family members of those in AOD treatment, through education and 
information resources 
Within Recommendation 6 we specifically recommend the following: 
• The development of resources especially for family members of those in AOD 
treatment; 
• Partnering with Family Drug Support Australia to expand their support services to 
Queensland families and develop resources aims at reducing stigma.  
In both the literature review and participant interviews, we found the impact of the families, 
friends and loved ones was a significant part of how people who experience problems with AOD 
use view themselves.  
“Birthdays, gatherings, weddings, dinners and what not - no invites being handed out, 
because you’re an embarrassment. That’s what it comes down to.” (Interview 3, Male 30 
years) 
Families have powerful influences on people. By educating family members and increasing 
education and awareness through the provision of non-stigmatising resources, it is possible to 
reduce stigma for family members (and for the person in treatment) and encourage them to be 
able to better support their loved one. Tangible resources in the form of information brochures, 
as well as online resources (for example information pages, adapted awareness training modules, 
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or mobile-based apps) should be developed. Such resources could be developed through an 
integrated approach alongside design and development of AOD treatment marketing (see 
Recommendation 5). Related to Recommendation 2, an awareness training program or module 
could be developed, targeted specifically at families. 
People with lived experience of problematic AOD use should be involved in the design, 
development and delivery of such education and information resources, for example partnering 
with Family Drug Support Australia (http://www.fds.org.au/). Family Drug Support’s mission is 
to assist families throughout Australia to deal with alcohol and drug issues in a way that 
strengthens relationships and achieves positive outcomes. We understand that Family Drug 
Support are in the process of expanding their support services to Queensland families and 
significant others with new funding from the Queensland Government through Queensland 
Health. The funding will support more Queensland callers to the Telephone Support Line, 
establish additional Family Support Meetings and help deliver the Stepping Stones Program and 
Stepping Forward Sessions in targeted locations across the State. Extending this support to 
include partnering to develop tangible resources, by families for families, aimed at reducing 
stigma and discrimination would be beneficial.  
Recommendation 7: Invest in improvements in the physical facilities within AOD treatment services  
As noted in the literature review, the ways in which drug treatment services are stigmatised and 
‘marked’ as services ‘for junkies’ means that would-be help seekers seek to distance themselves 
from such settings (Radcliffe & Stevens, 2008). Negative connotations with treatment settings 
have practical implications and are a barrier to early intervention. As noted above, one option is 
to provide AOD treatment through both specialised as well as primary care settings (Lloyd, 
2013). Another approach is to actively improve the physical environment of AOD treatment 
settings to reduce the stigma associated with these spaces. The physical environment of 
treatment services is often not prioritised due to tight funding environments, however investing 
in the physical space can decrease the sense of shame felt by AOD treatment clients, show 
respect (by providing physical settings of an equivalent standard to those provided in other 
specialist health care settings) and help reduce discriminatory attitudes from the wider 
community. As per Recommendation 3, people who have experienced problematic AOD use as 
well as current- and ex-clients should have input into design.  
One option would be to partner with art rental services such as the Commonwealth-funded Art 
Bank program (http://artbank.gov.au/). Another avenue would be to partner with local 
Queensland arts institutions and galleries such as the Queensland Art Gallery and Gallery of 
Modern Art, or other local community-based galleries and organisations. We note that similar 
work has recently been undertaken in Queensland, in the Lady Cilento Children’s Hospital. Such 
partnerships may also feed into art programs in which AOD treatment clients may also 
participate.  
Recommendation 8: Employ peer workers/liaison officers in health care settings 
Many people with experience of problematic AOD use have repeatedly suffered discrimination 
in health care settings (as seen in the participant interviews). Given internalised stigma, people 
with experience of problematic AOD use may not be assertive in health care settings when 
feeling unwell, vulnerable and disempowered. Having peer workers and/or liaison officers on 
hand to advocate for this population group is one crucial way of addressing systemic 
discriminatory cultures and practices, as well as providing direct support for individuals.  
It is important for people with experience of problematic AOD use to have easy access to 
mechanisms for support in health care settings, to help overcome structural stigma and 
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discriminatory attitudes of individual health care workers, and gain access to the health care they 
need. The employment of peer workers and/or liaison officers is one such mechanism. 
While ideally resources would be provided to employ peer workers or liaison officers in all health 
care settings in Queensland, as an initial step we suggest that an audit take place to establish sites 
of particular concern (for example hospitals or emergency department settings which regularly 
see people with experience of problematic AOD use such as Royal Brisbane Hospital).  
As such, within Recommendation 8 we specifically recommend the following: 
• Undertake an audit of existing peer worker/liaison officers across all health care settings 
in Queensland to establish key settings of need, and map systems already in place; 
• Provide resources to sites of particular concern where liaison officers are note currently 
engaged. 
Recommendation 9: Audit complaints mechanisms in health care settings   
Complaints mechanisms are one way in which the ongoing issue of stigma and discrimination 
leading to poor treatment being received can be addressed, and so they play a vital role in 
empowering clients as well as ensuring continuous improvements to health care services. Formal 
complaints mechanisms are available in Queensland, through for example the Office of the 
Health Ombudsman. There may also be local systems in place, within particular services, settings 
or districts. 
A full audit of complaints mechanisms in health care settings is required, given the findings of 
this report, particularly the accounts provided by interview participants. This audit should cover 
emergency departments, primary care, pharmacies, AOD treatment services, as well as other 
health care settings (including community health). 
The focus of this audit should not be limited to mere availability of complaints mechanisms. 
Complaints mechanisms must be: (1) available; (2) easy to access (even for people with low 
literacy, or internalised stigma); (3) publically and openly advertised; and (4) non-stigmatising 
(e.g. the potential for anonymity when making a complaint is especially important for individuals 
who use illicit drugs, or for those who are in precarious living conditions and for whom health 
care access is essential). (Operationally there is overlap between this recommendation and 
Recommendation 8 above – peer workers or liaison officers may be one important way of 
facilitating access to complaints mechanisms). Another key aspect of such an audit would be 
mapping barriers in cases that do not proceed to finalisation by complaint agencies or Tribunals 
(Legal and Discrimination Working Party of MACBBVS, 2013). 
As such, within Recommendation 9 we specifically recommend the following: 
• Undertake an audit of complaints mechanisms available in health care settings 
(emergency departments, primary care, pharmacies, AOD treatment services, community 
health) across Queensland to establish gaps, and map systems already in place. 
• Conduct an analysis of mapping of cases that do not proceed to finalisation by complaint 
agencies or Tribunals to understand barriers. 
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Recommendation 10: Conduct consumer rights ‘training’   
As noted in the literature review, and demonstrated in participants’ accounts, self-stigma or 
internalised stigma can impact on people with problematic AOD use in multiple ways. This may 
include being reluctant to make complaints; people who have internalised the stigma associated 
with problematic AOD use may not believe that they are entitled to appropriate care and 
treatment or see themselves as full citizens. Educating and empowering people through 
consumer rights ‘training’ is another mechanism by which discrimination in health care settings 
can be addressed. This can be implemented by increasing funding for community groups, legal 
centres and human rights agencies to engage in outreach, community education and rights 
awareness for priority populations (Legal and Discrimination Working Party of MACBBVS, 
2013).  
Recommendation 11:  Develop and disseminate clear clinical advice about pain management in people with opioid 
dependence for emergency departments and primary health care settings  
Through the participant interviews and case examples, we identified a problem related to denial 
of appropriate pain management. Denial of pain management may be due to suspicions about 
drug seeking behaviour and/or lack of clinical understanding of pain management issues for 
people with opioid dependence. It is essential that people who experience problematic AOD use 
have access to appropriate health care (including appropriate pain management) and that 
stigmatising stereotypes about people with a history of drug use do not guide interactions with 
clients. This is especially important for people currently engaged in opioid substitution treatment 
programs. Clear clinical guidance (in the form of best practice guidelines and awareness training) 
especially in relation to pain management amongst this population is required across all health 
care settings ranging from hospital emergency departments to local general practice and primary 
care.  
Recommendation 12:  Develop and disseminate clear clinical advice about access to medications for those with 
concurrent physical and mental health disorders and AOD use 
Relatedly, through the participant interviews and case examples we also identified a problem 
regarding access to medications for people with concurrent physical and mental health disorders 
and AOD use. In particular, accessing continual care and consistent prescribing of medications 
for psychiatric disorders and conditions such as ADHD was difficult for some participants. 
People with experience of problematic AOD use are stigmatised by medical professionals and in 
some cases denied medications for physical and mental health conditions with which they have 
been diagnosed. Clear clinical advice (in the form of best practice guidelines and awareness 
training) is required along with effective dissemination to clinicians treating patients with 
concurrent physical and mental health disorders and problematic AOD use. As noted in 
Recommendation 11, stigmatising stereotypes about people with a history of drug use should not 
guide interactions with clients nor prescribing decisions.  
Recommendation 13: Ensure consumer participation mechanisms are not just part of health care service provider’s 
accreditation, but are implemented 
Consumer participation mechanisms need not only to be present, but implemented comprehensively in 
all Queensland health services and AOD treatment settings. Often such mechanisms form part 
of a health care provider’s accreditation, but we suggest that there might be additional ways of 
ensuring comprehensive implementation, for example through reporting and data collection 
related to government funding of services. Consumer participation should be a reportable key 
performance indicator.  
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Moreover, organisations such as Health Consumers Queensland (http://www.hcq.org.au/) 
should be properly trained and equipped to manage issues relating to alcohol and other drug 
treatment, and understand the stigma experienced by people with experience of problematic 
AOD use across all health services. We suggest that a strategic partnership between Health 
Consumers Queensland and QuIHN would be beneficial.  
Recommendation 14: Review reporting and monitoring systems to ensure anti-stigma actions are part of 
organisational Key Performance Indicators 
One issue identified in the conduct of this project is that while many anti-stigma initiatives 
appear to be in place, there are often insufficient formal levers for their continuation or 
maintenance. To achieve multifaceted and multilevel stigma reduction, organisations and 
governments need to be held to account. One way of increasing the accountability, ensuring 
maintenance of anti-stigma initiatives and potentially incentivising them is to make sure that the 
initiatives form part of ongoing monitoring systems (such as key performance indicators).  
Reporting systems can be reviewed with an eye to ensure that reporting becomes one way that 
stigma and potentially stigmatising practices might be (1) documented and (2) reduced. What is 
counted in performance measures and compulsory reporting is what matters in practice; activities 
inevitably focus on these reportable requirements. For example reporting in relation to referral 
rates (e.g. to housing services, AOD treatment) might help foster the provision of holistic, 
person-centred care and reduce discrimination for people experiencing problematic AOD use 
and homelessness.  
Recommendation 15:  Develop and implement programs aimed at resilience to internalised stigma for people 
experiencing problematic AOD use and AOD treatment clients 
As noted in the literature review, there are a small number of interventions which are aimed at 
addressing internalised stigma (that is, when individuals take on and endorse public stigma within 
themselves) (Harper, et al., 2014; Luoma, et al., 2007; Rao, et al., 2012). 
The programs developed in relation to HIV (e.g. Fuster-Ruizdeapodaca, et al., 2016; Harper, et 
al., 2014; Rao, et al., 2012) can be adapted for people with experience of problematic AOD use, 
to help functioning and quality of life, enable coping mechanisms and increase self-esteem. This 
program should be adapted in collaboration with consumer representatives to ensure consumer 
input and program acceptability. This program could be adapted for people currently 
experiencing problematic AOD use, as well as those in AOD treatment. It could be delivered 
through peer-based organisations (such as QuIHN), through needle and syringe programs, as 
well as through all AOD treatment services. 
Recommendation 16: Consider introducing a supervised injecting facility  
A publically endorsed space to inject more safely, under supervised conditions, reduces stigma in 
a number of ways. Most fundamentally it denotes that society cares for these people, and in 
practical terms it provides a secure space, not under scrutiny from police nor the general public. 
There are a number of well-documented public health reasons to implement these services, as 
demonstrated in the existing efficacy and cost-effectiveness literature (as outlined in the Drug 
Policy Modelling Program’s annotated bibliography: 
https://dpmp.unsw.edu.au/resource/supervised-injecting-facilities). Since opening in 2001, the 
Sydney Medically Supervised Injecting Centre has supervised more than 1 million injections, and 
now managed more than 6000 overdoses without a single death.  
Introducing a supervised injecting facility is one way to provide a compassionate and practical 
health service that connects with people who inject drugs in a non-discriminatory way. These 
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services also provide an opportunity for brief interventions and provide links to treatment, 
support and other social support services. A number of our interview participants recognised the 
need for such a service, and mentioned this as a key stigma-reducing intervention: 
“make a little area for drug users to go to and feel safe, that they can use their drugs, like 
they’ve got in Sydney.” (Interview 12, Male 59 years) 
We recognise that the introduction of such a service requires considerable discussion, and 
notably must be implemented in an area with an existing high rate of public street-based 
injecting.  
Recommendation 17: Consider reform of the ‘notifiable conditions’ sections of public health law 
In the analysis of legislation we identified a range of provisions with stigmatising potential, one 
of which is the public health laws related to notifiable conditions. The key issue here is whether 
the name of the person who has acquired a notifiable condition such as hepatitis C must be 
provided and also whether the likely source or origin of that acquisition must also be declared (it 
would appear that this is required by the current Queensland Health Notifiable Conditions form: 
https://www.health.qld.gov.au/__data/assets/pdf_file/0023/444245/notif-conditions-rpt.pdf). 
If the likely source is noted as ‘injecting drug use’ for example, and the notification is identifiable 
(i.e. the person is named), the possibility of stigma and/or discrimination increases. The public 
health implications for making such notifications non-identifiable need to be carefully 
considered. Questions of how these data are used, stored, and shared is crucial. The key issue for 
people with experience of problematic AOD use is whether their history of alcohol or drug use 
is somehow made ‘known’ through this system. This is important for stigma and discrimination 
not only for people currently using alcohol or drugs, but also for those who may have ceased 
some years ago (and, for example may have undergone hepatitis C treatment and been cured) but 
still have ‘drug use status’ attached to their records within health systems.  
Recommendation 18: Amend legislation pertaining to HIV/hepatitis C 
There is a consensus building that the criminal law is not the most appropriate avenue for 
dealing with issues around blood borne virus transmission, and that alternatives to prosecution 
such as public health management are preferable. We note that in other jurisdictions this area of 
law is being reformed (NSW). In their report on the criminal transmission of HIV in New South 
Wales, the HIV/Aids Legal Centre and Phillips Fox (Mitchell, 2009, p.16) noted that: 
No studies to date have shown that applying the criminal law to HIV transmission has 
prevented HIV transmission. There is a serious risk that harsh punitive justice will 
reinforce the HIV/AIDS related stigma, spread misinformation about HIV/AIDS and 
create a disincentive to HIV testing, as people fear a threat of incurring criminal liability. 
Furthermore, application of criminal sanctions may in fact hinder access to counselling 
and support, by discouraging honest disclosure to medical staff and creating a false sense 
of security that the criminal law can protect a person from contracting HIV. 
Section 143 of the Public Health Act 2005 provides for an offence for recklessly putting someone 
at risk of contracting a controlled notifiable condition. Also, under the Criminal Code, s 317(b) 
states: “Any person who, with intent to do some grievous bodily harm or transmit a serious 
disease to any person; is guilty of a crime, and is liable to imprisonment for life”, and s 320 
states: “any person who unlawfully does grievous bodily harm to another is guilty of a crime, and 
is liable to imprisonment for 14 years”. We understand that these provisions are rarely used to 
prosecute individuals who transmit conditions such as HIV and hepatitis C to others (although 
see, for example, R v Reid [2006] QCA 202). Nevertheless, the use (and possible use) of these 
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provisions has the potential, as noted above, to reinforce stigma associated with HIV/AIDS and 
other blood borne viruses.  
How Queensland might reform these sections is worthy of consideration, given their 
stigmatising effects/potential. Such reform will reduce stigma for those who are either 
HIV/hepatitis C positive – regardless of the mode of acquisition – and for people with 
experience of problematic AOD use (due to the co-stigmas associated with this condition, as 
discussed in the literature review).  
6.3 Welfare and support services, including housing 
Recommendation 19: Apply the recommendations from health care to welfare and support services 
The recommendations relating to health care outlined above also apply to welfare and support 
services, including housing and legal aid. We reiterate the following Recommendations and 
suggest that the recommendations outlined in relation to health services be adapted in relation to 
welfare and support services as follows: 
Recommendation 4:   
Increase the availability of welfare and support services – 
Provision of welfare and support services shows care and concern for the welfare and wellbeing 
of people who experience problematic AOD use, and treats with respect and dignity the problem 
of AOD use and people who use AOD. The provision of services emphasises that problematic 
AOD use is a health and social issue, to be addressed as such. 
Recommendation 5:   
Improve welfare services marketing (public service announcements) – 
Improving welfare services marketing reduces stigma associated with seeking help through these 
services, and with AOD issues specifically. Marketing materials (whether generated by the 
Queensland government or by NGO services) should redress stigma by providing accurate 
information about access to services, and self-evidently not use images or language that may 
increase stigma associated with problematic AOD use. The involvement of consumer and family 
representatives in the development of such materials is essential.  
Recommendation 7:   
Invest in improvements in the physical facilities within welfare and support services – 
Actively improve the physical environment of welfare and support services can reduce the stigma 
associated with these spaces. The physical environment of services is often not prioritised due to 
tight funding environments, however investing in the physical space can decrease the sense of 
shame felt by clients, show respect and help reduce discriminatory attitudes from the wider 
community. 
Recommendation 8:  
Employ peer workers/liaison officers in welfare and support service settings – 
As has been noted in relation to AOD treatment and health care settings, it is important for 
people with experience of problematic AOD use to have easy access to mechanisms for support 
in welfare and support service settings, to help overcome structural stigma and discriminatory 
attitudes of individual workers, and gain access to the services they need. The employment of 
AOD peer workers and/or liaison officers in welfare and support services (similar to health care 
settings) is one such mechanism. 
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While ideally resources would be provided to employ peer workers or liaison officers in all 
welfare and support services settings in Queensland, as an initial step we suggest that an audit 
take place to establish sites of particular concern (for example inner-city services which regularly 
see a high volume of people with experience of problematic AOD use).  
Recommendation 9:  
Audit complaints mechanisms in welfare and support service settings – 
Complaints mechanisms are one way in which the ongoing issue of stigma and discrimination 
leading to poor treatment being received can be addressed, and so they play a vital role in 
empowering clients as well as ensuring continuous improvements to services.  
While these systems are more established in health care systems, we suggest a full audit of 
complaints mechanisms in welfare and support service settings, given the findings of this report, 
particularly given the accounts provided by interview participants.  
Recommendation 10:  
Implement consumer rights ‘training’ in relation to welfare and support services – 
Educating and empowering people through consumer rights ‘training’ is another mechanism by 
which discrimination in welfare and support services settings can be addressed. As with health 
care settings, this can be implemented by increasing funding for community groups, legal centres 
and human rights agencies to engage in outreach, community education and rights awareness for 
priority populations (Legal and Discrimination Working Party of MACBBVS, 2013).  
Recommendation 13:  
Ensure consumer participation mechanisms are a part of welfare and support services’ 
accreditation, and are implemented – 
We recommend that consumer participation mechanisms are not only present, but implemented 
comprehensively in all Queensland welfare and support services. Such mechanisms could form part 
of welfare and support services’ accreditation, but we suggest that there might be additional ways 
of ensuring comprehensive implementation, for example through reporting and data collection 
related to government funding of services. Consumer participation should be a reportable key 
performance indicator.  
Recommendation 14:  
Review reporting and monitoring systems – 
We recommend that reporting systems be reviewed with an eye to ensure that reporting becomes 
one way that stigma and potentially stigmatising practices might be (1) documented and (2) 
reduced. What is counted in performance measures and compulsory reporting is what matters in 
practice; activities inevitably focus on these reportable requirements.  
Recommendation 15:   
Develop and implement programs aimed at resilience to internalised stigma, delivered through 
welfare and support service settings – 
We recommend that programs developed in relation to HIV (e.g. Fuster-Ruizdeapodaca, et al., 
2016; Harper, et al., 2014; Rao, et al., 2012) be adapted for people with experience of 
problematic AOD use, to help functioning and quality of life, enable coping mechanisms and 
increase self-esteem. Such programs should be delivered in welfare and support service settings. 
This program should be adapted in collaboration with consumer representatives to ensure 
consumer input and program acceptability.  
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6.4 Police, public order and criminal law 
Recommendation 20: Encourage police to be aware of and where possible facilitate access to services 
Through the participants’ accounts, it is clear that many people who experience problematic 
AOD use come into regular contact with the police. Police are often the ‘front line workers’ in 
dealing with people who may require help, and as such this presents an opportunity to intervene 
in ways that will reduce harm and increase the likelihood that the person will change their 
behaviour. We also note in the interviews and the literature review that police encounters can be 
stigmatising and discriminatory. One potential way to reduce this perception is to provide police 
with resources to be able to offer access to services. 
While the role of police is to enforce the law, if they had resources to facilitate access to services, 
especially housing, welfare and AOD treatment services for those in need, a less stigmatising 
experience may result. As noted by participants, changing the quality of police encounters can 
reduce stigma. Partnerships will need to be put in place between local police and services in the 
area, and in some cases memoranda of understanding established. Such facilitation activities 
should also be formally recognised in reporting mechanisms (accounted for as part of the work 
of police, rather than seen as an “added extra”).  
Recommendation 21: Consider a pilot of tracking police encounters 
Participants reported experiences of police harassment, and this has also been raised in the 
international literature. Consideration of a pilot of tracking police encounters would increase 
accountability for police. One such trial has been conducted in Victoria, focussed on issues of 
equality in police encounters. The ‘Receipting Proof of Concept’ was developed to test receipting 
of police encounters, and collect data relating to individual police members, work locations and 
the contact person’s race and ethnicity (as the project was focussed on issues of discrimination 
related to racial profiling) (Victoria Police, n.d.). The system was not adopted following 
evaluation in Victoria, in part due to design issues, but approaches to increase police 
accountability have been documented and adopted in the UK 
(http://www.policeaccountability.org.au/research_resources/). Queensland should consider 
whether such a pilot would support police transparency and accountability in relation to 
encounters with marginalised people, so as to reduce perceptions of harassment, stigma and 
discrimination.  
Recommendation 22: Ensure Memoranda of Understanding are in operation between police and health care and 
harm reduction service providers 
It is essential that people experiencing problematic AOD use can access treatment services, harm 
reduction services (such as needle and syringe programs) and other health care services without 
fear of police attention or surveillance of these services. This was raised as an issue by interview 
participants, and highlighted in the literature review.  
Memoranda of understanding (MOUs) should be standard practice between all health care and 
harm reduction services, and local police. In some cases, such MOUs are in place as part of local 
community arrangements, but efforts should be made to standardise these practices across 
Queensland. Moreover, clients of services should be fully informed as to the kind of MOUs that 
are in place, to help reduce fear and encourage service access.  
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Recommendation 23: Reform areas of criminal law where the definition of the behaviour has the potential to be 
stigmatising or applied in discriminatory ways 
As highlighted in the legislation analysis, provisions in criminal law where the definition of the 
targeted behaviour is not clearly defined in the legislation provides the potential for that 
legislation to be stigmatising and applied in discriminatory ways. Reforms to ensure clear and 
adequate definitions within legislation protect both the target of the law and the police when 
exercising the law. 
In particular, we identified the following provisions: 
Section 18(3) of the Major Events Act makes it an offence for a person to enter a major event if 
that person “appears to be drunk or adversely affected by a drug”. Similarly, Section 26 of the 
Major Events Act allows for an authorised person to direct a person who “appears to be drunk or 
adversely affected by a drug” to leave the arena of a major event. Both of these are examples of 
provisions that inadequately define the behaviour and could result in stigmatisation and 
discriminatory practices in relation to people with AOD problems, as well as people on opioid 
pharmacotherapies or other medications which may impair speech or movement. The test for 
drunkenness/adverse effect should be reviewed and more clearly defined and/or that any 
guidelines pertaining to the exercise of discretion under these section be reviewed.  
Section 390E of the Police Powers and Responsibilities Act 2000 authorises police to detain and 
transport an intoxicated person to a sober safe centre if: 
1. (a)  a police officer reasonably suspects a person is intoxicated; and  
2. (b)  the person is behaving in a way the police officer reasonably suspects—  
(i) constitutes a nuisance offence; or  
(ii) poses a risk of physical harm to the person, or another person; and  
(c) the behaviour mentioned in paragraph (b) is in a public place located in a prescribed 
safe night precinct for a sober safe centre.  
The meaning of ‘intoxicated person’ is not defined. While we acknowledge that the rationale for 
this provision is sound (i.e. it is ostensibly designed to protect the intoxicated person), the Act 
does not define ‘intoxicated person’ and thus might be open to misinterpretation and 
misapplication (Quilter, et al., 2016b).  
Section 10 of the Summary Offences Act states that a person must not be intoxicated in a public 
place. For the purposes of this provision, “intoxicated means drunk or otherwise adversely 
affected by drugs or another intoxicating substance” (section 10(2) Summary Offences Act).  The 
test for intoxication should be reviewed and more clearly defined, and/or that any guidelines 
pertaining to the exercise of discretion under this section be subject to review (Quilter, et al., 
2016b). 
Section 328A of the Criminal Code makes it an offence to dangerously operate a vehicle whilst 
“adversely affected by an intoxicating substance”. Section 365(C) of the Criminal Code states that: 
(1) A person is taken to be adversely affected by an intoxicating substance if—  (a) the 
concentration of alcohol in the person's blood is at least 150mg of alcohol in 100mL of blood; or  
(b) the concentration of alcohol in the person's breath is at least 0.150g of alcohol in 210L of 
breath; or  (c) any amount of a drug prescribed by regulation is present in the person's saliva; or  
(d) the person fails to provide a specimen as required under the Transport Operations (Road Use 
Management) Act 1995, section 80 as applied under the Police Powers and Responsibilities Act 2000, 
chapter 18A. Although section 365(C)(1)(c) may legitimately capture people who are driving 
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while under the influence of (or intoxicated by) drugs, the provision, as it is presently drafted, 
also risks criminalising past use, where a person is not presently intoxicated or adversely effected 
but does retain traces of a drug in their saliva. Where such a provision criminalises past use it is 
akin to a minor drug possession charge (see Recommendation 24) and risks increasing stigma 
and discrimination. The test for being “adversely affected” should be reviewed and more clearly 
defined. 
(These issues of definition should also be taken into account when reviewing other areas of law, 
as we have highlighted throughout the legislation review, including laws related to public health.) 
Recommendation 24: Decriminalise the personal use/possession of drugs  
Much of the stigma and discrimination we documented through this project comes from the fact 
that the personal consumption of drugs is a criminal offence. The decriminalisation of personal 
use/possession offences (with threshold limits) provides the opportunity for a health response, 
rather than criminal justice response, and facilitates greater treatment seeking and opportunities 
for recovery. A past criminal record for drug use/possession reduces the chances of 
reintegration into society (by limiting opportunities for work and sometimes even the ability to 
care for or spend time with one’s children) and increases stigma. The stigma of a criminal record 
carries through life, even long after someone has sought treatment and stopped drug use. As 
participants noted in their interviews, reconnection to work and family is often a motivator in 
treatment, and such motivation is thwarted when the legacy of a criminal history remains. 
Participants noted that decriminalisation would make a difference to the stigma and 
discrimination experienced in their lives: 
“Decriminalisation. […] [It’s] the main stigma - because it’s against the law. It’s okay to 
be an alcoholic because you can buy it over the counter but you can’t be a drug addict 
because it’s against the law.  That’s my main argument for it. Straight out.  Not just that, 
our jails are full of drug users […] once they’re in that system they usually end up staying 
in that system.  They end up back in that system because that’s the only system they 
know, it’s the only place they can get a feed or a roof over their head or some support. 
Which is sad.”  (Interview 11, Male 44 years) 
As has been noted in research, there is strong public support in Australia for decriminalisation 
approaches. The research evidence indicates that decriminalisation of drug use: (1) Reduces the 
costs to society, especially the criminal justice system costs; (2) Reduces social costs to 
individuals, including improving employment prospects; (3) Does not increase drug use; (4) 
Does not increase other crime; (5) May, in some forms, increase the numbers of people who 
have contact with the criminal justice system (net widening). Many countries around the world 
have decriminalised drug use and possession in various ways (the full Drug Policy Modelling 
Program decriminalisation briefing note is available here: 
https://dpmp.unsw.edu.au/sites/default/files/dpmp/resources/Decriminalisation%20briefing
%20note%20Feb%202016%20FINAL.pdf). 
Recommendation 25: Amend laws regarding peer distribution of injecting equipment  
Amending section 10(3) of the Drugs Misuse Act 1986 to remove prohibitions related to 
distribution of injecting equipment would reduce stigma. Previous research (Lancaster, Seear, & 
Treloar, 2015) has demonstrated the stigmatising potential of the prohibition on peer 
distribution of injecting equipment in Australia; a point echoed in the legislative component of 
our analysis. In this research, the authors argued that the prohibition on peer distribution of 
injecting equipment increased the risk of stigma, and that: “it is important that this highly 
stigmatised and marginalised group be able to participate in practices that challenge dominant 
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conceptualisations of them and remake the stereotype of the irresponsible ‘addict’” (Lancaster, 
Seear, et al., 2015, p.1204). This law significantly curtails public health strategies in relation to 
blood borne virus prevention (including the operations of needle and syringe programs), and 
pre-dates the discovery of the hepatitis C virus and understandings of the links between sharing 
injecting equipment and transmission. Given that it is relatively common practice for peers to 
collect and distribute sterile injecting equipment within their community, and that these practices 
likely play an essential role in preventing the transmission of BBVs, there is a strong argument 
against criminalising the conduct of a person who gives a clean syringe to another (Lancaster, 
Seear, et al., 2015). Similar recommendations have been made over a number of years by a 
number of other organisations and bodies, including the Australian Injecting and Illicit Drug 
Users League (AIVL) (2010), the Australian National Council on Drugs (ANCD) (2013) and the 
Legal and Discrimination Working Party of the Ministerial Advisory Committee on Blood Borne 
Viruses and Sexually Transmissible Infections (MACBBVS) (2013). Following the 
recommendations of this research, the ACT, NT and Tasmania have reformed equivalent 
provisions, removing criminal offences associated with distribution of injecting equipment.  
6.5 Employment 
Recommendation 26: Review policies regarding criminal history checks at pre-employment  
As noted in Recommendation 24, a criminal history pertaining to drug use can be highly 
stigmatising and can cause major barriers to employment for people with a history of 
problematic AOD use. As the interviews demonstrated, this is not only limited to drug 
use/possess offences per se, but also criminal history related to acquisitive crime during periods 
of drug dependence. The barrier a criminal history poses to employment in some sectors is 
significant. This limits opportunities for employment and reconnection with the community even 
after people have been through AOD treatment.  
As well as our recommendation to decriminalise minor drug use/possession offences, we suggest 
that a review of the ways in which criminal history checks are used as pre-employment screening 
be conducted across industries. Self-stigma and lack of formal mechanisms of review often 
prevent individuals from accounting for such criminal pasts. We acknowledge that there are 
situations where particular criminal offences should preclude certain types of employment or 
employment that involves contact with vulnerable populations (e.g. working with children if the 
individual has been found guilty of child sex offences). However, where criminal checks 
encompass minor use or possession offences and/or low-level acquisitive crime, and such 
criminal history is not materially relevant to that employment, these policies should be revised.   
Recommendation 27: Encourage uptake of clear employer guidelines regarding AOD use in the workplace and 
how to best respond  
Workplace dismissals for AOD use can result in both stigmatising and highly negative outcomes 
for the person. As was shown in the interviews and case examples, it is far better to try and 
engage the employee in some form of assistance rather than simply dismissing them from the 
role. Mechanisms for seeking help (as noted below in Recommendation 28) should be easily 
accessible, and rather than dismissing employees, systems should be put in place to allow 
employees to seek help then return to work after a suitable period of time. The focus should be 
on how to reduce problematic alcohol and other drug use, wherever possible, using the least 
restrictive or punitive means available.  
We note that good guidelines are in place governing public service employees in the Queensland 
government, in relation to AOD use in the workplace. We suggest that systems be put in place to 
encourage uptake of these guidelines by private employers. In so far as is possible for 
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Queensland government to incentivise such mechanisms in private workplaces (for example, as a 
condition of accreditation or for organisations in receipt of government funding or contracts) 
this should be implemented. WorkCover Queensland may be a key partner and facilitator across 
industries.  
Recommendation 28: Improve access to Employee Assistance Programs 
Employee Assistance Programs (EAPs) play a vital role in ensuring that people gain access to 
appropriate AOD interventions, in a confidential, non-stigmatising situation. The case examples 
clearly show how such systems are to the benefit of both employees and employers. If employers 
support the person, and help them to make the treatment connection, there are better health 
outcomes. 
There should be clear, accessible and well-documented systems in place to facilitate access to 
EAPs for people who may be experiencing AOD problems. Early intervention is important, and 
EAPs should be low-threshold services to minimise stigma. Confidentiality is essential to ensure 
that employees do not fear discrimination in the workplace, as a result of seeking help.  
Such programs should include strategies for facilitating returning to work after a period of 
treatment or rehabilitation, and should encompass AOD along with mental health or other 
disabilities. All EAP systems should include in-built opportunities for referral and interventions, 
where required (not simply be limited to phone counselling etc). The Queensland Government 
can play a role in developing best-practice guidelines to help employers put systems in place. 
WorkCover Queensland may be a key partner and facilitator across industries.  
Recommendation 29: Develop and support pathways into employment for people completing AOD treatment  
Employment is a very important signal to an individual that they are worthwhile, respected and 
able to contribute. However stigma prevents people from gaining employment post-AOD 
treatment.   
As one participant noted: 
“I think there needs to be opportunities to help people grow […] especially with work. 
Give people the opportunity to prove themselves. I can't speak for each individual, but if 
I could go and get an apprenticeship tomorrow, […] if there was a system there for 
recovering addicts to stay clean, a program or whatever, to go and do a traineeship, that'd 
be great. Everyone knows where I'm at, everyone knows where I'm heading forward. It 
doesn't become a surprise to anybody and no one has to make any judgment.” (Interview 
4, Male 27 years) 
There is a need for specific programs that provide incentives for employers to help people get 
into employment quickly upon leaving treatment. Such programs are in place in relation to 
disability for example, and such models could be extended to AOD treatment. At present, based 
on the interviews conducted, relationships between employers and treatment services are ad hoc 
and largely driven by particular treatment services. A more systemic and comprehensive 
approach is required. 
Recommendation 30: Encourage and support flexible work hours policies  
There is a need for flexibility within the workplace to access ongoing support as required (or, as 
noted in the interviews, attend appointments or to pick up pharmacotherapy medication). 
Research undertaken by our team (KS) that has not yet been published suggests that flexibility is 
a common practice in other countries, such as Canada. In Canada, many employers attempt to 
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accommodate the needs of people who are experiencing problematic alcohol and other drug use, 
and this may include offering flexible work hours (such as later start and finish times) for those 
who need it.  
As an employer, the Queensland Government could introduce a state-wide policy allowing for 
flexibility for issues related to AOD problems and treatment-seeking and encourage other non-
government workplaces to make similar opportunities available. Incentives could be provided to 
non-government and private employers. At a more basic level, a resource or best practice guide 
could be developed for advising employers on how to manage these issues where employees 
request it, to help reduce stigma and discrimination in the workplace.  
6.6 Society at large 
Recommendation 31: Exercise extreme caution in mass media campaigns for drug use prevention  
The images used in mass marketing campaigns that aim to prevent drug use are often 
stigmatising and perpetuate stereotypical images of people who use drugs. Such images do not 
help people to access treatment and, as participants have noted, often end up alienating 
individuals from their friends and family out of fear. Research evidence shows that some mass 
media drug prevention campaigns can further compound and contribute to experiences of 
stigma and marginalisation. 
In addition, there is not a clear evidence base that mass media campaigns for drug prevention 
actually work as intended. A large body of international research shows that mass media 
campaigns have no effect on drug use behaviour, and moreover, negative effects have been 
shown in some studies. Hence they are by no means cost effective. A systematic review of the 
effectiveness of mass media campaigns (in this review termed ‘anti-illicit drug public service 
announcements’) by Werb et al. (2011) identified and examined seven randomised trials and four 
observational studies from Australia and internationally. Their analyses of these evaluations 
concluded that there was limited evidence to support the use of mass media campaigns for illicit 
drug prevention. Specifically:  
• No trial demonstrated any significant benefits;  
• No studies reported any long term effectiveness of mass media campaigns;  
• Overall mass media campaigns had a limited impact on the intention to use illicit drugs 
or on illicit drug use amongst the target population. In one example of the more 
common negative findings, evaluation of the ‘Montana Meth Project’ found that the 
graphic advertising campaign to deter methamphetamine use amongst young people was 
ineffective (compared to an unexposed control comparison (Anderson, 2010);  
• Importantly, two randomised controlled trials in the systematic review found evidence 
that public service announcements actually increased intention to use drugs. Werb et al. 
(2011) argued that this is because mass media campaigns increase the perception that 
drug use is widespread, which may lead to a greater likelihood of initiation of drug use.  
Given that mass media campaigns have been demonstrated to be ineffective for drug use 
prevention and may carry the risk of negative effects (such as increased stigma and 
discrimination, increased initiation to drug use, and changing perceptions about the social norms 
of using a particular drug) we suggest that the Queensland Government approach the use of 
drug prevention mass media campaigns with extreme caution.  
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Recommendation 32: Explore running a mass media campaign to reduce stigma 
While there seems an obvious opportunity to develop and run a different kind of mass media 
campaign – that is, an anti-stigma campaign around drug use - in Queensland, the research 
evidence remains somewhat equivocal. As noted in the literature review, a systematic review has 
shown mixed findings as to the effectiveness of anti-stigma campaigns (Clement, et al., 2013). 
The authors found that anti-stigma mass media campaigns may reduce prejudice, but there was 
insufficient evidence to determine if the campaigns reduced discrimination. Nor were any of the 
interventions assessed for cost-effectiveness.  
We suggest that the Queensland Government explore the option of an anti-stigma mass media 
campaign, but proceed with caution to ensure that the campaign is evidence-based and 
developed in consultation with drug user organisations. AIVL has done market research work 
exploring viable mass media campaign options, and this work should be taken into account: e.g. 
http://www.aivl.org.au/stories/afternoons-with-max-marshall/. A Melbourne based project, 
Lives of Substance, may also be informative and provide partnership in content development: 
http://www.livesofsubstance.org/. 
Recommendation 33: Improve Queensland media reporting of AOD issues 
As has been noted in the literature review and through participants’ accounts, the ‘junkie 
stereotype’ perpetuated in some media reporting can be highly stigmatising. A range of 
recommendations in relation to media reporting of illicit drugs has been developed in previous 
research (see for example, page 110: 
https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/19%20Media%20reporting
%20on%20illicit%20drugs%20in%20Australia.pdf)(see also: Lloyd, 2010). A new website 
(launched in February 2017) also provides guidance to journalists, and highlights case examples 
of problematic media reporting (http://aodmediawatch.com.au/).  
Improving Queensland media reporting on AOD issues is an important component to an 
effective, systemic response to stigma and discrimination. Guidelines ensuring that AOD use is 
not presented in a stigmatising or discriminatory light could be developed and implemented in 
relation to all Queensland media outlets. Review of journalistic and broadcast Codes of Practice 
to ensure that any clauses relating to discrimination within these codes relate to problematic 
AOD use as well is also recommended. A monitoring and support role (noting where breaches 
may occur, supporting journalists with access to reference material, as noted above) is also 
recommended.  
Recommendation 34: Implement guidelines for government department communication about AOD issues 
Related to Recommendation 33, the development of clear guidelines for all government 
department communications (press releases, online media, resources, reports etc) should ensure 
that no language or portrayals of people who use alcohol and other drugs which could be 
stigmatising occur. These could be developed from the resources listed above. As noted in the 
literature review, one aspect to be addressed would be ensuring the use of person-centred 
language in government department communication about AOD issues (Office of National 
Drug Control Policy, 2017). 
6.7 Consideration of priorities 
In light of more than 30 recommendations, and the fact that some are relatively straightforward 
to implement and others would require substantial thought and resources, we have undertaken to 
provide some sense of prioritisation, based on the research we have conducted and our own 
understanding of some of the critical issues in moving towards implementation. 
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Some of the recommendations focus on making change at the individual or interpersonal level 
(for example interventions aimed at health practitioners or workers in services) and some focus 
on structural arrangements (such as organisational policies). For success, interventions aimed at 
ameliorating individuals’ discriminatory attitudes and behaviour need to be implemented alongside 
structural and systemic reforms aimed at addressing stigma and discrimination. For example, 
conducting anti-stigma awareness training for health practitioners (i.e. implementing 
Recommendation 2 in health care settings) should be done in conjunction with the kind of 
structural and organisational change contained in Recommendation 14 (i.e. reviewing reporting 
and monitoring systems to ensure anti-stigma actions are part of organisational Key Performance 
Indicators). Making sure both individual level reforms are implemented together with structural 
reforms is important to maximise impact. 
We use two categories in considering prioritisation: 
1. Resources: whether the recommendation requires a relatively small amount of resource versus 
whether the recommendation has significant resource implications. This did not take into 
account the cost savings associated with some of the measures. For example while creating new 
treatment places is costly, the health, economic and social benefits outweigh the costs: as per the 
famous quote from the Californian study “for every dollar spent on treatment, society saves 
$7.00” (Ettner, et al., 2006). 
2. Time frames: whether the recommendation could be implemented relatively quickly (using in 
the next 12 months or so as the metric here) or whether the recommendation reflects a long-
term effort requiring substantial engagement with multiple parties. 
Based on this two-way categorisation, and a ‘first pass’ assessment by us, without detailed costing 
or implementation analysis, the 34 recommendations fall as such: 
Table 6: Consideration of priorities 
 Low resource requirements High resource requirements 
Relatively fast 
timeframe for 
implementation 
Recommendation 03: Ensure 
consumer participation in policy and 
actions designed to reduce stigma 
and discrimination 
Recommendation 05: Improve the 
marketing of AOD treatment 
Recommendation 06: Better support 
family members of those in AOD 
treatment, through education and 
information resources 
Recommendation 09: Audit 
complaints mechanisms in health 
care settings 
Recommendation 13: Ensure 
consumer participation mechanisms 
Recommendation 02: Conduct anti-
stigma awareness training across all 
relevant workforces 
Recommendation 32: Explore 
running a mass media campaign to 
reduce stigma 
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 Low resource requirements High resource requirements 
are not just part of health care 
service provider’s accreditation, but 
are implemented 
Recommendation 18: Amend 
legislation pertaining to 
HIV/hepatitis C 
Recommendation 22: Ensure 
Memoranda of Understanding are in 
operation between police and health 
care and harm reduction service 
providers 
Recommendation 25: Amend laws 
regarding peer distribution of 
injecting equipment 
Recommendation 31: Exercise 
extreme caution in mass media 
campaigns for drug use prevention 
Recommendation 34: Implement 
guidelines for government 
department communication about 
AOD issues 
Relatively long 
timeframe for 
implementation  
Recommendation 01: Implement a 
Queensland Human Rights Charter 
Recommendation 13: Review 
reporting and monitoring systems to 
ensure anti-stigma actions are part of 
KPIs 
Recommendation 17: Consider 
reform of the ‘notifiable conditions’ 
sections of public health law 
Recommendation 20: Encourage 
police to be aware of and where 
possible facilitate access to services 
Recommendation 21: Consider a 
pilot of tracking police encounters 
Recommendation 23: Reform areas 
Recommendation 04: Increase the 
access and availability of AOD 
treatment 
Recommendation 07: Invest in 
improvements in the physical 
facilities within AOD treatment 
services  
Recommendation 08: Employ peer 
workers/liaison officers in health 
care settings 
Recommendation 10: Conduct 
consumer rights ‘training 
Recommendation 11: Develop and 
disseminate clear clinical advice 
about pain management in people 
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 Low resource requirements High resource requirements 
of criminal law where the definition 
of the behaviour has the potential to 
be stigmatising or applied in 
discriminatory ways 
Recommendation 24: Decriminalise 
the personal use/possession of drugs 
Recommendation 26: Review policies 
regarding criminal history checks at 
pre-employment  
Recommendation 27: Encourage 
uptake of clear employer guidelines 
regarding AOD use in the workplace 
and how to best respond 
Recommendation 33: Improve 
Queensland media reporting of 
AOD issues   
with opioid dependence for 
emergency departments and primary 
health care settings 
Recommendation 12: Develop and 
disseminate clear clinical advice 
about access to medications for 
those with concurrent physical and 
mental health disorders and AOD 
use 
Recommendation 15: Develop and 
implement programs aimed at 
resilience to internalised stigma for 
people experiencing problematic 
AOD use and AOD treatment 
clients 
Recommendation 16: Consider 
introducing a supervised injecting 
facility 
Recommendation 19: Apply the 
recommendations from health care 
to welfare and support services 
Recommendation 28: Improve 
access to Employee Assistance 
Programs 
Recommendation 29: Develop and 
support pathways into employment 
for people completing AOD 
treatment  
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APPENDIX A – LAW CODING SYSTEM 
1. How are people who use, possess, consume (etc.) AOD described as a target of the law?  
2. Is there a definition of the person, activity or targeted AOD behaviour?  
3. Who is the decision-maker or authority? 
4. What is the decision-maker/authority able to do?  
5. In what ways does the law offer protections to the targeted person?  
6. In what ways does the law offer protections to others? 
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APPENDIX B – SEMI-STRUCTURED INTERVIEW GUIDE 
1. Tell me a bit about yourself? 
2. Tell me about your experiences of alcohol and other drug use? 
- Different drugs / routes of administration – contexts / turning points 
3. Have you ever sought help with your alcohol and other drug use? 
- Can you tell me about that experience?  
- What was positive about that experience? 
- What was negative about that experience? 
4. Do you think you have ever been treated differently as a result of your alcohol or other 
drug use?  
- In what ways? 
- Can you describe a specific time when you think you were treated differently? 
- Why do you think you were treated like that? 
5. Do you think you have ever experienced stigma or discrimination as a result of your 
alcohol or other drug use? 
- Can you tell me about a specific time when you think that occurred? What happened? 
- What were the consequences of that? 
- How did that make you feel? How significant was that experience for you? 
6. When you think about the times you think you’ve been treated differently, or 
experienced stigma or discrimination, where have those interactions taken place? 
- Who have you been speaking to? 
- What are the settings where this has occurred? Prompt with: treatment services, 
health settings, interactions with police or law enforcement, or the legal system, 
housing etc.  
7. Have you had different or really positive experiences where you have not experienced 
stigma and discrimination? 
- Can you tell me about a specific time when that occurred? What happened? 
- What was different about those times?  
8. How have these different experiences impacted on your alcohol and other drug use, or 
your treatment journey, or your life experiences more generally? 
9. Participant’s additional thoughts  
- Based on your experiences, what would you like to see changed? 
- Anything you would like to add or reflect on before finishing?  
- Anything that you think would be helpful for us to think about? 
 
 
